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tIckInG on Pandora’s Box 
Partially based on 
‘Emerging tick-borne pathogens: Ticking on Pandora’s Box’, 
S. Jahfari and H. Sprong 
‘Ecology and the prevention of Lyme borreliosis’, 
4th volume of Ecology and Control of Vector Borne diseases, 
published by Wageningen Academic Publishers (2016)
The vermin only teaze and pinch 
Their foes superior by an inch. 
So, naturalists observe, a flea 
Has smaller fleas that on him prey; 
And these have smaller still to bite ‘em, 
And so proceed ad infinitum.
Jonathan Swift from “On Poetry: a Rhapsody” (1733)




Since the discovery of Borrelia burgdorferi as the causative agent of Lyme borreliosis in 
1982, tick-borne pathogens have been the focus of extensive attention in scientific research, 
in the fields of veterinary and human medicine. The list of new or re-emerging tick-borne 
pathogens transmitted by the Ixodes species is growing and constantly evolving [1]. These 
developments may be attributed to various factors: i) novel approaches in the field of 
molecular biology have led to discovery of new tick-borne pathogens, ii) new evidence for 
human disease by microbes previously not considered as such, or thought to be restricted 
to animals [2], and iii) the geographical spread of tick vectors, hosts and their pathogens 
into new areas in Europe [3]. Furthermore, there are other factors that have resulted in an 
increase in the number of humans who are bitten by ticks in Europe, namely: iv) changes 
in land use that enabled the resurgence of large hosts, contributing to a sharp increase in 
tick densities [4, 5]; v) habitat encroachment and alterations due to recreational activities 
and tourism in areas with high tick densities [6]; and vi) demographic changes such as an 
aging population and a higher number of chronically ill people [7, 8]. The increase in the 
number of reported tick bites demonstrates that the risk of acquiring a tick-borne infection 
is growing [9]. Hence, these tick-borne diseases constitute a novel public health burden of 
unknown proportions.
Lyme borreliosis is the most prevalent vector-borne disease in North America and Europe 
[10, 11]. Furthermore, in the past decades, human exposure to tick bites has risen in most 
European countries. Therefore, there have been marked increases in the incidence of Lyme 
borreliosis and tick-borne encephalitis over the past ten to twenty years [12-14]. Lyme 
borreliosis can present with a wide range of clinical manifestations. The most common and 
earliest manifestation is an expanding rash at the site of the tick bite (erythema migrans), 
which -when left untreated- can progress towards disseminated disease. Occasionally, the 
infection disseminates and affects a patient’s nervous system, joints, skin, and in rare cases 
the heart or eyes [10]. The causative agents of Lyme borreliosis are spirochetes belonging 
to the Borrelia burgdorferi sensu lato (s. l.) complex. They are generally transmitted by 
ticks of the Ixodes ricinus complex [15] and are maintained in enzootic cycles by different 
vertebrate hosts [16-18]. At least five genospecies of B. burgdorferi s. l. complex have been 
shown to be pathogenic to humans, namely Borrelia burgdorferi sensu stricto (s. s.), Borrelia 
afzelii, Borrelia garinii, Borrelia spielmanii and Borrelia  bavariensis [10, 19]. Other Borrelia 
genospecies, such as Borrelia lusitaniae, have occasionally been found to cause disease 
as well [20-23]. In the Netherlands, a retrospective study among general practitioners has 
shown a continuing increase in consultations for tick bites and erythema migrans between 
1994 and 2014 [9, 24, 25]. The increasing number of tick bites, adding up to 1.1 million tick 
bites in 2009 [9], poses a growing risk of disseminated Lyme borreliosis and of other tick-
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borne diseases. Despite the high exposure through tick bites, tick-borne diseases other than 
Lyme borreliosis are rarely diagnosed.
Besides the Borrelia burgdorferi s. l. genospecies which, the generalist tick species Ixodes 
ricinus can transmit other established tick-borne pathogens, namely Borrelia miyamotoi, 
Anaplasma phagocytophilum, Candidatus Neoehrlichia mikurensis, Rickettsia helvetica, 
Rickettsia monacensis, several Babesia species, Louping ill virus, and tick-borne encephalitis 
virus. Besides these established pathogens, there are other bacteria, such as Coxiella and 
Francisella, and possibly Bartonella that can be transmitted by I. ricinus. Ticks may play a 
role in the enzootic cycles of these pathogens; however, other transmission routes have 
a more prevalent role in the transmission to humans [26-28]. Furthermore, there are new 
potential pathogens currently emerging [29, 30]. The human infection incidence of these 
microbes caused by a tick bite is still a matter of debate; none of these debatable pathogens 
will be covered in this thesis. This thesis focuses on tick-borne pathogens transmitted by 
I. ricinus that pose an emerging public health concern in Europe, with an emphasis on the 
Netherlands. 
2. THE VECTOR
Ticks are classified into two superfamilies: the Ixodidae (hard ticks) and the Argasidae (soft 
ticks). In Europe, Ixodes ricinus species complex is by far the most important and widespread 
tick while I. persulcatus is found in Russia and Asia and I. pacificus and I. scapularis are 
found in western North America  and eastern North America, respectively [10, 31] (Figure 
1). Typically, I. ricinus have a three-host life cycle that usually takes two to four years to 
complete where each stage (except for the egg) of the tick feeds only once, such that it can 
enter the next stage of its lifecycle [32] (Figure 2). In contrast to many other tick species I. 
ricinus is known to have a very large host range, it feeds on over 300 vertebrate species [31]. 
The larvae, nymphs and adults tend to feed on animals of different sizes, but all life stages 
can be found feeding on humans. The larvae are mostly found on smaller animals, mostly 
rodents. Nymphs feed mostly on rodents and birds [18], whereas the adult typically feed on 
larger animals, such as red and roe deer and wild boar but also livestock, cattle and domestic 
animals [33]. Mating takes place in the vegetation and on the host during blood feeding. 
The fertilized female lays between 1,000-5,000 eggs in the shrub layer and subsequently 
dies [31]. 
After attachment to its host, the tick pierces the host’s skin and inserts a hypostome [34]. 
Various substances are produced and injected in the host by the tick salivary gland including; 
a cement to anchor the mouthparts to the skin, enzymes, vasodilators, anti-inflammatory, 
immunosuppressive and anti-hemostatic substances but also pathogens [34]. When it is not 
seeking a host, I. ricinus can be found at the base of vegetation, where the relative humidity 
is higher [33].
Figure 1: Global distribution of the vectors Ixodes ricinus species complex, map from European Union 
Concerted Action on Lyme Borreliosis [10] (figure used with approval of EUCALB). 
Transmission dynamics of tick-borne pathogens in ticks and vertebrate hosts
An understanding of the relative risks of (re-)emergence of a tick-borne pathogen requires 
insight into the transmission dynamics of that pathogen in ticks and vertebrate hosts. As 
humans are considered accidental hosts of all tick-borne pathogens, these pathogens 
require one or more vertebrate host species for maintenance in enzootic cycles in nature 
[35]. A greater understanding of the biology of the vector, the host and the vector-borne 
pathogens therefore provides the best basis for risk assessment in the field of public health 
and public health policy-making. An interdisciplinary approach offers benefits because it 
addresses questions regarding tick-borne pathogens in the context of public health.
Since I. ricinus is a three-host tick, the feeding behavior of I. ricinus in each life stage has an 
impact on the risk of tick-borne infection for humans (Figure 2). The transmission dynamics 
are multi-faceted and different for each pathogen. Overall, several conditions must be met 
for transmission cycles to be sustained. Firstly, a vertebrate host must be present that is 
susceptible to infection with the pathogen. In addition, the host must experience a sufficient 
level of infection in the blood or skin tissue to enable the pathogen to be transmitted to 
other ticks during blood feeding. Thirdly, it must be possible to maintain a pathogen in the 
tick for extended periods, including molting into the next life stage. After molting, the tick 
must be able to transmit the infection to another vertebrate host. Finally, sufficient numbers 
of susceptible vertebrate hosts must be present in an area to maintain both the ticks and the 
pathogens in enzootic cycles.
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Figure 2: Life cycle of Ixodes ricinus. A blood meal is required to develop from one stage into the 
next, and for the adult female to mate and lay eggs. The arrows depict transovarial and transstadial 
transmission routes of pathogens and transmission by co-feeding. Humans are incidental hosts for the 
ticks.
Transmission cycles of pathogens among ticks and vertebrate hosts can only be preserved 
when ticks transfer pathogens between susceptible hosts (horizontal transmission), and will 
not be sustained when transmission is directed toward dead-end hosts. These dead-end 
hosts are incapable of experiencing high levels of the pathogen in blood or tissue (tangential 
transmission), or are occasionally bitten by ticks, such as humans. Depending on the micro-
organism, the reservoir or amplification host responds differently to infection with a tick-
borne pathogen. This has a direct impact on transmission dynamics. For example, Babesia 
species are parasites of red blood cells and are often associated with relatively mild - or 
asymptomatic-, but  chronic infections of the reservoir host (e.g. cattle). These long-term 
infected animals therefore offer many opportunities for feeding ticks to become infected. 
On the other hand, most viral and bacterial infections are either potentially fatal or can 
induce an immune response in the vertebrate host. This limits the period during which 
the pathogen circulates in high numbers. In these situations, where the time window for 
other feeding ticks to become infected is limited, the tick itself becomes the crucial link 
in maintaining the enzootic cycle in nature. When the perpetual route of survival of the 
pathogen is the tick, ticks can serve as the reservoir for the pathogens, mostly due to the 
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ticks have a longer lifespan than some of their host (e.g. small mammals like rodents). In 
that case, the vertebrate host acts as a so-called amplifier of the pathogen. Pathogens 
can be transmitted between the different life stages of ticks in different ways: i) through 
transstadial transmission, i.e. by transmission between different stages of tick development, 
from larva to nymph or from nymph to adult; ii) through transovarial transmission, i.e. by 
transmission of the pathogen between generations, or more precisely, from an adult female 
to her eggs; or iii) by means of a mechanism called co-feeding, where the micro-organism 
is transmitted from one tick to another during feeding in close proximity on the same host.
3. TICK-BORNE PATHOGENS ENDEMIC TO THE NETHERLANDS
Anaplasma phagocytophilum
Anaplasma phagocytophilum is a gram-negative obligate intracellular pathogen of the 
family Anaplasmatacae in the order Rickettsiales. It causes disease in humans and animals 
by infecting neutrophils, granulocytes and monocytes [36]. In 2001, the taxonomical 
description of the family Anaplasmatacae underwent extensive reorganization, supported 
by detailed phylogenetic analyses. Bacteria that had been known under various designations 
were all renamed A. phagocytophilum, including the organisms formerly known as Ehrlichia 
phagocytophila, E. equi and Cytoecetes phagocytophila [37]. Anaplasma phagocytophilum 
have been detected in questing nymphal and adult I. ricinus ticks in studies across Europe, with 
infection rates ranging from 0.4% to 34% [36] and with lower prevalence rates in nymphs in 
comparison to adult ticks. In the Netherlands, infection rates in questing nymphs and adults 
vary between 0% and 11% in questing I. ricinus ticks [38, 39]. Transovarial transmission of A. 
phagocytophilum has not been proven experimentally to occur in Ixodes species. However, 
there are some indications that transovarial transmission does occur in low frequencies. 
Since, low rates of A. phagocytophilum in questing larvae have been reported [39], and A. 
phagocytophilum has even been detected in larvae of a breeding colony after two to four 
generations of molting [40]. In the field, however, the bacteria are thought to be primarily 
maintained through enzootic cycles between vector and vertebrate hosts.
Various reservoir hosts are implicated to play a role in the maintenance of the endemic life 
cycle of A. phagocytophilum in nature. The animals identified as reservoir hosts range from 
domestic and wild ungulates, to small mammals like rodents and insectivores, to birds and 
lizards [1, 36].
In domestic ruminants and horses, clinical manifestations of anaplasmosis have been 
described since the 1950s [41] and 1960s [42], respectively. However, the first cases of 
Human Granulocytic Anaplasmosis (HGA) were not reported until 1994 in the US [43]. Cases 
of human infection were later reported worldwide [44]. Symptoms are generally mild, virus-
like and aspecific.
In the Netherlands, the first and strangely enough the only reported human case dates 
from 1999 [45], despite the widespread presence of A. phagocytophilum in questing I. 
ricinus ticks. Furthermore, seropositivity against A. phagocytophilum has been observed 
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in the Netherlands in risk groups such as forestry workers (1.3%), and in febrile patients 
(3.7%), and potential Lyme borreliosis patients (4%), but not in healthy controls [46]. Since 
several A. phagocytophilum strains are reported in nature, some could be more virulent to 
humans than others. This may well explain the discrepancy in infection rates reported in 
questing ticks and the exposure levels measured using serological methods in comparison to 
reported symptomatic human cases. Antibodies to A. phagocytophilum antigens appear to 
have extensive serological cross-reactivity [47]. Serological tests are generally group-specific 
and cannot be used to distinguish antibodies resulting from exposure to, or infection with 
individual strains. Human granulocytic anaplasmosis (HGA) is currently thought to be the 
third most common tick-transmitted disease in Europe [48], and therefore poses a growing 
public health concern. Since HGA is not a nationally reportable disease in most European 
countries, an accurate estimate of HGA incidence remains a challenge.
Figure 3: Life cycle of Ixodes ricinus and the most relevant reservoir host of Anaplasma phagocytophilum 
for each life stage of the tick. 
Candidatus Neoehrlichia mikurensis
Candidatus Neoehrlichia mikurensis is a relatively novel clade in the family of 
Anaplasmataceae and was first described in wild rats and found in Ixodes ovatus ticks in Japan 
[49]. This bacterium has retained its ‘Candidatus’ status, since it has not been cultivated in 
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variously designated species of ticks and rodents from Europe and Asia [51-57]. The Asian 
strains showed a 99% similarity, based on the 16S rRNA component, to the ‘Schotti variant’ 
found in I. ricinus that was first described in the Netherlands [51]. Since then, Candidatus 
Neoehrlichia mikurensis has been found in I. ricinus all over mainland Europe, with infection 
rates varying from 0.1% to 22% [58, 59].
In the Netherlands, infection rates of Candidatus Neoehrlichia mikurensis in questing I. ricinus 
nymphs range from 6% to 8%, rising to 11% for questing adult I. ricinus [60]. Transovarial 
transmission in ticks is thought not to occur [61]. So far, Candidatus Neoehrlichia mikurensis 
is thought to depend entirely on vertebrate hosts to maintain its endemic life cycle in nature. 
However, one study found Candidatus Neoehrlichia mikurensis in questing larvae [62].
Rodents are the assumed reservoir hosts of this bacterium. Experimentally, infected 
wild rodents have proven to be competent hosts that transmit Candidatus Neoehrlichia 
mikurensis to laboratory ticks [61]. In Europe, six rodent species (Apodemus agrarius, A. 
flavicollis, A. sylvaticus, Myodes glareolus, Microtus agrestis and Mi. arvalis) have been 
shown to be infected with Candidatus Neoehrlichia mikurensis [58]. Prevalence rates in 
rodents and ticks follow a seasonal pattern [38, 63, 64]. Furthermore, infection rates may 
vary considerably between rodent species.
In studies where ticks from humans were tested for Candidatus Neoehrlichia mikurensis in 
Italy, Germany and the Netherlands, infection rates varied from 4% to 10% [52, 65-67]. These 
figures indicate that human exposure to Candidatus Neoehrlichia mikurensis is significant 
and real. The relatively low number of human neoehrlichiosis cases reported is possibly due 
to the virtual absence of routine diagnostic tools, and a lack of awareness. Since, Candidatus 
Neoehrlichia mikurensis has not yet been cultivated in the laboratory, serological assays 
such as whole-cell IFA or specific ELISA tests are not yet available.
In 2010, the first case of human neoehrlichiosis was reported in a patient from Sweden 
[68]. In the same year, five other human infections were described in Germany, 
Switzerland and the Czech Republic [69-71], and curiously a report of neoehrlichiosis in an 
immunocompromised dog [72]. The symptoms described in all the human cases (febrile 
illnesses with fever, headache, myalgia and malaise fever) were generally non-specific and 
are usually seen in any other ordinary inflammatory reaction and many other infectious 
diseases. These reports of human infection suggested that re-evaluation was needed 
regarding the human disease risk with this pathogen. Most of the reported neoehrlichiosis 
cases occurred in immunocompromised patients who often showed severe clinical 
manifestations and prolonged disease [58, 59, 73]. Other neoehrlichiosis cases have been 
reported more recently in immunocompetent patients who had relatively mild symptoms 
or were even asymptomatic in Poland, China, Sweden and the Netherlands [74-78]. Two 
of these studies also showed that the DNA of Candidatus Neoehrlichia mikurensis can be 
detected for several months in the blood of these patients, who nevertheless did not display 
major clinical manifestations or complications [74, 76]. These findings indicate that the true 
infection rates have been underestimated. 
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Figure 4: Life cycle of Ixodes ricinus and the most relevant reservoir host of Candidatus Neoehrlichia 
mikurensis for each life stage of the tick.
Borrelia miyamotoi
Borrelia miyamotoi belongs to the relapsing fever group of the Borrelia genus and was 
discovered in Japan in 1995 [79, 80]. This relapsing fever bacterium is more distantly related 
to the group of spirochetes that are the causative agents of Lyme borreliosis [81, 82]. It is 
the only member of the relapsing fever family that is transmitted by the hard tick Ixodes 
species. In Europe, B. miyamotoi infection rates vary between 0.5% and 4% in I. ricinus tick 
vectors [83]. In the Netherlands, these figures are the same for questing I. ricinus ticks, and 
the bacterium is found in all three life stages [84, 85]. Borrelia miyamotoi is thought to be 
transmitted transovarially and transstadially by ticks, and coexists with B. burgdorferi s. l. 
[81, 82, 86]. Experimentally, transovarial transmission has only been shown in I. scapularis 
[81], but since B. miyamotoi is widely found in questing I. ricinus larvae, it is likely that 
transovarial transmission does occurs [87], although probably inefficiently with an infection 
rate of 0,5% of questing larvae [83]. Nonetheless, since the total abundance of larvae is 
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Interestingly, B. miyamotoi results in a short-term systemic infection in rodents, therefore 
making rodents excellent but transitory amplifying hosts of this bacterium [61]. Borrelia 
miyamotoi was detected in blood or tissue of various rodent species, namely Myodes 
glareolus, M. arvalis, Apodemus flavicollis and A. sylvaticus [61, 88, 89]. Whether vertebrates 
other than rodents may also become infected is not clear.
It took more than 15 years after the first discovery of Borrelia miyamotoi before the first 
human cases were recognized [90]. Mainly due to the non-specific nature of the illness 
[91], cases may have been confused with viral infections or other tick-borne diseases such 
as anaplasmosis [91]. Relapsing fever Borrelia infections are characterized by febrile-like 
illness and one or more relapse episodes of bacteremia and fever. In 2011 a series of cases 
was reported in Russia [90]. After this report, the pathogenicity of this bacterium was 
reconsidered and in 2013, several case reports from the US and the Netherlands followed in 
rapid succession [92-95]. Cases were later also reported from Japan [96] and Germany [97]. 
Additionally, another study revealed that people in the Netherlands are indeed exposed on 
a wide scale to ticks that carry this pathogen [85]. In this study, 3.6% of the ticks that fed 
on humans tested positive for B. miyamotoi. How widespread the levels of B. miyamotoi 
exposure, infection and disease are remains to be examined. 
Figure 5: Life cycle of Ixodes ricinus and the most relevant amplifying host of Borrelia miyamotoi for 
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Spotted fever group Rickettsiae: Rickettsia helvetica and Rickettsia monacensis
In Europe, Rickettsia helvetica and Rickettsia monacensis are the two main Rickettsia 
bacteria found in I. ricinus. These obligate intracellular bacteria belong to the spotted fever 
group of the Rickettsiae. Rickettsia helvetica was first described in 1979 from a questing I. 
ricinus tick in Switzerland [98], but it was not until 1993 that it was officially recognized as a 
spotted fever group Rickettsia [99]. Rickettsia monacensis, on the other hand, is a relatively 
novel bacterium in this same group. It was first described in 2000 in ticks from Slovakia 
[100], and later also in Germany [101]. Since their discovery, R. helvetica and R. monacensis 
have both been reported in questing I. ricinus ticks all over Europe. The infection rates vary 
from 0.5% to 66% and from 0.5% to 57% for R. helvetica and R. monacensis, respectively 
[102]. In the Netherlands, R. helvetica is widespread in the questing tick population, with 
infection rates ranging from 6% to 66% [38, 103, 104]. In contrast, R. monacensis is reported 
in only about 0.8% of questing ticks [38]. Like all spotted fever Rickettsiae, transmission 
occurs transstadially and transovarially. Therefore, ticks in nature are usually thought to 
be the main reservoir and vectors of this group of Rickettsiae [105]. Although transovarial 
transmission has not been studied in R. monacensis, it is not thought to differ from the 
process in other Rickettsia species in the spotted fever group. Still, despite the transovarial 
transmission, vertebrate hosts act as an amplifier of Rickettsiae, playing a vital role in 
transmission cycles. A study investigating transmission competence found that rodents 
were not able to transmit R. helvetica or R. monacensis to I. ricinus larvae [61]. However, 
various reports of bird-feeding ticks that tested positive for R. helvetica suggest that birds 
may play a role in the transmission cycle [102]. In a recent study, it was shown that birds are 
indeed important amplifying host for R. helvetica [106].
The amplification hosts of R. monacensis seem to be more elusive. A study where R. 
monacensis was detected in lizard tissue (7%) and fed I. ricinus ticks (41%) on Madeira 
Island, Portugal [107] suggest that lizards may be a potential reservoir or amplification host 
for R. monacensis.
Both Rickettsiae have been reported in a small number of human cases. Infections with 
Rickettsia helvetica were reported in different cases in Sweden [108-111]. Furthermore, 
R. helvetica infections were reported in France, Italy and Slovakia [112-114]. Rickettsia 
monacensis infections have been reported in patients with Mediterranean spotted fever-
like illness in Spain and Italy [115, 116]. In the Netherlands, R. helvetica or R. monacensis 
were identified using serological and molecular methods in skin biopsies of erythema 
migrans patients. Interestingly, co-infections with both bacteria were also found in Lyme 
neuroborreliosis patients [117, 118]. However, the clinical relevance of these findings 
are difficult to interpret from that study, it is not yet clear whether co-infection affected 
the clinical manifestations and the severity of the disease, especially in Lyme borreliosis 
patients. However, further evaluation and isolation of the bacterium from clinical samples 
and further studies are required to determine the pathogenicity of R. helvetica. 
Figure 6: Life cycle of Ixodes ricinus and the most relevant amplifying host of Rickettsia helvetica for 
each life stage of the tick.
Babesia species
In Europe, three intra-erythrocytic protozoan parasites are known to have I. ricinus as 
their vector: Babesia divergens, Babesia venatorum and Babesia microti. Like Malaria 
(Plasmodium), they are classified as unicellular and obligate endoparasites (apicomplexan) 
of the Piroplasmida suborder and the Babesiidae family. The infection rate of Babesia spp. 
in questing ticks ranges from 0.9% to 20% [119]. The infection rate of Babesia species in 
questing I. ricinus ticks in the Netherlands is around 2% [38, 120], and all three Babesia 
genospecies have been found to occur. The maintenance and persistence of Babesia’s 
within the tick vector is ensured through transstadial and transovarial transmission, with 
the exception of B. microti where transovarial transmission does not appear to occur in I. 
ricinus [121]. Cattle have been identified as the main reservoir host of B. divergens. Other 
ungulates like roe deer, fallow deer, red deer, mouflon and sheep can also be infected with 
this protozoan parasite [121]. The main reservoir of B. venatorum seems to be roe deer, 
and small rodents and shrews appear to be the main reservoir of B. microti [1]. Although 
babesiosis is mainly known to cause disease in animals, it is a zoonotic disease that can also 
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it causes disease in livestock and in companion animals [122]. In humans, B. divergens has 
been reported as the causative agent in most of the cases of babesiosis in Europe [1, 122]. 
Only four clinical cases caused by B. venatorum have been described in Europe, namely 
in Austria, Italy and Germany [123-125]. Only one case of B. microti infection has been 
reported in Germany [119]. All these babesiosis reports concerned immunocompromised 
patients, mainly patients without a (functional) spleen [122]. This is largely due to the fact 
that disease manifestations are more severe and often life-threatening in such heavily 
immunocompromised patients. In immunocompetent patients, Babesia infection is often 
mild with viral-like symptoms or even asymptomatic. The reported seroprevalence rates 
in Germany (5.4% to 8% for B. microti and 3.6% for B. divergens) suggest that exposure to 
Babesia is more widespread and that the number of patients is underestimated, probably 
due to the relatively mild symptoms or asymptomatic infections. Only two cases of human 
babesiosis have been reported in immunocompetent patients from France, of which one 
was caused by B. divergens [126].
Figure 7: Life cycle of Ixodes ricinus and the most relevant reservoir host of Babesia species for each 
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Tick-borne encephalitis viruses
In Europe, the first reported case of Tick-borne encephalitis (TBE) occurred in 1931 in Austria, 
when an outbreak of meningitis was reported [127]. The causative agent – tick-borne 
encephalitis virus (TBEV) – was not isolated until 1937 in the former Soviet Union [128]. Tick-
borne encephalitis virus is a member of the genus Flavivirus and the Flaviviridae family. Most 
members of this virus genus are arthropod-borne. This group of tick-borne flaviviruses (the 
TBEV serocomplex) comprises ten other viruses, including Omsk hemorrhagic fever virus, 
Powassan virus, and Louping ill virus [129, 130]. The virus has a linear positive-stranded RNA 
genome that consists of a single open reading frame [131]. TBEV can be divided into three 
subtypes: Siberian (TBEV-Sib), Far Eastern (TBEV-Fe) and European (TBEV-Eu) [132]. Only 
the TBEV-Eu subtype has I. ricinus as its main vector; the other two subtypes are associated 
with I. persulcatus.
In endemic areas in Europe, TBEV infection rates vary between 0.1 and 5% in ticks. Infection 
rates increase during the tick’s development from stage to stage. Reported infection rates 
are usually less than 1% [133], with fairly high infection rates (up to 27%) in microfoci [134]. 
Transmission in tick populations occur transstadially, with co-feeding identified as the most 
efficient route of infection in naive larvae. Transovarial transmission also occurs, and even 
sexual transmission has even been suggested in ticks [133, 135].
Various rodent species serve as the main reservoir or amplifying host. They are able to 
transmit the virus via viremia to feeding ticks and by co-feeding. The rodent species A. 
flavicollis, A. sylvaticus, M. glareolus and M. arvalis are important reservoir hosts for TBEV-
Eu [133]. These species can even maintain the virus in nature through latent persistent 
infection [136-138]. Migratory birds have been described as playing an essential role in the 
geographical distribution of TBEV-infected ticks, thus contributing to new foci. Still, little 
is currently known about the possible role of birds as TBEV reservoirs [139]. However, the 
prevalence of TBEV-infected bird-feeding I. ricinus is relatively low [1]. Ungulates that roam 
freely – such as goats, sheep, deer and wild boar – are thought not to contribute to the 
amplification of the virus. These animals are only viremic during a very short period and do 
not display any clinical symptoms, although they can serve as sentinels for the identification 
of TBEV foci in serological studies [133, 140]. In the Netherlands some sero-reactivity 
has been observed in wild animals and horses, although none of these cases could be 
confirmed through Hemagglutination Inhibition (HI) or Serum Neutralization Testing (SNT) 
for neutralizing antibodies [141, 142]. Although the I. ricinus vector of the TBEV-Eu subtype 
as well as the rodent reservoir are widely present in the Netherlands, it is unclear why TBEV 
does not thrive in an enzootic cycle. This is particularly notable considering recent reports 
from Belgium, where wild cervids and 2% to 4% of cattle have tested positive for TBEV with 
neutralizing antibodies [143-145]. These findings indicate that TBEV foci are present.
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Figure 8: Life cycle of Ixodes ricinus and the relevant amplifying host of tick-borne encephalitis virus 
species for each life stage of the tick.
According to the European Centre for Disease Prevention and Control (ECDC), TBEV is currently 
endemic in 27 European counties [133, 146]. Furthermore, expansion northwards and to 
higher altitudes has been reported in recent years [147, 148]. Still, no known autochthonous 
cases have been reported from Spain, Portugal, the United Kingdom, Ireland or Belgium 
[133]. Until 2015, this was also the case for the Netherlands. The western European TBE 
subtype often has a biphasic course. The first phase is associated with non-specific flu-like 
symptoms (e.g. fever, fatigue, myalgia, nausea, or headache). This initial phase is followed 
by an afebrile asymptomatic interval that could precede the second phase, when the central 
nervous system is affected (such as meningoencephalitis, myelitis or paralysis) [146, 149]. 
Considering that two-thirds of human TBEV infections are believed to be asymptomatic 
[150] and that the TBEV-Eu subtype is associated with milder disease [149], it is possible 
that human cases are underreported in Europe. This underreporting could also be due to 
notification policies of different countries, since notification of the disease is not mandatory 
in all countries, but only notifiable in 17 European countries [151]. However since 2012, TBE 
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The incidence of TBE appears to be increasing in some European countries such as Poland, 
Germany, Czech Republic, Slovakia, and Switzerland but also Scandinavian countries, have 
seen an increasing trend in TBE cases [133, 151]. The number of human TBE cases increased 
during the last 2 decades, with a mean of 892 annual cases reported to ECDC from 1990 to 
1999 and a mean of 1382 annual cases from 2000 to 2009 [133]. Besides tick-bite prevention, 
vaccination is the most effective protective measure against TBE according to the World 
Health Organization (WHO) [153]. The WHO and the ECDC recommend TBE vaccination for 
people who live in TBE risk areas or people who frequently visit grasslands and forests  in 
TBE risk areas [146, 153].
In several European countries, TBE vaccination currently is included in official government 
vaccination programs, under certain conditions [151]. In Austria, the vaccination program 
has been implemented, a coverage rate of 88% of the total population received at least 
one dose of the vaccine and more than half the population (58%) being within the officially 
recommended vaccination schedule (a shot every couple of years) [154]. In contrast, other 
highly endemic counties have much lower vaccination coverage for instance: Latvia 39% 
(2008), Estonia 20% (2008), Lithuania 19% (2008), Switzerland 17% (2007), the Czech 
Republic 16% (2009), Slovenia 13% (2009) and Sweden 13% (2008) [8]. 
4. CO-INFECTION
Since all the previously described agents can coexist in I. ricinus ticks, co-infections in 
ticks are frequently reported. However, only a small number of systematic and large-scale 
studies have been conducted to investigate the composition of mixed tick-borne pathogen 
infection rates [155]. Some studies have attempted to determine the infection rates of the 
entire range of pathogens among I. ricinus through reverse line blot analysis and other PCR 
amplification methods. However, the findings of these studies are difficult to compare due 
to differences in methodology. The outcomes of such studies are strongly affected by the 
methods used for tick collection, the sample size, the selection of tested tick life-stages, the 
selection of tested tick-borne pathogens, the DNA extraction methods, and the selection of 
primers and probes. Furthermore, without sequence analysis there is little discrimination 
amongst strain variants that are not associated with human disease. Consequently, in most 
European countries there is little accurate information about the co-infection rates for all 
tick-borne pathogens among I. ricinus.
According to two studies, co-infection of two or more tick-borne pathogens occurs relatively 
frequently in questing I. ricinus ticks. For instance, about 6% to 7% of questing ticks is 
infected with more than one pathogen [38, 156]. In a more recent study that used a novel 
molecular platform to test an entire range of tick-borne microbes in adult ticks, 45% of the 
ticks was found to be co-infected with at least two microorganisms [30]. 
These findings suggest that people bitten by ticks run the risk of being exposed to multiple 
pathogens at once or concomitantly. In other words, human co-infection with tick-borne 
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pathogens can occur following a single bite from a tick infected with multiple pathogens, 
or following several simultaneous bites from ticks that carry single pathogens. Both these 
scenarios can potentially result in co-infection of different tick-borne pathogens in humans 
[155]. Co-infections may affect the severity of disease and influence clinical outcomes. 
However, to what extend co-infection occurs, and influences disease outcome in a clinical 
setting is not known yet. 
5. OTHER FACTORS THAT INFLUENCE HUMAN EXPOSURE TO TICKS AND 
TICK-BORNE PATHOGENS
The transmission cycles of tick-borne pathogens have multiple drivers. Many factors 
influence vector distribution and pathogen dynamics, such as land use, habitat destruction, 
degradation and fragmentation. These factors influence host density and host composition 
in specific areas. In addition, weather factors are important since they affect the intensity and 
temporal patterns of vector activity throughout the year, leading particularly to increased 
biting rates in humans. Climate also influences habitat suitability and therefore the survival 
and reproduction rates of (new) vectors and hosts. In the Netherlands, climate change is 
one of the many factors that influence vector habitats. Changes in landscape management 
(e.g. the conversion of agricultural land into habitats suitable for the maintenance of large 
populations of deer and other ungulates) contribute to a sharp increase in tick densities 
[4-6, 157]. In addition, socio-economic factors such as recreational activities in rural areas 
with high tick densities have resulted in increased human exposure to ticks. Demographic 
changes are another important factor, with elderly people making up a substantial portion of 
the population and improvements in healthcare for chronically ill or immunocompromised 
patients. In 2013, for instance, 16% of the Dutch population was older than 65 and almost 
one-third of the entire Dutch population suffered from one or more chronic diseases [7]. 
These groups can suffer more complications and severe disease when infected with a tick-
borne pathogen. Furthermore, public awareness of ticks and the pathogens carried by them 
also plays a role in the increased reports of tick bites. 
Table 1: Tick-borne pathogens transmitted by Ixodes ricinus in the Netherlands. With the pathogen; 
reservoir or amplifying host, mode of transmission in the vector, human or veterinary disease, cell 
tropism, and characteristics
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6. THESIS AIM AND OUTLINE
The overall aim of this dissertation is to determine to what extent endemic tick-borne 
pathogens other than Lyme spirochetes cause disease and/or aggravate Lyme borreliosis in 
humans. The disease incidence and disease burden of tick-borne diseases other than Lyme 
borreliosis is unknown, mostly because of poor medical awareness and absence of (good) 
supportive laboratory diagnostic tools. Raising awareness and improvement of the diagnosis 
for tick-borne diseases other than Lyme borreliosis is only warranted when there is more 
knowledge about the substantial risk of acquiring these diseases. To this end, we used a 
multidisciplinary approach to assess prevalence, enzootic cycles, epidemiology and human 
exposure, infection and disease of a range of pathogens transmitted by Ixodes ricinus ticks, 
as the dominant tick species present in the Netherlands.
Therefore, the objectives of the thesis are:
1. Identifying the enzootic cycles and main reservoir hosts for the various tick-borne 
pathogens in the Netherlands transmitted by Ixodes ricinus
2. Determining the human exposure, and possibly infection and disease of tick-borne 
pathogens other than Lyme spirochetes
Table 1: Tick-borne pathogens transmitted by Ixodes ricinus in the Netherlands. With the pathogen; 
reservoir or amplifying host, mode of transmission in the vector, human or veterinary disease, cell 
tropism, and characteristics (continued)
This thesis has been divided in two parts, in part I, the different tick-borne pathogens (as 
described in the introduction and table 1 of the introduction) found in the Netherlands are 
studied in the field and their enzootic cycles are unraveled. To be more precise, in Chapter 
2, we assessed the acarological risk of exposure to several tick-borne pathogens (Borrelia 
burgdorferi s. l. genospecies, Anaplasma phagocytophilum, Candidatus Neoehrlichia 
mikurensis, Rickettsia helvetica, Rickettsia monacensis, several Babesia species), in the 
Netherlands. While testing whether these pathogens might share similar enzootic cycle, 
this by determining patterns of co-infection and spatial and seasonal dynamics of infection 
in questing Ixodes ricinus nymphs. 
In the following chapters, we focus on the individual tick-borne pathogens by identifying 
their main reservoir hosts. Candidatus Neoehrlichia mikurensis is an emerging and vector-
borne zoonosis. The first human disease cases were reported in 2010. Limited information 
is available about the prevalence, distribution, its natural life cycle and reservoir hosts. In 
Chapter 3, we aim to investigate the distribution and prevalence of Candidatus Neoehrlichia 
mikurensis in questing ticks the Netherlands, Belgium and the UK. To understand the 
enzootic cycle and main vector transmitting this newly emerging Candidatus Neoehrlichia 
mikurensis, we assess the infection rate in different tick species and possible transmission 
routes of Candidatus Neoehrlichia mikurensis in non-experimental settings and its putative 
mammalian hosts.
Anaplasma phagocytophilum is the etiological agent of Human Granulocytic Anaplasmosis 
(HGA) and anaplasmosis in animals. Knowledge on the distribution of A. phagocytophilum 
in ticks and wildlife in the Netherlands and Belgium is scarce. Wild animals and ticks play 
key roles in the enzootic cycles of this pathogen. The host range, zoonotic potential and 
transmission dynamics has only incompletely been resolved for A. phagocytophilum. 
The aim of Chapter 4 is to investigate the distribution of A. phagocytophilum in different 
stages of endemic tick species and in wildlife hosts and free ranging domestic animals. 
The potential vectors and animal samples are tested by qPCR and conventional PCR, to 
determine whether they are infected with A. phagocytophilum. We investigated whether 
genetic delineation, based on groEL gene correlates with host distribution/species and 
zoonotic potential. To assess whether the differential distribution of the genetic variants is 
due to geographic variation, all available groEL sequences of European A. phagocytophilum 
isolates are collected and subjected to similar analyses. Population genetic analyses are 
used to determine which of the ecotypes is expanding. 
Tick-borne encephalitis virus (TBEV) is an important public health concern and endemic 
in 27 European countries. The number of recognized human tick-borne encephalitis (TBE) 
cases in endemic regions of Europe has increased in the last decades, and expansion TBEV 
subtypes northwards and to higher altitudes is reported in recent years. The Netherlands 
and Belgium are not considered endemic for TBEV. However, recent reports from Belgium, 
where wildlife and ~3% of cattle have tested positive for TBEV with neutralizing antibodies, 
prompted us to reinvestigate the presence of TBEV in the Netherlands, in Chapter 5. In this 
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chapter, we investigate whether there is an endemic cycle tick-borne encephalitis virus in 
the Netherlands. By using roe deer as sentinels, we screen their sera for TBEV neutralizing 
antibodies. In addition, molecular screening for TBEV of questing I. ricinus ticks. 
European hedgehogs (Erinaceus europaeus) are urban dwellers and host both I. ricinus and 
Ixodes hexagonus. These ticks transmit several zoonotic pathogens like B. burgdorferi s. l., A. 
phagocytophilum, R. helvetica, B. miyamotoi and Candidatus Neoehrlichia mikurensis. It is 
unclear to what extent hedgehogs in (sub)urban areas contribute to the presence of infected 
ticks in these areas, which subsequently pose a risk for acquiring a tick-borne disease for 
humans. In Chapter 6, we aim to investigate to what extent hedgehogs contribute to the 
enzootic cycle of these tick-borne pathogens, and to shed more light at the mechanisms of 
the transmission cycles involving hedgehogs and both ixodid tick species. By determining the 
prevalence of B. burgdorferi s. l. genospecies, B. miyamotoi, A. phagocytophilum, Candidatus 
Neoehrlichia mikurensis and R. helvetica in the different stages of the I. hexagonus and 
I. ricinus tick species sampled from European hedgehogs from Belgium. Furthermore, 
assessing the role of these tick species and that of the hedgehog in the enzootic cycle of 
the different pathogens. By using epidemiological analysis and comparing the infection 
prevalences of the different pathogens from engorged ticks collected from hedgehogs with 
questing nymphs from the vegetation, we determine the reservoir status of the European 
hedgehog for B. burgdorferi s. l. genospecies, B. miyamotoi, A. phagocytophilum, Candidatus 
Neoehrlichia mikurensis and R. helvetica. We also investigate the vector competence of I. 
hexagonus for tick-borne pathogens in non-experimental settings. 
In part II of this thesis and following chapters, I translate these environmental findings to 
human exposure, infection and disease, in relation to public health. 
Both early localized and late disseminated forms of Lyme borreliosis are caused by B. 
burgdorferi s. l. Differentiating between the spirochetes that only cause localized skin 
infection from those that cause disseminated infection, and tracing the group of medically-
important spirochetes to a specific vertebrate host species, are two critical issues in disease 
risk assessment and management. It has been postulated that this genetic diversity is at the 
base of the multiple clinical manifestations that infection with these bacteria can display. At 
least five genospecies of B. burgdorferi s. l. are commonly associated with Lyme borreliosis 
in Europe: B. afzelii, B. garinii, B. burgdorferi s. s., B. spielmanii, and B. bavariensis. In 
Chapter 7, we want to understand the transmission and/or amplification host for each 
Borrelia burgdorferi s. l. that can cause disease and link that to a clinical manifestation of 
Lyme borreliosis. Therefore, we aim to directly link a transmission and/or amplification host 
for B. burgdorferi s. l. to a clinical manifestation of Lyme borreliosis. We hypothesize that 
a transmission cycle for a genotype is one factor that determines the clinical manifestation 
of Lyme borreliosis. We test this hypothesis by a quantitative molecular epidemiologic 
approach. Our sample collection covers both clinical sources (Lyme borreliosis patients 
having erythema migrans, Lyme neuroborreliosis, acrodermatitis chronica atrophicans, or 
Lyme arthritis) and field sources (ticks feeding on birds, rodents and hedgehogs). Plasmid 
genes, regulatory, housekeeping and neutral genetic loci from a number of samples are 
input to the statistical test of the hypothesis.
Tick-borne diseases are the most prevalent vector-borne diseases in Europe. Still, 
knowledge on the incidence and clinical presentation of other tick-borne diseases than 
Lyme borreliosis and tick-borne encephalitis is minimal, despite the high human exposure 
to these pathogens through tick bites. Using molecular detection techniques, the frequency 
of tick-borne infections after exposure through tick bites was estimated. In Chapter 8, we 
aim to investigate whether infection with tick-borne pathogens other than B. burgdorferi 
s. l. can be shown in patients with early localized Lyme borreliosis and in people exposed 
to tick bites in the Netherlands, by using molecular detection techniques, the frequency of 
tick-borne infections after exposure through tick bites will also be estimated. In addition, we 
aim to determine the clinical picture of patients with DNA of tick-borne pathogens in their 
blood. 
Ixodes ricinus ticks transmit B. burgdorferi s. l., the causative agent of Lyme borreliosis and 
transmit B. miyamotoi, which was recently found to cause infections and disease in humans. 
In Chapter 9, we aim to determine the prevalence of B. miyamotoi infection in ticks and 
natural amplifying hosts in the Netherlands and to what extent ticks are co-infected with 
B. burgdorferi s. l.. In addition, erythema migrans has been sporadically described in B. 
miyamotoi infected patients, but these skin lesions might as well represent co-infections with 
B. burgdorferi s. l.. However, thus far only one PCR-confirmed patient has been described 
in the Netherlands, suggesting under-diagnosis due to a lack of awareness, lack of severe 
symptoms, lack of widely available diagnostic tools and/or misdiagnosis. Because no routine 
diagnostics are currently performed for B. miyamotoi in the AMC (tertiary) multidisciplinary 
Lyme disease center, we aimed to investigate if (co-) infections with B. miyamotoi were 
missed over the past years. By using B. miyamotoi-specific real-time PCR on ticks and in 
spleen samples from potential reservoir hosts in nature and in Lyme borreliosis-suspected 
human skin biopsies, which were previously tested for B. burgdorferi s. l. by PCR.
Substantial exposure to B. miyamotoi occurs through bites from I. ricinus ticks in the 
Netherlands, this tick species transmits besides B. burgdorferi s. l. also A. phagocytophilum 
and other pathogens. Direct evidence for B. miyamotoi infection in European populations 
is scarce. A viral-like illness with high fever, resembling Human Granulocytic Anaplasmosis 
(HGA), has been attributed to B. miyamotoi-infections in relatively small groups. Borrelia 
miyamotoi-infections associated with chronic meningoencephalitis have also been 
described in occasional case reports. In Chapter 10, the objective is to gain more insight 
in the public health risk of B. miyamotoi. As a first attempt to describe the exposure of B. 
miyamotoi in the Netherlands, using a newly in-house developed serological assay based on 
the Glycerophosphodiester phosphodiesterase (GlpQ) antigen, which appears to be highly 
conserved among all members of the relapsing fever Borreliae, including B. miyamotoi, but 
distinct for the spirochetes causing Lyme borreliosis and their near relatives. In addition, we 
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determined here the seroprevalence of anti-B. miyamotoi antibodies in different risk groups 
within the general population. Apart from important epidemiologic insights, our findings 
will facilitate the future identification of the clinical symptoms of B. miyamotoi infections 
and might serve as a starting point for further development of serological assays.
In the synthesis (Chapter 11), I summaries the findings in the different chapters and discuss 
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Ixodes ricinus transmits Borrelia burgdorferi sensu lato, the etiological agent of Lyme disease. 
Previous studies have also detected Rickettsia helvetica, Anaplasma phagocytophilum, 
Candidatus Neoehrlichia mikurensis, and several Babesia species in questing ticks in the 
Netherlands. In this study, we assessed the acarological risk of exposure to several tick-
borne pathogens (TBPs), in the Netherlands. Questing ticks were collected monthly between 
2006 and 2010 at 21 sites and between 2000 and 2009 at one other site. Nymphs and adults 
were analyzed individually for the presence of TBPs using an array-approach. Collated data 
of this and previous studies were used to generate, for each pathogen, a presence/absence 
map and to further analyze their spatiotemporal variation. Rickettsia helvetica (31.1%) and 
B. burgdorferi sensu lato (11.8%) had the highest overall prevalence and were detected 
in all areas. Candidatus Neoehrlichia mikurensis (5.6%), A. phagocytophilum (0.8%), and 
Babesia spp. (1.7%) were detected in most, but not all areas. The prevalences of pathogens 
varied among the study areas from 0 to 64%, while the density of questing ticks varied from 
1 to 179/100 m2. Overall, 37% of the ticks were infected with at least one pathogen and 
6.3% with more than one pathogen. One-third of the Borrelia-positive ticks were infected 
with at least one other pathogen. Coinfection of B. afzelii with Candidatus Neoehrlichia 
mikurensis and with Babesia spp. occurred significantly more often than single infections, 
indicating the existence of mutual reservoir hosts. Alternatively, coinfection of R. helvetica 
with either B. afzelii or Candidatus Neoehrlichia mikurensis occurred significantly less 
frequent. The diversity of TBPs detected in I. ricinus in this study and the frequency of their 
coinfections with B. burgdorferi s. l., underline the need to consider them when evaluating 
the risks of infection and subsequently the risk of disease following a tick bite.
INTRODUCTION
In the Netherlands, the hard tick Ixodes ricinus is the main vector of a variety of human 
pathogens. The most prevalent tick-borne disease is Lyme borreliosis [10]. This multi-
systemic disorder is caused by several members of the Borrelia burgdorferi sensu lato 
complex. Of the 18 genospecies of this complex [158], B. afzelii, B. garinii, B. spielmanii, B. 
bavariensis, and B. burgdorferi sensu stricto have already been detected in the Netherlands, 
in both patients and questing ticks. Borrelia lusitaniae, and B. valaisiana were detected in 
questing I. ricinus, but their public health significance is less clear [21, 159-161]. Over the 
last decades, the incidence of Lyme borreliosis has increased significantly in Europe [13]. A 
long-term retrospective study among general practitioners in the Netherlands has shown a 
continuing increase in consultations for tick bites and erythema migrans in the last decade 
[162]. The incidence of erythema migrans patients increased from 39 per 100,000 inhabitants 
in 1994 to 134 per 100,000 inhabitants in 2009. Previous studies in the Netherlands have 
identified the presence of other pathogens in questing I. ricinus as well. Human babesiosis 
is caused by the intra-erythrocytic protozoa Babesia divergens, B. venatorum (EU1), and B. 
microti  [163]. A recent study reported these three Babesia species in approximately 1% 
of questing I. ricinus [120]. The spotted fever syndrome is caused by at least 15 different 
Rickettsia species, some of which are transmitted by I. ricinus [164]. Rickettsia conorii and R. 
monacensis are probably the most common tick-borne Rickettsiae to cause disease in Europe 
[164], whereas the pathogenicity of R. helvetica is still questionable [165]. All three rickettsial 
species have been previously found in the Netherlands [103] with local prevalences varying 
from <1% (R. conorii) to as high as 66% (R. helvetica). Anaplasma phagocytophilum, the 
etiologic agent of human granulocytotropic anaplasmosis [103], has been detected in ticks, 
from the Netherlands in several studies [66, 104]. Candidatus Neoehrlichia mikurensis can 
be considered an emerging zoonosis, as more than eight human cases have been described 
in Europe since 2010, while previously it was considered non-pathogenic. Despite an overall 
prevalence of Candidatus Neoehrlichia mikurensis in questing ticks of approximately 7% 
[60], no human cases have been reported in the Netherlands. 
Autochthonous tick-borne diseases other than Lyme disease have not been reported, 
except for a single case of granulocytotropic anaplasmosis in 1999 [45]. This may be caused 
by lower pathogenicity, lack of overt symptoms, or lack of awareness of public and health 
professionals. Multiple studies have reported coinfection with some of the tick-borne 
pathogens (TBPs) [156, 166-170]. It is known that the severity of Lyme disease may be 
affected by simultaneous infections with other TBPs [155, 166]. Some of them, such as A. 
phagocytophilum, modulate host immunity and increase susceptibility to various second 
pathogens, including B. burgdorferi [171, 172]. Thus, coinfection might be partly responsible 
for the variability in clinical manifestations that are usually associated with Lyme borreliosis.
The acquirement of a tick-borne disease depends on many environmental, societal, and 
immunological factors, but it is always preceded by the bite of a tick infected with the causal 
agent. Previous studies have shown that the risk of infection of humans by TBPs depends 
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mainly on the density of questing infected ticks—the acarological risk [173-176]. The study 
of mixed infections in questing ticks might therefore, reveal patterns of coinfection of B. 
burgdorferi s. l. with two or more other pathogens, allowing us to generate hypotheses 
on the transmission cycle of some more obscure pathogens from the dynamics of better-
known ones. The aim of this study was to assess the acarological risk of exposure to TBPs in 
the Netherlands by comparing the abundances of questing ticks infected with B. burgdorferi 
s. l. and with other TBPs.
METHODS
Collection of ticks and tick data 
All ticks were collected on a monthly basis between 2006 and 2010 in 21 sites. In Duin & 
Kruidberg field sampling was conducted between 2000 and 2009. The sites were spread 
all over the Netherlands and they have been selected based on Lyme borreliosis incidence 
in humans, and the availability of volunteers. The same sites were described in some 
previous studies regarding ticks and TBPs in the Netherlands [103, 177-179]. Sampling of 
ticks was done by blanket dragging, using a 1 m2 cloth on a 100 m long transect. Based on 
morphological criteria, ticks were identified to species level, with stage and sex recorded. 
The density of ticks was estimated as the number of questing ticks per 100 m2. Additionally, 
data on the presence of ticks and TBPs in other 39 areas were collected from some previous 
studies that have used the same sampling and analysis methodology [51, 60, 66, 104]. 
DNA Extraction of ticks 
All the collected ticks were immersed in 70% alcohol and stored at −20◦C until the DNA 
extraction. DNA from questing ticks was extracted by alkaline lysis [177]. Questing larvae 
were not taken into account as humans are generally bitten by either nymphs or adult I. 
ricinus [66, 180]. 
PCR detection and identification of pathogens
The presence of the DNA of different TBPs (Rickettsia spp., B. burgdorferi s. l., Ehrlichia/
Anaplasma spp., and Babesia spp.) was determined by polymerase chain reaction (PCR) 
followed by reverse line blotting (RLB) as described before [104, 177]. To minimize cross 
contamination and false-positive results, positive and negative controls were included in 
each batch tested by PCR and RLB assays. Furthermore, DNA extraction, PCR mix preparation, 
sample addition, and PCR analysis were performed in assigned separate labs. PCR products 
of some samples were sequenced by dideoxy-dye termination sequencing of both strands, 
and compared with sequences in GenBank (http://www.ncbi.nlm.nih.gov/), using BLAST 
[181]. The sequences were aligned and analyzed using BioNumerics 6.6 (Applied Maths, 
Kortrijk, Belgium). The prevalence of infection was calculated as the percentage of ticks 
infected with a certain microorganism.
Acarological risk
To calculate the densities of questing ticks infected with each of the five pathogens’ genera, 
we multiplied the prevalence of infection with the density of questing ticks in each of the 
investigated sites.
Correlation between prevalence and tick density
For some pathogens, we noticed that the prevalence might correlate with the density of 
questing ticks at the sampling locations. To test this possibility we fitted a binomial model 
to our data, by defining the prevalence of infection as an exponential function of the tick 
density (d) at each sampling location. Knowing that the number of infected ticks (k) out 
of the total number of ticks tested (n), is binomially distributed with a probability (p), we 
used the function p = aExp[bd], 0 < a < 1, to test an alternative model (b < 0) against a null 
model (b = 0) by a likelihood-ratio test. The alternative (decreasing exponential) model fitted 
significantly better to our data with p-value P ≤ 0.05.
Seasonal dynamics
To test for the seasonal dynamics of the prevalence against a constant prevalence of infection, 
a binomial model for the prevalence of infection (p) was fitted to our tick abundance data, 
in combination with the sampling days (d). The prevalence of infection was thus a cosine 
function of the sampling days. We tested an alternative model (                                                                 ) 
against a null model (                                             ). We calculated the test statistic (difference) 
for the likelihood-ratio and we determined whether the alternative (seasonal) model fitted 
better our data by deriving the probability of the difference (where a difference with a 
p-value ≤ 0.05 was considered significant). Based on the binomial likelihood, a significant 
seasonal dependence of the prevalence was assessed for each pathogen. All the statistical 
analyses were performed with Wolfram Mathematica 9.
RESULTS
The mean density of questing  nymphs  and  adult  ticks  varied greatly between sites, from 
as low as 1 (at Houtvesterijen Heide) up to 179/100 m2 (at Duin & Kruidberg; Table 2), results 
that are consistent with previous Dutch studies [177].
Pathogen detection and identification
A total of 5570 questing nymphs and adult I. ricinus from 22 different study areas were 
tested for the presence of TBPs by PCR amplification followed by RLB (Table 1). The recently 
identified B. bavariensis reacted consistently with our B. garinii probe [182], and therefore 
we grouped these two Borrelia genospecies. Five Borrelia genospecies were found in this 
study in all twenty-two study areas (Table 1), with the overall prevalence (11.8%) inscribed 
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in the interval of average European prevalence [183], and comparable with previous studies 
in the Netherlands [177, 178]. Borrelia afzelii was predominant (6.7%), followed by B. 
garinii/B. bavariensis (1.5%), B. valaisiana (1.2%), and B. burgdorferi sensu stricto (0.2%). 
The remaining fraction of the Borrelia positive samples could not be further identified to 
the species level by RLB. Sequencing several of these samples revealed the presence of B. 
spielmanii, corroborating previous findings of this genospecies in the Netherlands [184]. 
Borrelia lusitaniae, which was recently found in the Netherlands [104], was not detected in 
this study.
Rickettsia helvetica was most frequently detected in tick lysates, its 31.1% average 
prevalence (Table 1) being among one of the highest in Europe [range 1.5 to more than 
40.6% [185, 186]]. A previous study from our laboratory found R. helvetica not only in 
vertebrate hosts, but also in tick larvae at comparable prevalences as for the other tick 
stages, indicating a high efficiency of transovarial transmission [103]. Thirty-three Rickettsia 
isolates could not be identified up to the species level by RLB. Sequencing of these samples 
revealed the presence of R. monacensis, which was reported in the Netherlands before 
[103]. Rickettsia conorii was detected in only three questing ticks from one study area 
(Veldhoven). Anaplasma phagocytophilum-infected ticks were recorded with an overall 
prevalence of only 0.8% (Table 1). Candidatus Neoehrlichia mikurensis DNA was found with 
a global prevalence of 5.6% (Table 1). Ehrlichia canis DNA was detected in only 5 tick lysates 
from four different study areas, which resulted in an overall prevalence of 0.1% (5/5343). 
Ninety-nine Ehrlichia isolates could not be identified to the species level neither by RLB nor 
by sequencing. Babesia venatorum, formerly also known as B.EU1 [187], was present with a 
global prevalence of 1.0% (41/4238). The prevalence of B. microti in questing ticks was 0.4% 
(17/4238), and the protozoan was detected in 6 from 19 sites. Only one tick from the Duin & 
Kruidberg area contained the DNA of previously reported B. divergens [120]. Twelve Babesia 
sp. could not be further identified by neither RLB, or sequencing. The average prevalence of 
Babesia-positive ticks in the study areas was 1.6% (Table 1).
Spatial distribution and variation
Collated data were used  to  generate  presence/absence  maps  of the five major TBPs 
in the Netherlands (Figure 1).  The presence/absence of Borrelia spp., R. helvetica, A. 
phagocytophilum, Candidatus Neoehrlichia mikurensis, and Babesia spp. was assessed 
for 61, 24, 39, 39, and 25 locations, respectively. The presence of these pathogens was 
observed in 58, 24, 33, 20 and 18 areas, respectively, heterogeneously distributed across the 
Netherlands. The few absence points were scattered over the Netherlands as well, and did 
not cluster in any geographic region (Figure 1).
Table 1: Observed and expected coinfections. Chi-square tests were used to calculate the associations 
of several combinations of pathogens *Significant positive associations and ** and significant negative 
associations (P<0.05) are shown in bold.
Observed (%) R. helvetica A. phagocytophilum N. mikurensis Babesia (all)
Borrelia (all) 3.3% 0.1% 1.6% 0.4%
B. afzelii 1.8% 0.0% 1.3% 0.3%
R. helvetica 0.3% 2.2% 0.5%
A. phagocytophilum 0.0% 0.0%
N. mikurensis 0,1%
Expected (%) R. helvetica A. phagocytophilum N. mikurensis Babesia (all)
Borrelia (all) 3.9% 0.1% 0.7% 0.2%
B. afzelii 2.2% 0.1% 0.4% 0.1%
R. helvetica 0.3% 1.9% 0.5%
A. phagocytophilum 0.0% 0.0%
N. mikurensis 0.1%
Chi-test (p-value) R. helvetica A. phagocytophilum N. mikurensis Babesia (all)
Borrelia (all) 0.03** 0.30 0.00* 0.01*
B. afzelii 0.03** 0.24 0.00* 0.00*
R. helvetica 0.80 0.05** 0.77
A. phagocytophilum 0.10 0.42
N. mikurensis 0.66
Borrelia prevalence was between 5% (Houtvesterijen Heide) and 50% (Bellingwedde; where 
only six ticks were tested), while for R. helvetica it varied even more, from 3% in some sites 
(Apeldoorn), to 64% in others (Duin & Kruidberg) (Table 2). Lower variations in prevalences 
were observed for Candidatus Neoehrlichia mikurensis, A. phagocytophilum and Babesia 
spp. (Table 2). For Candidatus Neoehrlichia mikurensis, the prevalence was on average 
of 5%, but some areas displayed values of over 10% (Table 2). Babesia spp. showed an 
over- all prevalence of 1.7%, similarly to Germany and Luxembourg [169, 188]. Anaplasma 
phagocytophilum was the least prevalent pathogen in our study, with a mean prevalence of 
0.8%—comparable with the 0.5–1% prevalence found in different European countries [186, 
189, 190]. However, one of the sites displayed a 10-fold higher prevalence than average 
(Bilthoven 8%, Table 2).
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Identification of high risk-areas depends on both pathogen prevalence and density of 
questing ticks (nymphs and adults). The density of questing ticks varied between 1/100 m2 
(Houtvesterijen Heide) and 179/100 m2 (Duin & Kruidberg; Table 2). The density of questing 
Borrelia-infected ticks varied between 0 and 19 ticks per 100 m2  (Figure 2), whereas 
the maximum densities of A. phagocytophilum, Candidatus Neoehrlichia mikurensis and 
Babesia spp. infected ticks were 3.0, 13, and 2.9 ticks per 100 m2, respectively. The density 
of questing R. helvetica-infected ticks varied between 0 and 22 ticks per 100 m2, with one 
notable exception:  Duin & Kruidberg area had both a high tick density and an exceptionally 
high R. helvetica prevalence, which resulted in a density of questing R. helvetica- infected 
ticks of up to 119 ticks per 100 m2. Considering that these are calculated as average values 
for an entire season, it is therefore inevitable that the densities of infected questing ticks are 
actually higher for peak months of tick activity [i.e., May-June [178]]. Based on a likelihood 
ratio test, performed for a decreasing model and a constant one, we detected a significant 
negative correlation between the density of questing ticks and the infection prevalence with 
B. burgdorferi s. l. (p = 3.6 × 10−10) and Babesia spp. (p = 4.9 × 10−5) (Figure 3). On the other 
hand, there was no correlation found between these variables for R. helvetica (p = 1.0), 
Candidatus Neoehrlichia mikurensis (p = 1.0) and A. phagocytophilum (p = 0.69) (Figure 3). 
Graphs for the density of infected questing ticks against the density of questing ticks revealed 
that the former is linearly increasing with the latter for R. helvetica, Candidatus Neoehrlichia 
mikurensis and A. phagocytophilum (Figure 4). For the other two pathogens— Babesia spp. 
and B. burgdorferi s. l., the density of infected questing ticks reached the maximum values 
at densities of questing ticks of 119 and 268, respectively (Figure 4).
Temporal variation
To gain insight into long-term dynamics of ticks and their pathogens, we analyzed the 
data obtained from Duin & Kruidberg, where a 10-year (2000–2009) tick-surveillance was 
performed. This area was selected at that time because of its unusual high tick density/
activity. The prevalences of all pathogens were relatively stable over the past decade (B. 
burgdorferi s. l. 7.0%, B. afzelii 4.6%, A. phagocytophilum 0.7%, R. helvetica 65%, Babesia 
spp. 1.1%), except for Candidatus Neoehrlichia mikurensis, whose prevalence increased 
from 3.5% (2000–2007) to 12% in the last 2-year interval (2008–2009). The average density/
activity of adult ticks remained relatively low with 7–34 ticks per 100 m2. The average 
density/activity of nymphal ticks was more pronounced (102–410 ticks per 100 m2) and 
peaked in 2004–2005 (Figure 5). The likelihood ratio test detected similar decreasing trends 
in the temporal relation between the prevalence and the tick density as for the spatial 
variation analysis (not shown). Despite the inverse relationship between the prevalence and 
the tick density, the peaks of density/activity of infected ticks coincided with the peak of 
high densities of questing ticks in 2004–2005 (Figure 5).
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Figure 1: Aggregated presence/absence map of questing I. ricinus nymphs/adults infected with B. 
burgdorferi s.l. (A), R. helvetica (B), N. mikurensis (C), A. phagocytophylum (D), Babesia species (E). 
Presence/absence points from previous studies [205-212] were also incorporated.
Figure 2: Identification of high risk-areas depends on both prevalence and tick density/activity. Their 
calculated product defines the density/activity of infected ticks (nymphs and adults/100 m2). The 
error bars depict the upper limit of the 95% confidence interval. Duin en Kruidberg’s density of R. 
helvetica infected ticks reaches to 119/100 m2.
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Figure 3: Density  and prevalence relations. Significant negative correlations between the density of 
questing ticks and the infection prevalence were found for B. burgdorferi s.l. (p = 3.6 × 10−10 ) and 
Babesia spp. (p = 4.9 × 10−5). On the other hand, there was no correlation found between these 
variables for R. helvetica (p = 1.0), N. mikurensis (p = 1.0), and A. phagocytophilum (p = 0.69). Note 
that due to the very small exponents, the curves look approximately linear, although they are in fact 
exponential, as explained in the text. The data set included all of the areas except for Duin&Kruidberg.
Figure 4: Evolution of the density of infected ticks (y-axis) with the density of questing ticks (x-axis). 
The density of infected ticks is calculated as the product of the infection prevalence (from the highest 
likelihood model) with the density of questing ticks. The numbers are expressed as ticks/100 m2. The 
grey area marks the normal questing ticks densities (0-179/100 m2) in The Netherlands.
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Figure 5: Changing average of density of infected ticks and tick density/activity in Duin & Kruidberg 
area. Density/activity of nymphs and adults are depicted in the bottom right graph as continuous and 
dotted line, respectively.
Coinfection
Overall, 37% (2064/5570) of the ticks was infected with one or more pathogens and 6.3% 
(350/5570) with more than one pathogen of different genera. Furthermore, 37% (234/628) 
of the Borrelia-positive ticks were infected with at least one other pathogen of a different 
genus. Almost 5% (29/628) of the Borrelia-positive ticks were also positive for three or more 
other pathogens. One tick carried the DNA of B. afzelii, R. helvetica, Candidatus Neoehrlichia 
mikurensis, and B. microti. Mixed infections, involving two or three Borrelia genospecies, 
occurred in only 0.3% (15/5308) of the tick lysates. Coinfection of B. afzelii with Candidatus 
Neoehrlichia mikurensis or with Babesia spp. occurred significantly more than random, 
whereas infection of R. helvetica with either B. afzelii or Candidatus Neoehrlichia mikurensis 
occurred significantly less frequent (Table 3).
Seasonal dynamics
Seasonality modeling of the prevalence indicated a different periodicity of the analyzed 
pathogens (Figure 6). Thus, B. afzelii, Candidatus Neoehrlichia mikurensis and Babesia 
spp. showed highest prevalences in ticks at time periods corresponding to October, while 
non- afzelii B. burgdorferi and R. helvetica had the highest prevalence around June. Annual 
prevalence of A. phagocytophilum was not seasonal.
Table 3: Observed and expected coinfections. Chi-square tests were used to calculate the associations 
of several combinations of pathogens *Significant positive associations and **significant negative 
associations (p < 0.05) are shown in bold.
Observed (%) R. helvetica A. phagocytophilum N. mikurensis Babesia spp.
Borrelia (all) 3.3 0.1 1.6 0.4
B. afzelii 1.8 0.0 1.3 0.3
R. helvetica 0.3 2.2 0.5
A. phagocytophilum 0.0 0.0
N. mikurensis 0.1
Expected (%) R. helvetica A. phagocytophilum N. mikurensis Babesia spp.
Borrelia (all) 3.9 0.1 0.7 0.2
B. afzelii 2.2 0.1 0.4 0.1
R. helvetica 0.3 1.9 0.5
A. phagocytophilum 0.0 0.0
N. mikurensis 0.1
Chi2-test (p-value) R. helvetica A. phagocytophilum N. mikurensis Babesia spp.
Borrelia (all) 0.03** 0.30 0.00* 0.01*
B. afzelii 0.03** 0.24 0.00* 0.00*
R. helvetica 0.80 0.05** 0.77
A. phagocytophilum 0.10 0.42
N. mikurensis 0.66
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Figure 6: Seasonal variation of the infection rate in ticks. The maximum infection rates of non-afzelii B. 
burgdorferi, and R. helvetica are in June, while the amplitudes of B. afzelii, N. mikurensis, and Babesia 
spp. overlap in October.
DISCUSSION
In order to assess the acarological risk of acquiring a tick-borne infection in the Netherlands, 
the abundance of questing ticks infected with B. burgdorferi s. l. and four other genera of 
TBPs were compared. Our study revealed the nationwide circulation of TBPs in enzootic 
cycles. Although the most common tick-borne infection is acknowledged to be Lyme 
borreliosis, our results showed that there are other pathogens present in questing ticks 
at prevalences comparable with B. burgdorferi (i.e., R. helvetica, Table 2). Due to the fact 
that our investigations only detected the DNA of the microorganisms under discussion, and 
not the viable cells, we cannot asseverate their infectiousness for other vertebrate hosts. 
However, previous studies implicate Ixodes ricinus ticks as vectors for these microorganisms 
[32, 60, 103, 164, 191-197], and therefore the risk for public health should not be neglected. 
Although no human disease with the organisms other than B. burgdorferi s. l. was reported 
so far in the Netherlands, it is known that infection with some of them (e.g., Ehrlichia) is 
generally either asymptomatic or mild, self-limiting diseases [198]. 
Spatial distribution and variation
All the pathogens were observed in most of the areas in which investigations were 
conducted, regardless of the geographical position. The absence in certain areas might be 
explained by the relatively low number of ticks collected/tested (Table 2). The prevalences 
of infection in the ticks varied significantly between the areas investigated. The lack of a full 
perspective on the host community at each of the sites does not allow us to make a definite 
statement on why we see such a variation of the prevalence of infection. We propose, 
however, that the extremely high local variability of the pathogens may be associated with 
the differences in host assemblages in the investigated habitats. As ticks can feed on many 
different animals and every host species has a unique reservoir competence [e.g., rodents 
being the most competent reservoirs of B. afzelii [199]], the presence of different hosts in 
different communities affects the prevalence of infection with various microorganisms.
In terms of the risk for public health, neither the density of questing ticks, nor the prevalence 
of infection alone, has any significance. Instead, it is their product—the density of infected 
questing ticks—that defines high or low risk areas [173-176]. We noticed that in some areas, 
where tick densities were highest, the mean prevalence of Borrelia infection had very low 
values (8% for Duin & Kruidberg; Table 2). Using a log-likelihood ratio statistics, we tested 
the hypothesis of a constant prevalence over the range of questing ticks density. The test 
confirmed the independence of the two variables but only for R. helvetica, Candidatus 
Neoehrlichia mikurensis, and A. phagocytophilum, while for B. burgdorferi and Babesia spp. 
it indicated a slight negative correlation of the prevalence with the tick density (Figure 3). 
Thus, we would expect that the density of ticks infected with B. burgdorferi and Babesia spp. 
would decrease as the density of questing ticks increases. Plotting the density of infected 
questing ticks as an exponential function of the questing ticks’ densities, however, revealed 
that over the usual range of questing ticks densities the density of infected ticks is also 
increasing, and the downward  trend  might  be  observed  only for questing ticks densities 
of over 100 (for Babesia spp.) or 200/100 m2 (for B. burgdorferi) (Figure 4). This observation 
is consistent with the finding made by Randolph [200] that, in Europe the density of 
Borrelia  infected  ticks  depends much more on the density of all ticks than on the infection 
prevalence, and that only in areas where the tick density is unusually high (100–450/100 
m2) is the infection prevalence consistently low.
Temporal variation
In terms of temporal variation, the longest series of data we had was for 10 successive years 
(Duin & Kruidberg, Figure 5). At this site, the density of questing ticks was highest in 2004–
2005, and it was due to a steep increase in the number of questing nymphs. The variations in 
tick density might indicate yearly fluctuations in the composition and availability of reservoir 
hosts. For example, a mast year might have been responsible for the increment in small 
mammals’ population size (i.e., rodents), with the upsurge of nymphs at a consequential rate. 
The trend line indicated the maintenance of relatively constant prevalences for B. burgdorferi, 
A. phagocytophilum, and R. helvetica. Babesia prevalence showed a slight decrease over time 
while, on the contrary, Candidatus Neoehrlichia mikurensis showed a steep increase (almost 
3-fold). The maintenance of relatively constant prevalences of infection in time implies that 
the acarological risk is predominantly dependent on the density/activity of ticks (Figure 5).
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One-third of the ticks infected with Borrelia were also infected with at least one other TBP. 
Recent studies in other European countries have shown that mixed infections of the TBPs 
do not represent an exception but more likely the rule. A negative significant association 
was found between all Borrelia (and B. afzelii alone) and R. helvetica, as well as between 
Candidatus Neoehrlichia mikurensis and R. helvetica (Table 3). On the other hand, 
significant positive associations were found between Borrelia (and particularly B. afzelii) 
and Candidatus Neoehrlichia mikurensis and between Borrelia and Babesia spp. (Table 3). 
These findings lead us to the hypothesis that B. afzelii, Candidatus Neoehrlichia mikurensis, 
and Babesia might share the same reservoir hosts, while R. helvetica is maintained in other 
enzootic cycles.
Seasonal dynamics
Further evidence for our hypothesis came from the seasonality modeling of the infection 
prevalence. This indicated a variation in the same phase for B. afzelii, Candidatus 
Neoehrlichia mikurensis and Babesia spp. on the one side and for non-afzelii B. burgdorferi 
and R. helvetica on another (Figure 6). That means that the infection peak in questing 
ticks is different for different pathogens, further suggesting that they were acquired from 
the distinct vertebrate hosts. Scientific literature confirms this. Rodents are known to be 
competent transmission hosts for B. afzelii [199, 201] and B. microti [196], and they have 
been designated as potential reservoirs for Candidatus Neoehrlichia mikurensis [167, 202]. 
On the other hand, non-afzelii Borrelia, like B. garinii and B. valaisiana have been shown 
to be associated with birds [199, 203], while a study of de la Fuente and co-workers [204] 
found that A. phagocytophilum infections occurred in deer, cattle and various bird species, 
meaning that birds might serve as reservoirs for both these bacteria.
Rikettsia helvetica was previously found at high rates in both rodents (29%) and roe deer 
(19%) [103]. The fact that R. helvetica was negatively associated with B. afzelii, although they 
might share the same hosts, is possibly due to that the former is transovarially transmitted 
in ticks which act thus as both vectors and reservoirs of the rickettsiae [103]; therefore, 
they alone can be responsible for the maintenance of the bacteria, without the intervention 
of a rodent host in the cycle. Hence, our findings are not coincidental, and indicate that 
certain coinfections are more likely to occur than the others, given particular combinations 
of vertebrate hosts. Although previous meta-analyses indicate that coinfection and co-
exposure for some of the TBPs appear to occur somewhat unpredictably across different 
areas and different hosts [168], it is anticipated that future wildlife studies will help define 
geographical risks of coinfection and provide insight into the dynamics of infection within 
reservoir hosts.
CONCLUSION
We have shown that ticks and the five genera of TBPs have a ubiquitous distribution in the 
Netherlands, with the few absence point presumably determined by the small number of 
collected ticks. The pathogens were found in sites all over the Netherlands, encompassing 
a variety of habitats, from open areas such as dune and heather to deciduous or coniferous 
forests.
This study brings valuable information on the prevalence, geographic distribution and 
temporal variation of B. burgdorferi s. l., R. helvetica, Candidatus Neoehrlichia mikurensis, 
A. phagocytophilum and Babesia spp. in questing I. ricinus. Due to their omnipresence, we 
underline the need to consider all of these pathogens when evaluating the risks of infection 
and subsequently of disease following a tick bite. Whereas the incidence of Lyme disease 
is on the rise, other tick-borne diseases remain heavily unreported, and even knowledge 
on the human exposure to them is scarce. Our study suggests that there are pathogens 
positively associated with Borrelia (i.e., Candidatus Neoehrlichia mikurensis and Babesia 
spp.) in questing ticks. This strengthens the idea of established enzootic cycles (common 
reservoir hosts) in which these microorganisms are maintained, and it is consequently 
possible that they might follow the same upward trend as the Lyme spirochetes. In the case 
of Candidatus Neoehrlichia mikurensis we have in fact witnessed the beginning of what 
might be a following upward trend.
Human activity in any natural habitat is accordingly accompanied by an imminent risk of 
exposure to any of the pathogens. Although the risk, as measured by the density of infected 
ticks, may vary in time and space, its driving factor appears to be the tick density/activity. 
It is therefore possible that the risk of exposure to TBPs would be minimized by developing 
effective and sustainable methods for the control of Ixodes ricinus populations.
CHAPTER 3
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Background: Candidatus Neoehrlichia mikurensis is an emerging and vector-borne zoonosis. 
The first human disease cases were reported in 2010. Limited information is available about 
the prevalence, distribution, its natural life cycle and reservoir hosts. An Ehrlichia-like 
“schotti” variant has been described in questing Ixodes ricinus ticks, which could be identical 
to Candidatus Neoehrlichia mikurensis. 
Methods: Three genetic markers, 16S rDNA, gltA and groEL of Ehrlichia schotti-positive 
tick lysates were amplified, sequenced and compared to sequences from Candidatus 
Neoehrlichia mikurensis. Based on these DNA sequences, a multiplex real-time PCR was 
developed to specifically detect of Candidatus Neoehrlichia mikurensis in combination with 
Anaplasma phagocytophilum in tick lysates. Various tick species from different life-stages, 
particularly Ixodes ricinus nymphs, were collected from the vegetation or wildlife. Tick 
lysates and DNA derived from organs of wild rodents were tested by PCR-based methods for 
the presence of Candidatus Neoehrlichia mikurensis. Prevalence of Candidatus Neoehrlichia 
mikurensis was calculated together with confidence intervals using Fisher’s exact test.
Results: The three genetic markers of Ehrlichia schotti-positive field isolates were similar or 
identical to Candidatus Neoehrlichia mikurensis. Candidatus Neoehrlichia mikurensis was 
found to be ubiquitously spread in the Netherlands and Belgium, but was not detected in 
the 401 tick samples from the UK. Candidatus Neoehrlichia mikurensis was found in nymphs 
and adult Ixodes ricinus ticks, but neither in their larvae, nor in any other tick species tested. 
Candidatus Neoehrlichia mikurensis was detected in diverse organs of some rodent species. 
Engorging ticks from red deer, European mouflon, wild boar and sheep were found positive 
for this bacterium.
Conclusions: Ehrlichia schotti is similar, if not identical, to Candidatus Neoehrlichia 
mikurensis. Candidatus Neoehrlichia mikurensis is present in questing Ixodes ricinus ticks 
throughout the Netherlands and Belgium. We propose that Ixodes ricinus can transstadially, 
but not transovarially, transmit this microorganism, and that different rodent species may 
act as reservoir hosts. These data further imply that wildlife and humans are frequently 
exposed to Candidatus Neoehrlichia mikurensis-infected ticks through tick bites. Future 
studies should aim to investigate to what extent Candidatus Neoehrlichia mikurensis poses 
a risk to public health.
BACKGROUND
The most prevalent tick-borne infection of humans in the Northern hemisphere is Lyme 
borreliosis [12]. The same tick species transmitting the etiologic agents of Lyme borreliosis 
also serve as the vector of pathogens causing tick-borne encephalitis and several forms of 
rickettsiosis, anaplasmosis and ehrlichiosis [162].  Members of the family Anaplasmataceae 
are obligatory intracellular bacteria that reside within membrane-enclosed vacuoles. Human 
ehrlichiosis and anaplasmosis are two closely related diseases caused by various members 
of the genera Ehrlichia and Anaplasma. A major difference between these two members is 
their cellular tropism. Ehrlichia chaffeensis, the etiologic agent of human monocytotropic 
ehrlichiosis (HME), is an emerging zoonosis that causes clinical manifestations ranging from 
a mild febrile illness to a fulminant disease characterized by multi-organ system failure 
[164]. Anaplasma phagocytophilum causes human granulocytotropic anaplasmosis (HGA), 
previously known as human granulocytotropic ehrlichiosis [198]. Despite the presence of 
Anaplasma phagocytophilum in questing Ixodes ricinus ticks in the Netherlands [177], only 
one human case has been reported [45]. Seropositivity against anaplasmosis was observed 
in risk groups, such as forestry workers and suspected Lyme borreliosis patients, but not 
in control groups [46]. Still, the incidence of these tick-borne diseases and the associated 
public health risks remain largely unknown.
A novel candidate species in the family of Anaplasmataceae, called Candidatus Neoehrlichia 
mikurensis, was first isolated from wild rats and was also found in I. ovatus in Japan [49]. 
Candidatus Neoehrlichia mikurensis can be distinguished from other genera based on 
sequence analysis of 16S rDNA, citrate synthase (gltA) and heat shock protein groEL genes 
[49]. This recently identified bacterium is detected in several tick species and rodents in 
different parts of the world under different names [49, 51-53, 213]. Candidatus Neoehrlichia 
mikurensis found in I. ricinus ticks in Italy has been referred to as Candidatus Ehrlichia 
walkerii [52, 54] and the Ehrlichia species isolated from a rat in China was called “Rattus 
strain” [53]. Furthermore, a Candidatus Neoehrlichia mikurensis has been described in 
I. persulcatus in Russia [56, 57] and I. ovatus from China and Japan [49, 53, 214]  In the 
US, an Ehrlichia-like organism, closely related to Candidatus Neoehrlichia mikurensis, was 
previously detected in raccoons. This variant is called Candidatus Neoehrlichia lotoris [215, 
216]. The Asian Candidatus Neoehrlichia mikurensis strains showed a 99% similarity based 
on the 16S rDNA to the Ehrlichia schotti. Ehrlichia schotti was first described in 1999 in I. 
ricinus in the Netherlands by Leo Schouls and was named after his technician [51]. Later 
this species was reported in I. ricinus in Russia [217], and subsequently in Germany and 
Slovakia [218, 219]. These findings raised the question whether Ehrlichia schotti is the same 
as Candidatus Neoehrlichia mikurensis.
It is unclear whether Candidatus Neoehrlichia mikurensis poses a risk to public health. 
Until recently, there were no human infections reported. In 2010, the first case of human 
Candidatus Neoehrlichia mikurensis infection was reported in a patient from Sweden [68]. 
In the same year, five other human infections were described in Germany, Switzerland and 
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the Czech Republic [69-71]. More recently, a canine infection was reported in Germany 
[72]. The symptoms described in all of these cases were generally non-specific and usually 
seen in any other ordinary inflammatory reaction (Table 1). These reported cases of human 
infections imply that re-evaluation is needed regarding the pathogenesis of this species. All 
but one case that have been described so far have occurred in patients who were immuno-
compromised. The non-specificity of the reported symptoms, poor diagnostic tools and the 
lack of awareness of public health professionals could explain the absence of (reported) 
patients.
In this study we aim to investigate (i) whether Ehrlichia schotti is similar to the described 
Candidatus Neoehrlichia mikurensis family, (ii) the distribution and prevalence of Candidatus 
Neoehrlichia mikurensis in the Netherlands, Belgium and the UK, (iii) possible transmission 
routes of Candidatus Neoehrlichia mikurensis in non-experimental settings and (vi) its 
putative mammalian hosts.
METHODS
Collection, identification and DNA extraction of ticks questing I.  ricinus from  all  stages  and 
Dermacentor reticulatus adults were collected in 2009 and 2010 by flagging the vegetation 
at geographically different locations in the Netherlands and Belgium. Ticks collected in 
the UK and Vrouwenpolder (NL) have been described before [179]. Questing I. arboricola 
were collected from bird nests in two different areas in Belgium.  Ixodes hexagonus feeding 
on hedgehogs were collected in a hedgehog-shelter in 2010.  Ixodes  ricinus  feeding  on 
red  deer  (Cervus elaphus), European  mouflon (Ovis  orientalis musimon), wild  boar  (Sus 
scrofa)  and  sheep  (Ovis  aries)  were collected. All the collected ticks were immersed in 
70% alcohol and stored at −20°C until the DNA extraction. Based on morphological  criteria, 
tick  species  and  stages  were identified to species level, with stage and sex recorded [224]. 
In doubtful cases, sequencing of tick mitochondrial 16S  rDNA  confirmed  the  tick-species 
[225]. DNA of questing ticks was extracted by alkaline lysis [162]. DNA of engorged  ticks 
was  extracted  using  the  Qiagen DNeasy Blood & Tissue Kit according to the manufacturer’s 
manual (Qiagen, 2006, Hilden; Germany) following the  manufacturer’s  protocol  for  the 
purification  of  total DNA from ticks.
Preparation of DNA lysates from wild rodents
Longworth traps (Bolton Inc., UK), baited with hay, apple, carrot, oatmeal and mealworm 
were used to capture different species of rodents and insectivores at 7 different locations in 
the Netherlands between 2007 and 2010. Animals were anaesthetized with isoflurane and 
euthanized by cardiac puncture. Serum was collected and stored at – 20°C. Spleen, liver, 
kidney, brain and other organs were collected and frozen at −80°C. DNA was extracted using 
the Qiagen DNeasy Blood & Tissue Kit according to the manufacturer’s manual (Qiagen, 
2006, Hilden; Germany). All animals were handled in compliance with Dutch laws on animal 
handling and welfare (RIVM/DEC permits).
Table 1: Reported human cases of Candidatus Neoehrlichia mikurensis (until October 2011)




Episodes of fever, nonproductive cough, left 
thoracic pain, vein thrombosis, hypochromic 
anemia, reduced numbers of leukocytes, decreased 
percentage of lymphocytes, increased proportion 
of monocytes and elevated levels of CRP, 
microbiological analysis were negative.
[220]
Germany Male, 57yr 
Previously healthy
Headaches, fever, intracerebral and subarachnoid 
hemorrhage, aneurysm, elevated CRP, pulmonary 
infiltration, microbiological analyses were negative, 






Transitory ischemic attack, hemolytic anemia, 
fever, erysipelas-like rash, transitory weakness of 
the left side of face and arm, hemolytic anemia, 
thrombocytopenia, thrombosis, pulmonary 
infiltration, increased proportion of monocytes and 
elevated levels of CRP, blood and other cultures 
were negative
[221]
Switzerland Male, 61yr 
CABG surgery
Malaise, fever, moderate dyspnea, elevated 
leukocytes/neutrophils, elevated CRP, 







Spiking fever, myalgias, arthralgias, erthema 
nodosum, elevated CRP, blood-, urine culture and 
pharyngeal swabs were negative. Antinuclear-, 
antinucleolar antigens and rheumatoid factor 







Spiking fever, extreme fatigue, joint pain, skin 
erythema, painful and stiffened subcutaneous veins, 
mild leukocytosis and elevated CPR, blood and urine 
cultures and pharyngeal swab were negative. 
[223]
Preparation of DNA lysates from wild rodents
Longworth traps (Bolton Inc., UK), baited with hay, apple, carrot, oatmeal and mealworm 
were used to capture different species of rodents and insectivores at 7 different locations in 
the Netherlands between 2007 and 2010. Animals were anaesthetized with isoflurane and 
euthanized by cardiac puncture. Serum was collected and stored at – 20°C. Spleen, liver, 
kidney, brain and other organs were collected and frozen at −80°C. DNA was extracted using 
the Qiagen DNeasy Blood & Tissue Kit according to the manufacturer’s manual (Qiagen, 
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2006, Hilden; Germany). All animals were handled in compliance with Dutch laws on animal 
handling and welfare (RIVM/DEC permits).
Polymerase chain reactions
Polymerase chain reaction (PCR) amplifications were performed in a Px2 Thermal Cycler 
(Thermo Electron Corporation, Waltham, Massachusetts, USA). The presence of Ehrlichia 
schotti in questing I. ricinus was studied by Reverse Line Blotting as described [177]. 
Fragments of the 16S rDNA, citrate synthase gene gltA, and the chaperonin groEL of ehrlicial 
species were amplified from tick lysates and rodent tissue samples using novel primers and 
primers that were previously described (Table 2). Amplification of gltA and groEL were both 
done in 50 μl reaction volumes containing 5 μl template DNA. gltA DNA was amplified using 
a final concentration of 800 nM of each primer, NMik fo-gltA and NMik re-gltA with the 
following PCR program, 15 min at 95°C, 40 cycles each consisting of 30 sec at 94°C, 25 sec 
at 53°C, and 10 min at 72°C. groEL DNA was amplified using, 500 nM of each primer NMik 
fo-groEL and NMik re-groEL. The PCR program used is as followed: 15 min at 95°C, 40 cycles 
each consisting of 30 sec at 94°C, 75 sec at 49°C, and 10 min at 72°C. The nested reaction 
was carried out at the same temperature as the first reactions; only 25 cycles were carried 
out with 1 μL of the first amplification product. The HotStarTaq Polymerase Kit (Qiagen) 
was used for all PCR experiments. PCR products were detected by electrophoresis in a 1.5% 
agarose gel stained with SYBR gold (Invitrogen).
Multiplex real-time PCR
Oligonucleotide primer and probe sequences were designed to be specific for the Candidatus 
Neoehrlichia mikurensis groEL gene using Visual OMP DNA (Software, Inc., Ann Arbor, USA). 
Primer sequences for the Candidatus Neoehrlichia mikurensis groEL gene were NMikGroEL-
F2a and NMikGroEL-R2b and generated a 99-bp fragment which was detected with the 
NMikGroEL-P2a TaqMan probe (Table 2). Sequences were evaluated on the basis of the 
following criteria: predicted cross-reactivity with closely related organisms, internal primer 
binding properties for hairpin and primer-dimer potential, length of the desired amplicon, 
G-C content, and melting temperatures (Tms) of probes and primers. The specificity of 
the groEL primers for Candidatus Neoehrlichia mikurensis in the multiplex real-time PCR 
assay was tested with DNA extracted from the following microorganisms: R. rickettsii, A. 
phagocytophilum, R. helvetica, Bartonella henselae, Ehrlichia canis, B. afzelii, B. garinii, B. 
burgdorferi sensu stricto, Babesia microti, Candidatus Midichloria mitochondrii and tick 
lysates containing Wolbachia species [177, 226]. None were amplified. Random samples 
of tick lysates which were Candidatus Neoehrlichia mikurensis groEL positive in the q-PCR 
were routinely confirmed by conventional PCR using NMik fo-gltA and NMik re-gltA primers, 
followed by DNA sequencing.
Optimized conditions for multiplex PCR
PCR was performed in a multiplex format with a reaction volume of 20 μl, using the iQ 
Multiplex Powermix (Bio-Rad Laboratories, Hercules, USA), in the LightCycler 480 Real-Time 
PCR System (F. Hoffmann-La Roche, Basel, Switzerland). Final PCR reaction concentrations 
were 1x iQ Powermix, primers ApMSP2F and ApMSP2R at 250 nM each, probe ApMSP2P-
FAM at 125 nM, primers NMikGroEL-F2a and NMikGroEL-R2b at 250 nM each, probe 
NMikGroEL-P2a-RED at 250 nM, and 3 μl of template DNA. Cycling conditions were: 95°C for 
5 min, followed by 60 cycles of a 5 sec denaturation at 95°C followed by a 35 sec annealing-
extension step at 60°C.
Ticks lysates were considered positive if the Ct-value of a proper sigmoid curve was maximally 
three cycles more than the highest dilution of the positive control sample. For each PCR and 
real-time multiplex PCR, positive, negative controls and blank samples were included. A 10-3 
to 10-5 dilution of a mixture of sequencing-confirmed Candidatus Neoehrlichia mikurensis-
positive tick lysates were used as positive controls. In order to minimize contamination, the 
reagent setup, the extraction and sample addition, and the real-time PCR as well as sample 
analysis were performed in three separate rooms, of which the first two rooms were kept at 
positive pressure and had airlocks.
Table 2: Primers used for amplification and sequencing of gltA and groEL genes of Candidatus 
Neoehrlichia mikurensis, and the amplification of the msp2 gene of A. phagocytophilum. Primers were 
either identical to or slightly modified from the primers described in the reference papers.
Gene Name Type Sequence Reference
gltA NMik fo-gltA Primer (forward) 5’-aagtgcatgctttgctacatt-‘3 This study
gltA NMik re-gltA Primer (reverse) 5’-tcatgatctgcatgtaaaataaat-‘3 This study
GroEL NMikGroEL-F2a Primer (forward) 5’-ccttgaaaatatagcaagatcaggtag-‘3 This study
GroEL NMikGroEL-R2b Primer (reverse) 5’-ccaccacgtaacttatttagtactaaag -‘3 This study
GroEL NMikGroEL-P2a Probe (RED) 5’-RED-cctctactaattattgctgaagatgtagaag
gtgaagc-BHQ2-‘3
This study
GroEL NMik fo-groEL Primer (forward) 5’-gaagyatagtytagtatttttgtc-‘3 [220]
GroEL NMik re-groEL Primer (reverse) 5’-ttaacttctacttcacttgaacc-‘3 [220]
GroEL NMik seq1groEL Primer (reverse) 5’-acatcacgcttcatagaaag-‘3 [220]
GroEL NMik seq2groEL Primer (forward) 5’-aaaggaattagtattagaatcttt-‘3 [220]
GroEL NMik seq3groEL Primer (forward) 5’-aatatagcaagatcaggtagac-‘3 [220]
GroEL NMik seq4groEL Primer (reverse) 5’-cttccattttaactgctaattc-‘3 [220]
Msp2 ApMSP2F Primer (forward) 5’-atggaaggtagtgttggttatggtatt-‘3 [227]
Msp2 ApMSP2R Primer (reverse) 5’-ttggtcttgaagcgctcgta-‘3 [227]
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DNA sequencing and genetic analysis
PCR amplicons were sequenced using the described primers (Table 2) and the BigDye 
Terminator Cycle sequencing Ready Reaction kit (Perkin Elmer, Applied Biosystems). All 
sequences were confirmed by sequencing both strands. Sequences were compared with 
sequences in Genbank, using BLAST after subtraction of the primer sequences (http://www.
ncbi.nlm.nih.gov/genbank/). The collected sequences were assembled, edited, and analyzed 
with BioNumerics version 6.5 (Applied Maths NV, Sint-Martens-Latem, Belgium). Resulting 
sequences were aligned with those from related organisms in Genbank. Phylogenetic 
analyses of the sequences and related organisms were  conducted  using the BioNumerics 
program using the neighbour-joining algorithm with Kimura’s two-parameter model. 
Bootstrap proportions were calculated by the analysis of 1000 replicates for neighbour-
joining trees. DNA sequences are available upon request.
RESULTS
Comparison of Ehrlichia schotti with Candidatus Neoehrlichia mikurensis 
Twenty-three tick lysates, which were previously tested positive for the presence of 
Ehrlichia Schotti-variant by PCR and Reverse Line Blotting were amplified by PCR on the 
three loci 16S rDNA gene, gltA and groEL using primers specific for Candidatus Neoehrlichia 
mikurensis (Table 2). Almost all Ehrlichia schotti-variant-positive tick lysates were also PCR-
positive on these three markers. None of these three loci were successfully amplified in 
fifteen Ehrlichia schotti-variant-negative ticks. The PCR products of parts of the 16S rDNA, 
gltA and groEL were sequenced and compared with Candidatus Neoehrlichia mikurensis 
sequences available in Genbank. The 1740 base pairs of the 16S rDNA sequences from 
the Ehrlichia schotti-variant were 99.6% to 100% similar to the Candidatus Neoehrlichia 
mikurensis sequences and the Candidatus Ehrlichia walkerii sequence in Genbank (Table 
3). The 233 base-pair fragment of the gltA sequences from the Ehrlichia schotti were 
identical to the Candidatus Ehrlichia walkerii gltA sequence (Table 3). The 1238 base- pairs 
of the groEL isolates amplified from the tick lysates showed a 94.3% and 95.5%, 98.7% 
and 100% (AB084583 and AB074461, EF633745 and FJ966365) match with the Candidatus 
Neoehrlichia mikurensis groEL sequences in Genbank, respectively. Phylogenetic analyses of 
the gltA and groEL sequences showed that the Ehrlichia schotti clustered with Candidatus 
Neoehrlichia mikurensis isolates, but not with A. phagocytophilum or any of the Ehrlichia 
species present in Genbank (Figure 1). 
Table 3: Members of the Candidatus Neoehrlichia mikurensis group are distinguished from other 
genera based on sequence analysis of 16SrDNA, citrate synthase (gltA) and heat shock protein groEL 
genes. This strain has been reported in different parts of the world under diverse nominations. The 
similarity of these isolates with Candidatus Neoehrlichia mikurensis isolates present in tick isolates 
from the Netherlands, were calculated.
Country (Ref.) Species Named Gene AccessionN Similarity 
Netherlands [210] I. ricinus Ehrlichia-like ‘schotti variant’ 16S AF104680 100%
Russia [228] I. ricinus
I. persulcatus
Ehrlichia-like ‘schotti variant’ 16S AF104680 100%


















China [232] Rattus norvegicus Ehrlichia-like ‘Rattus variant’ 16S AY135531 98.9%














USA [234] Procyon lotor Ehrlichia-like organism 16S AY781777 99.8%
Japan [235] A. argenteus








Russia [236] I. persulcatus Ehrlichia-like ‘schotti variant’ 16S AF104680 100%
Italy [55] C. glareolus C. N. mikurensis 16S AB213021 99.6%
Russia [237] M. rossiaemeridionalis
I. persulcatus
C. N. mikurensis 16S EF445398 100%











Slovakia [239] I. ricinus C. N. mikurensis 16S AB196305 99.7%
Russia  [237] I. persulcatus
A. peninsulae






















Germany [240] Dog C. N. mikurensis groEL EU432375 100%
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Figure 1: Phylogenetic tree of the groEL (top) and gltA (bottom) of different Anplasma and Ehrlichia 
species and their relation with Candidatus Neoehrlichia mikurensis and related species found around 
the world. Different groEL and gltA sequences were taken from Genbank. Their accession numbers 
are shown between brackets. The evolutionary distance values were determined by the method of 
Kimura, and the tree was constructed according to the neighbor-joining method. Bootstrap values 
higher than 90% are indicated at the nodes.
Prevalence and distribution of Candidatus Neoehrlichia mikurensis 
In order to estimate the prevalence and distribution of Candidatus Neoehrlichia mikurensis 
in North-West  Europe, questing I.  ricinus nymphs (~88%) and adults (~12%) were tested 
using a q-PCR for the simultaneous detection of Candidatus Neoehrlichia mikurensis and 
A. phagocytophilum. In all 12 study-areas in the Netherlands, Candidatus Neoehrlichia 
groEL
Schotti-variant- Wild rodents- the Netherlands
Anaplasma phagocytophilum  (AF383225) 
Ehrlichia canis    (U96731)         
Ehrlichia muris    (GU358686)   
Ehrlichia ewingii   (AF195273)       
Candidatus Neoehrlichia lotoris- (Procyon lotor RAC413)- USA  (EF633745) 
Candidatus Neoehrlichia mikurensis-Rattus norvegicus (TK4456)- Japan  (AB084583)   
Candidatus Neoehrlichia mikurensis- Wild rodents- Japan  (AB204865)       
Candidatus Neoehrlichia mikurensis- Ixodes ovatus ( IS58)- Japan  (AB074461)
Candidatus Neoehrlichia mikurensis- Wild rodents- Japan   (AB204864)         
Candidatus Neoehrlichia mikurensis- Ixodes persulcatus- Russia (FJ966359)         
Candidatus Neoehrlichia mikurensis- Apodemus peninsulae – Russia   (FJ966365)
Candidatus Neoehrlichia mikurensis- Human- Germany  (EU810406) 
Candidatus Neoehrlichia mikurensis- Ixodes ricinus- Germany (EU810407) 
Candidatus Neoehrlichia mikurensis- Dog- Germany  (EU432375)         















Schotti-variant- Wild rodents- the Netherlands






Ehrlichia sp.- Ixodes ricinus- France 
Candidatus Neoehrlichia lotoris- (Procyon lotor RAC413)- USA 
Candidatus Ehrlichia walkerii- Ixodes ricinus- Italy (AY098729)






mikurensis was detected with a prevalence varying from 1% to 16% (Table 5). Ticks from one 
study area (Duin en Kruidberg) were tested in two consecutive years. In 2009, 16% of the 
questing nymphs and adults I. ricinus were infected with Candidatus Neoehrlichia mikurensis. 
The prevalence of Candidatus Neoehrlichia mikurensis in questing ticks decreased to 8% in 
2010. Candidatus Neoehrlichia mikurensis positive I. ricinus ticks were found in two out of 
three regions in Belgium. A fraction of the ticks from the Candidatus Neoehrlichia mikurensis 
negative area (Brussels) were positive for A. phagocytophilum, which was comparable to other 
regions (data not shown), indicating that the processing and testing of ticks from this area 
was not affecting the outcome of the results. The results for the A. phagocytophilum will be 
published elsewhere. To determine whether Candidatus Neoehrlichia mikurensis is present in 
the UK, 338 I. ricinus and 63 D. reticularis ticks from a previous study were tested [241]. These 
ticks were collected at 7 dispersed study areas in the UK and were partially caught by blanket 
dragging and removed from wildlife, pets and humans. Anaplasma phagocytophilum, but not 
Candidatus Neoehrlichia mikurensis, was detected in these tick lysates.
Table 4: The prevalence and distribution of Candidatus Neoehrlichia mikurensis in questing I. ricinus in 
the Netherlands and Belgium. Confidence intervals (95%), which were calculated using Fisher’s exact 
test, are between brackets.
Location Tested (n) Positive (n) Prevalence (%)
Boswachterij Hardenberg 90 7 8% (3-15%)
Dintelse Gorzen 122 9 7% (3-14%)
Drents-Friese Wold 29 1 3% (0-18%)
Duin en Kruidberg (2009) 320 52 16% (12-21%)
Duin en Kruidberg (2010) 137 11 8% (4-14%)
Hoog Soeren 217 3 1% (0-4%)
Kop van Schouwen 238 23 10% (6-14%)
Denekamp 104 4 4% (1-10%)
Pyramide van Austerlitz 270 32 12% (8-16%)
Rijk van Nijmegen 53 1 2% (0-10%)
Ulvenhoutse bos 8 1 13% (0-53%)
Vijlenerbos 328 10 3% (2-5%)
Vrouwenpolder 86 6 7% (3-15%)
Brussel-area (Belgium) 153 0 0% (<2%)
Vlaanderen-area (Belgium) 114 3 3% (1-8%)
Wallonië-area (Belgium) 106 3 3% (1-8%)
Total of all ticks 2375 166 7% (6-8%)
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Role of ticks in the transmission of Candidatus Neoehrlichia mikurensis
Transovarial (vertical) transmission has been implicated for Rickettsia [103] and Anaplasma 
[242], but not for Ehrlichia species [243]. Whether Candidatus Neoehrlichia mikurensis is 
transmitted transovarially in I. ricinus has not been investigated so far. The prevalence of 
Candidatus Neoehrlichia mikurensis was determined in 55 pools of 5 questing I. ricinus larvae 
from Vrouwenpolder, where nymphal and adult ticks were found to be positive for Candidatus 
Neoehrlichia mikurensis (Table 4). None of the 55 pools were Candidatus Neoehrlichia 
mikurensis positive (Table 5). Some of the pools were positive for A. phagocytophilum, 
approving the used methodology. The prevalence of Candidatus Neoehrlichia mikurensis in 
questing I. ricinus nymphs was ~7%, whereas the prevalence in adult ticks was ~11% (Table 
5). No significant differences were observed in the prevalence between questing male and 
female I. ricinus ticks. To investigate the role of other tick species in the transmission of 
Candidatus Neoehrlichia mikurensis: Dermacentor reticulatus, I. hexagonus and I. arboricola 
were analyzed for the presence of Candidatus Neoehrlichia mikurensis (in the multiplex 
real-time PCR). None were found positive (Table 6). Again, some were found positive for 
the A. phagocytophilum msp2 gene (data not shown), indicating that there is no significant 
inhibition within these samples.
Table 5: Prevalence of Candidatus Neoehrlichia mikurensis in questing I. ricinus, divided by lifecycle 
stage. *Pools of 5 larvae. 95% Confidence intervals of the prevalence are between brackets.
Stage Tested (n) Positive (n) Prevalence (%)
Larvae 55* 0 0% (<1%)
Nymph 2003 137 7% (6-8%)
Female 92 10 11% (5-20%)
Male 173 19 11% (7-17%)
Table 6: D. reticularis, I. hexagonus and I. arboricola tested in the multiplex real-time PCR for Candidatus 
Neoehrlichia mikurensis. 95% Confidence intervals of the prevalence are between brackets.
Tick species Tested (n) Positive (n) Prevalence (%)
I. arboricola 79 0 0% (<5%)
I. hexagonus 169 0 0% (<2%)
Dermacentor reticulatus 177 0 0% (<2%)
Potential reservoir hosts of Candidatus Neoehrlichia mikurensis
To investigate the possible mammalian hosts for Candidatus Neoehrlichia mikurensis, 
79 spleen samples of different wild small mammals were tested by (nested)-PCR for the 
presence of gltA and groEL (Table 7). PCR-positive samples were sequenced to confirm 
the presence of Candidatus Neoehrlichia mikurensis. Both the groEL and gltA sequences 
isolated from spleen were identical to the Candidatus Neoehrlichia mikurensis sequences 
found in the questing ticks in the Netherlands (Figure 1). Spleen samples from Apodemus 
sylvaticus, Microtus arvalis and Myodes glareolus were Candidatus Neoehrlichia mikurensis 
positive. After the spleen was found positive, other organs (kidney, liver and brain) were also 
tested for Candidatus Neoehrlichia mikurensis. All the tested organs were positive.
Table 7: Spleens of wild rodent and insectivore species were tested by PCR and sequencing using 
Candidatus Neoehrlichia mikurensis specific primers.
Rodent species Tested (n) Positive (n)
Apodemus flavicollis 2 0
Apodemus sylvaticus 23 5
Crocidura russula 5 0
Microtus arvalis 8 2
Myodes glareolus 35 4
Sorex araneus 6 0
Total 79 11
Whether other mammals in the Netherlands are reservoir hosts is difficult to address, due 
to the protective status of these animals. An animal can be considered a potential reservoir 
host when the prevalence of Candidatus Neoehrlichia mikurensis in ticks feeding on this 
animal is significantly higher than the prevalence in questing ticks. This is for example the 
case for A. phagocytophilum [244-248]. Ixodes ricinus feeding on red deer (Cervus elaphus), 
European mouflon (Ovis orientalis musimon), wild boar (Sus scrofa) and sheep (Ovis 
aries) were tested by multiplex real-time PCR. The prevalence of Candidatus Neoehrlichia 
mikurensis in feeding ticks was comparable to the prevalence in questing ticks (Table 8).
Table 8: Ixodes ricinus ticks feeding on animals living in nature reserve areas in the Netherlands were 











Cervus elaphus 409 26 6% (4-9%) 17 10
Sus scrofa 48 4 8% (2-20%) 8 2
Ovis aries 264 33 13% (9-17%) 24 13
Ovis orientalis 
musimon
233 10 4% (2%-8%) 18 4
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Recently, six human and one canine case of Candidatus Neoehrlichia mikurensis infection 
were reported in different locations in Europe. These reports advocate a re-assessment of 
the occurrence of this microorganism in questing ticks. Schouls and colleagues described an 
Ehrlichia-like organism (Ehrlichia schotti) in Dutch ticks [51]. In our study, the three genetic 
markers 16S rDNA, gltA and groEL of Ehrlichia schotti-positive field isolates turned out to be 
similar and identical to DNA sequences available from Candidatus Neoehrlichia mikurensis. 
Thus, Ehrlichia schotti and Candidatus Neoehrlichia mikurensis are most likely one and 
the same species. Previous findings on Ehrlichia schotti can be interpreted as findings on 
Candidatus Neoehrlichia mikurensis. Thus, Candidatus Neoehrlichia mikurensis has already 
been present in the Netherlands in 1999 [104, 177]. Furthermore, 11% of 289 engorged I. 
ricinus removed from humans were Candidatus Neoehrlichia mikurensis positive, indicating 
that the Dutch population is being exposed to ticks infected with Candidatus Neoehrlichia 
mikurensis [66]. Remarkably, human and animal cases of Candidatus Neoehrlichia mikurensis 
infection in the Netherlands have not yet been described.
The development of a real time-PCR specific for Candidatus Neoehrlichia mikurensis 
allowed us to test significant numbers of ticks without having to perform the labor-intensive 
Reverse-Line blotting. These analyses showed that the Candidatus Neoehrlichia mikurensis 
is present in vegetation ticks throughout the Netherlands and Belgium. No Candidatus 
Neoehrlichia mikurensis -positive ticks were found in one location in Belgium. One possible 
explanation is that this location in the Brussels-area is exceptional due to its reduced fauna 
and flora caused by human interference. This forest in the Brussels-area is also highly 
fragmented because of a railroad and several major motorways that run through the forest. 
Several parts of it can be ecologically considered ‘islands,’ which could -through isolation 
of mammal and tick populations- explain the absence of the pathogen in this forest. More 
ticks of this unique area need to be tested in order to address this hypothesis. Candidatus 
Neoehrlichia mikurensis was also not detected in ticks from the UK. This could indicate that 
these species have not (yet) been established on this island.
The overall prevalence of Candidatus Neoehrlichia mikurensis in questing nymphs and adults 
is approximately 7%. From the public health point of view, it indicates that a significant 
proportion of people contracting a tick bite are exposed to Candidatus Neoehrlichia 
mikurensis. Transmission of the Candidatus Neoehrlichia mikurensis in ticks appears to 
occur horizontally rather than vertically. None of the tested larvae were found positive, even 
though the prevalence of nymphs is approximately 7% and 11% for adults. Other tick species, 
with more restricted host preference than I. ricinus, were also tested for the presence of 
Candidatus Neoehrlichia mikurensis. Dermacentor reticulatus, I. hexagonus and questing 
I. arboricola were found negative. The data indicate that these tick species probably play 
insignificant roles in the transmission of Candidatus Neoehrlichia mikurensis. In contrast, I. 
ricinus can be considered as its main vector in the Netherlands and Belgium.
A potential group of reservoir hosts for Candidatus Neoehrlichia mikurensis are wild 
rodents. Indeed, spleen samples and other organs (kidney, liver and brain) of some rodent 
species turned out to be Candidatus Neoehrlichia mikurensis positive, which indicates 
a systemic infection of these rodents with Candidatus Neoehrlichia mikurensis. The 
Candidatus Neoehrlichia mikurensis isolates from ticks and wild rodents (Table 7) were 
genetically identical, indicating that rodents are potential reservoir hosts [202]. However, 
the reservoir potential of rodents can only be by xeno-diagnosis or experimental infection. 
The prevalence of Candidatus Neoehrlichia mikurensis in I. ricinus ticks feeding on red deer, 
European mouflon, wild boar and sheep were comparable to the prevalence in questing 
ticks. From these prevalence data, it was not possible to infer the role of these animals in the 
transmission of Candidatus Neoehrlichia mikurensis. However, it is clear that these animals 
are being exposed to the Candidatus Neoehrlichia mikurensis through tick bites. Further 
experiments are necessary to determine whether there are other mammalian reservoirs 
than wild rodents.
CONCLUSION
Although human infection of the Candidatus Neoehrlichia mikurensis has not been reported 
in the Netherlands, it is unclear to what extent Candidatus Neoehrlichia mikurensis poses 
risks to public health. The symptoms described in all of the Candidatus Neoehrlichia 
mikurensis infection cases were generally non-specific and usually seen in any other 
ordinary inflammatory reaction. What’s more, most of the Ehrlichia infections are known 
to be either asymptomatic or mild, self-limiting diseases [198]. In other words, infection 
can occur without causing disease. So far, diagnosis has relied only on PCR amplification 
of the Candidatus Neoehrlichia mikurensis. The lack of serological tests makes diagnosis 
particularly difficult. Against these backdrops, the actual incidence of human infection with 
Candidatus Neoehrlichia mikurensis is likely to be much higher than currently reported in 
Europe. Thorough surveillance and improvement of diagnostic tools will probably increase 
the number of identified human cases, and consequently provide more insight in the public 
health relevance of Candidatus Neoehrlichia mikurensis.
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Anaplasma phagocytophilum is the etiological agent of granulocytic anaplasmosis in 
humans and animals. Wild animals and ticks play key roles in the enzootic cycles of the 
pathogen. Potential ecotypes of A. phagocytophilum have been characterized genetically, 
but their host range, zoonotic potential and transmission dynamics has only incompletely 
been resolved.
Methods
The presence of A. phagocytophilum DNA was determined in more than 6000 ixodid ticks 
collected from the vegetation and wildlife, in 289 tissue samples from wild and domestic 
animals, and 69 keds collected from deer, originating from various geographic locations in the 
Netherlands and Belgium. From the qPCR-positive lysates, a fragment of the groEL-gene was 
amplified and sequenced. Additional groEL sequences from ticks and animals from Europe 
were obtained from GenBank, and sequences from human cases were obtained through 
literature searches. Statistical analyses were performed to identify A. phagocytophilum 
ecotypes, to assess their host range and their zoonotic potential. The population dynamics 
of A. phagocytophilum ecotypes was investigated using population genetic analyses. 
Results
DNA of A. phagocytophilum was present in all stages of questing and feeding Ixodes ricinus, 
feeding I. hexagonus, I. frontalis, I. trianguliceps, and deer keds, but was absent in questing I. 
arboricola and Dermacentor reticulatus. DNA of A. phagocytophilum was present in feeding 
ticks and tissues from many vertebrates, including roe deer, mouflon, red foxes, wild boar, 
sheep and hedgehogs but was rarely found in rodents and birds and was absent in badgers 
and lizards. Four geographically dispersed A. phagocytophilum ecotypes were identified, 
that had significantly different host ranges. All sequences from human cases belonged 
to only one of these ecotypes. Based on population genetic parameters, the potentially 
zoonotic ecotype showed significant expansion.
Conclusion
Four ecotypes of A. phagocytophilum with differential enzootic cycles were identified. So 
far, all human cases clustered in only one of these ecotypes. The zoonotic ecotype has the 
broadest range of wildlife hosts. The expansion of the zoonotic A. phagocytophilum ecotype 
indicates a recent increase of the acarological risk of exposure of humans and animals.
INTRODUCTION
Anaplasma phagocytophilum is an obligate intracellular bacterium of the family 
Anaplasmataceae in the order Rickettsiales that causes disease in humans and animals [47]. 
It infects neutrophils, resulting in influenza-like symptoms clinically and on rare occasions is 
even a fatal condition in humans [249]. The first cases of Human Granulocytic Anaplasmosis 
(HGA) were reported in the USA in 1994 [43]. This incidence has increased gradually to 6.1 
cases per million persons in 2010. The first European case was reported in Slovenia in 1995. 
Since, HGA cases have been occasionally reported throughout Europe [36]. It is unclear 
to what extent HGA poses a risk to public health in Europe: epidemiological data on the 
disease incidence and disease burden is either incomplete or lacking from most European 
countries [250]. The non-specificity of the reported symptoms, poor diagnostic tools and 
lack of awareness of public health professionals further complicate these estimations [36, 
164, 251]. 
Anaplasma phagocytophilum is transmitted to humans by the bite of an infected tick [252]. 
The main vector in Europe is I. ricinus, which also transmits Borrelia burgdorferi sensu lato, 
the causative agent of Lyme borreliosis. In the Netherlands, Lyme borreliosis is on the rise: 
there has been a threefold increase in consultations of general practitioners for tick bites 
and Lyme borreliosis since 1994. This rise can be partially explained by spatiotemporal 
increases in the abundance and activity of questing ticks [161, 253, 254]. It is to be expected 
that growth in tick abundance and activity will also increase the risk of human exposure to 
other tick-borne pathogens such as A. phagocytophilum, but evidence for this extrapolation 
is lacking [38, 255]. 
Anaplasma phagocytophilum is maintained in nature through enzootic cycles between ticks 
and wild animals [252]. The pathogen has been detected in ticks in most European countries 
and the infection rates range from 0.4% to 67% [36]. In the Netherlands, infection rates in 
questing nymphs and adults vary between 0% and 8% [38]. Anaplasma phagocytophilum has 
been detected in a wide range of wildlife species, including ruminants, rodents, insectivores, 
carnivores, birds and even reptiles [36]. The relative roles of each tick stage and wildlife 
species in the enzootic life cycles of A. phagocytophilum have not been fully elucidated yet 
[36]. 
Anaplasma phagocytophilum is currently considered as a single bacterial species. Cross-
infection experiments, where isolates from distinct host origins were not uniformly infectious 
for heterologous hosts, indicate that host specialization of A. phagocytophilum may occur 
[256, 257]. Furthermore, Anaplasma phagocytophilum can be genetically divided into either 
a few or many subclusters, depending on the genetic markers used. As sequence-based 
clusters in the bacterial world appear to correspond to an “ecotype”, defined as a population 
of cells in the same ecological niche [258], subclustering may be related to variation in space, 
host preference, and pathogenicity. Initially, sequences from the 16S rRNA gene have been 
78  
CHAPTER 4  Circulation of four Anaplasma phagocytophilum ecotypes in Europe
 79
4
used for subclustering, but this gene was shown to not be informative enough to delineate 
distinct ecotypes of A. phagocytophilum [259, 260]. Highly variable gene fragments encoding 
for major surface proteins [261, 262], and ankA, a secretory protein [263-265], have been 
used as well. The groEL heat shock operon has an intermediate genetic variability and is 
expected to act as a marker for demographic analyses [266-269]. Sequences from the groEL 
operon have been shown to more clearly delineate ecotypes of A. phagocytophilum than do 
sequences of the 16S rRNA gene [266, 270].
Knowledge on the distribution of A. phagocytophilum in ticks and wildlife in the Netherlands 
and Belgium is scarce. The aim of this study was to investigate the distribution of A. 
phagocytophilum in different stages of endemic tick species and in wildlife hosts and free 
ranging domestic animals. The potential vectors and animal samples were tested by qPCR 
and conventional PCR, to determine whether they were infected with A. phagocytophilum. 
We investigated whether genetic delineation, based on groEL, correlates with host 
distribution/species and zoonotic potential. To assess whether the differential distribution 
of the genetic variants was due to geographic variation, all available groEL sequences of 
European A. phagocytophilum isolates were collected and subjected to similar analyses. 
Population genetic analyses were used to determine which of the ecotypes is expanding. 
METHODS
Collection of samples and DNA extraction
Questing I. ricinus and Dermacentor reticulatus were collected by blanket dragging at 17 
different sites in the Netherlands and Belgium [205, 271]. Ixodes arboricola and I. frontalis 
(nymphs and adults and fed larvae) were collected from bird nest boxes and from birds that 
were captured with mistnets and nest traps in forested areas around the city of Antwerp 
(Belgium) [271]. Ixodes hexagonus feeding on European hedgehogs (Erinaceus europaeus) 
were collected in a hedgehog-shelter [205]. Ixodes trianguliceps and I. ricinus feeding on 
bank voles (Myodes glareolus) and wood mice (Apodemus sylvaticus) were collected at 
several different sites in the Netherlands and Belgium. Ixodes ricinus feeding on red deer 
(Cervus elaphus), European mouflon (Ovis orientalis musimon), wild boar (Sus scrofa), 
sheep (Ovis aries), wood mouse (A. sylvaticus), and sand lizard (Lacerta agilis) has been 
described in previous studies [205, 207, 272]. Volunteers collected I. ricinus feeding on roe 
deer (Capreolus capreolus) at various localities from deer-shelters. Hunters collected deer 
keds (Lipoptena cervi) from culled roe deer. Spleen samples were obtained from 19 animal 
species. These included samples from roe deer, several bird species and badgers (Meles 
meles), which were found dead or were euthanized and sent to the Dutch Wildlife Health 
Centre for postmortem examination. The spleen samples obtained from foxes (Vulpes vulpes) 
as well as the capture of wild rodents have been described elsewhere [205, 273]. EDTA-
blood from clinically and laboratory confirmed anaplasmosis from horses were collected in 
a veterinary hospital [274]. DNA from questing ticks was extracted by alkaline lysis [207]. 
Blood and spleen samples were kept frozen (-80 °C) until testing. DNA from engorged ticks, 
deer keds, and tissue samples was extracted using the Qiagen DNeasy Blood & Tissue Kit 
[205]. 
Polymerase chain reactions and sequencing
All samples were screened for the presence of A. phagocytophilum DNA with a real-
time polymerase chain reaction (qPCR) targeting a 77-bp portion of the msp2 gene. 
The primers used were ApMSP2F (5’-atggaaggtagtgttggttatggtatt-‘3) and ApMSP2R 
(5’-ttggtcttgaagcgctcgta-‘3), and the probe was ApMSP2P (5’-tggtgccagggttgagcttgagattg-‘3) 
labeled with FAM6 [227]. This qPCR was performed in a multiplex format with Candidatus 
Neoehrlichia mikurensis [205]. qPCR-positive samples were analyzed further with primers 
targeting a fragment of the groEL gene of A. phagocytophilum [275]. All sequences were 
confirmed by sequencing both strands. The sequences were stored and analyzed in 
Bionumerics (Version 7.1, Applied Math, Belgium), after subtraction of the primer sequences.
Molecular epidemiological database
Anaplasma phagocytophilum groEL DNA sequences with the geographical origin (country) 
and the host species from which the isolate originated were also downloaded from the 
Entrez Nucleotide Database (GenBank, NCBI). Anaplasma phagocytophilum sequences 
originating from Northern white-breasted hedgehogs (Erinaceus roumanicus) were from a 
previous study [276]. Sequences that did not originate from natural isolates were excluded. 
Sequences that were too short to cover regions of variation were also excluded from further 
analysis. A literature search was performed to specifically extract A. phagocytophilum 
groEL DNA sequences from human patients in Europe [277-282]. DNA sequences and 
epidemiological data used for this study are given in the supplementary Table 1. 
Phylogenetic and population genetic analysis
We delineated four A. phagocytophilum clusters (called ecotypes) by visually inspecting a 
phylogenetic tree (Supplementary Figure 1). A best-scoring maximum likelihood tree was 
obtained using RAxML 7.5.5 [283] with the option rapid bootstraps (n = 100). Each codon-
position was separately analyzed using a general-time-reversible model of base substitutions, 
gamma-distributed rates and invariant proportions. These models of DNA evolution were 
determined using PartitionFinder 1.0.1 [284]. The sequences were aligned using MAFFT 
[285] with default options. Alignment was trimmed (position 642 to 1084) to exclude short 
sequences to visualize genealogy of A. phagocytophilum haplotypes using Haploviewer 
(http://www.cibiv.at/~greg/haploviewer). Population genetics measures (Ewens-Watterson 
test, Tajima’s D, Fu’s Fs) were calculated using Arlequin [286] using untrimmed alignment. 
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Host distributions between and within ecotypes
One A. phagocytophilum ecotype might be over-represented among lysates from a particular 
host species. We tested this possibility using a multinomial model in which a lysate from a 
particular host species is evenly associated across all four ecotypes, i.e. with the probability 
of 1/4 per ecotype. We then estimated by the Monte Carlo method the probability that the 
number of most numerous ecotypes in a random realization from the multinomial is equal 
to or greater than the observed maximum among our lysates. The probability (i.e. P-values) 
less than 0.05 were considered significant support for selective distribution. Counting 
distinct host species is an alternative measure of host diversity per ecotype. However, 
observed number of distinct host species is best avoided because the sample availability 
varied by ecotype and a straightforward comparison in this case is invalid. Therefore, we 
applied the rarefaction analysis to our datasets and calculated whether the differences in 
observed number of distinct host species per ecotype were statistically significant and not 
a random variation due to the sampling bias. For this purpose, we computed p-values using 
EstimateS (Version 9, R. K. Colwell, http://purl.oclc.org/estimates).
RESULTS
A total of 3493 questing nymphs and adult I. ricinus from various geographical areas in 
the Netherlands and Belgium were tested for the presence of A. phagocytophilum by PCR. 
DNA of A. phagocytophilum was found in 2.6% of the tested ticks (90/3493), and in 13 of 
the 17 investigated areas (Table 1). Anaplasma phagocytophilum DNA was also detected 
in 1.3% (5/386) questing I. ricinus larvae (Table 2). The infection rate of adult I. ricinus was 
significantly higher than that of larvae or nymphs. No significant difference was observed 
between the infection rates of larvae and nymphs (Table 2). Anaplasma phagocytophilum 
DNA was not detected in I. arboricola (n=79) and I. frontalis (n=13) collected from nest 
boxes, nor in questing Dermacentor reticulatus (n=59), but was found in 42% of the deer 
keds (29/69) feeding on 10 roe deer.
Table 1: Infection rates of A. phagocytophilum in questing I. ricinus nymphs and adults. 
Ticks were collected by blanket dragging on various locations in The Netherlands and Belgium (three 
locations). The 95%-confidence intervals, which were calculated using Fisher’s exact test, are between 
brackets. The five locations with infection rates significantly lower than 3% are indicated in bold. The 
four locations with infection rates significantly higher than 3% are indicated in italic bold.
Location Tested (n) Positive (n) Infection rate (CI)
Denekamp 104 0 0.0% (<2.8%)
Vlaanderen-area (Belgium) 114 0 0.0% (<2.6%)
Pyramide van Austerlitz 270 1 0.3% (<1.8%)
Vijlenerbos 328 1 0.3% (0-1.5%)
Kop van Schouwen 238 2 0.8% (0.1-2.7%)
Rijk van Nijmegen 53 0 0.0% (<5.5%)
Ulvenhoutse bos 61 0 0.0% (<36%)
Wallonië-area (Belgium) 106 1 0.9% (0-5%)
Dintelse Gorzen 122 2 1.6% (0.2-5.8%)
Duin en Kruidberg 457 8 1.8% (0.8-3.4%)
Boswachterij Hardenberg 90 2 2.2% (0.3-7.8%)
Dwingeloo-area 1071 35 3.3% (2.3-4.5%)
Drents-Friese Wold 29 2 6.9% (0.8-22%)
Hoog Soeren 217 14 6.5% (3.7-10.3%)
Brussels-area (Belgium) 153 10 6.5% (3.1-11.7%)
Vrouwenpolder 86 7 8.0% (3.3-16%)
Hoge Veluwe 47 5 10.6% (4.0-22%)
Total of all ticks 3493 90 2.5% (2.0-3.1%)
Table 2: Infection rates of A. phagocytophilum in questing I. ricinus, divided by life stage. 
The 95%-confidence intervals, which were calculated using Fisher’s exact test, are between brackets. 
The infection rate of adults is significantly higher than larvae or nymphs (p<0.05).
Stage Tested (n) Positive (n) Infection rate (CI)
Larvae 386 5 1.3% (0.4-3.0%)
Nymph 3090 68 2.2% (1.7-2.8%)
Adult 306 18 5.9% (3.5-9.1%)
Female 113 5 4.4% (1.5-10.2%)
Male 193 13 6.7% (3.6-11.2%)
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To investigate the possible vertebrate host species for A. phagocytophilum, tissue samples 
of many different animals were tested (Table 3). Spleen samples from roe deer (26/38), 
red foxes (8/81), one wood mouse (1/23) and one common black bird (1/11) were positive 
(Table 3). Other organs, except brain, of the wood mouse and common black bird were 
also tested positive in the A. phagocytophilum qPCR (data not shown). Anaplasma 
phagocytophilum DNA was also amplified from 14 clinically- and laboratory confirmed 
horses. No A. phagocytophilum DNA was detected in the spleen samples of other rodents 
(n=45), insectivores (n=11), songbirds (n=26), and badgers (n=40).
Table 3: Presence of A. phagocytophilum in vertebrate tissue samples.
DNA extracts from spleen and EDTA-blood of wildlife and horses were tested by qPCR. The presence 
of A. phagocytophilum was confirmed in most cases by conventional PCR using groEL specific primer 
pairs, followed by sequencing. Positive animal species are shown in bold.
Species Common name Tested (n) Positive (n)
Apodemus flavicollis Yellow-necked mouse 2 0
Apodemus sylvaticus Wood mouse 23 1
Crocidura russula White-toothed shrew 5 0
Microtus arvalis Common vole 8 0
Myodes glareolus Bank vole 35 0
Sorex araneus Common shrew 6 0
Carduelis chloris Greenfinch 4 0
Coccothraustes coccothraustes Hawfinch 2 0
Fringilla coelebs Common chaffinch 3 0
Parus major Great tit 4 0
Phylloscopus trochilus Willow warbler 1 0
Pyrrhula pyrrhula Bullfinch 1 0
Turdus iliacus Redwing 5 0
Turdus merula Common blackbird 11 1
Turdus philomelos Song thrush 6 0
Capreolus capreolus Roe deer 38 26
Equus ferus caballus Domestic horse 14 14
Vulpes vulpes Red fox 81 8
Meles meles Badger 40 0
Total 289 50
Due to their protected status in the Netherlands and Belgium, it is very difficult to address 
the infection rate of A. phagocytophilum in wildlife. As a proxy for their infection rates, ticks 
feeding on wildlife were collected and tested. The infection rates of I. ricinus feeding on roe 
deer, red deer, hedgehog, sheep, and mouflon (Table 4) were significantly higher than the 
infection rate of questing adult I. ricinus (Table 2). Ticks from wild boar were also positive 
(5/48), but not significantly more than I. ricinus from the vegetation (Table 1). Only one 
of the 109 I. ricinus larvae feeding on wood mice were positive for A. phagocytophilum. 
This same wood mouse carried 18 A. phagocytophilum-negative larvae (data not shown). 
Only nine I. trianguliceps feeding on four wood mice (n=4) and three bank voles (n=5) were 
collected. All eight larvae were negative, whereas one female I. trianguliceps feeding on 
a wood mouse was A. phagocytophilum-positive (Table 4). Both I. ricinus (11/117) and I. 
frontalis (4/7) feeding on common black birds were A. phagocytophilum-positive (Table 
4). One I. frontalis (1/194) and none of the I. arboricola feeding on great/blue tit were A. 
phagocytophilum-positive. Ixodes ricinus ticks feeding on sand lizards were all negative for 
A. phagocytophilum (Table 4). 
Table 4: Infection rates of A. phagocytophilum in different Ixodid species feeding on wildlife. Larval (L), 
nymphal (N) and adult (A) stages of Ixodes ricinus (IR), I. trianguliceps (IT), I. frontalis (IF), I. arboricola 
(IA) and I. hexagonus (IH) feeding on different vertebrate species were tested for the presence of A. 
phagocytophilum DNA. The infection rates of ticks from animal species in bold are significantly higher 
than those of ticks from the vegetation (Table 1). The 95%-confidence intervals of these infection 
rates, which were calculated using Fisher’s exact test, are between brackets. Data from sand lizards 
are derived from a previous study [207].















Apodemus sylvaticus IR 109 L 1 0.9% (0-5%) 26 1
Apodemus sylvaticus IT 4 A/L 1 25% (1-81%) 4 1
Myodes glareolus IT 5 L 0 0% (<52%) 5 0
Turdus merula IR 117 N/L 11 9% (5-16%) 42 6
Turdus merula IF 7 N 4 57% (18-90%) 6 3
Parus major/caeruleus IF 194 A/N/L 1 1% (<3%) 120 3
Parus major/caeruleus IA 13 A/N/L 0 0% (<25%) 13 0
Lacerta agilis IR 165 A/N/L 0 0% (<2%) 93 0
Sus scrofa IR 48 N 5 10% (3.5-23%) 8 4
Erinaceus europaeus IH 193 A/N 44 23% (17-29%) ND ND
Ovis orientalis musimon IR 233 A 120 52% (45-58%) 18 18
Ovis aries IR 264 A 173 66% (59-71%) 24 24
Capreolus capreolus IR 301 A/N/L 245 81% (77-86%) 38 35
Cervus elaphus IR 409 A/N 351 86% (82-89%) 16 16
Total 2062 956 413 111
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In total, 162 groEL sequences were obtained from the qPCR-positive samples. Together with 
the groEL sequences from Genbank a phylogenetic tree was reconstructed (Supplementary 
Figure 1). Four major A. phagocytophilum clusters, called ecotypes, could clearly be delineated 
from this tree. Bootstrap support values were: 98% (ecotype I), 100% (ecotype III) and 100% 
(ecotype IV). Bootstrap support values for ecotype II was not explicitly computed, but the 
high support values for the ecotypes I, III and IV imply that the ecotype II is similarly well 
supported. These four ecotypes were also visually distinguishable in haplotype genealogies 
in samples both from all over Europe (Figure 1) and from the Netherlands/Belgium (not 
shown). Based on these four ecotypes, all the available sequences were subdivided further 
based on their vertebrate host (Table 5). The majority of A. phagocytophilum samples 
belonged to ecotype I or II (Table 5). Ecotype I was isolated significantly more often from 
cattle, dogs, hedgehogs, horses, mouflons, red deer, sheep, and humans, while ecotype 
II was isolated significantly more often from roe deer. Anaplasma phagocytophilum from 
wood mouse was identical to the groEL sequence found in the engorged I. trianguliceps. 
Both these samples belonged to ecotype III. Likewise, 18 European isolates from rodents, 
and two isolates originating from I. persulcatus belonged to ecotype III. Four I. frontalis, 
one I. ricinus feeding on common blackbirds, and one spleen from a common blackbird 
contained A. phagocytophilum isolates belonging to ecotype IV. Samples from birds were 
significantly more often associated with ecotype IV than with other ecotypes (Table 5).
Ecotype I contained the largest number of distinct hosts, whereas the observed host range 
of the other three ecotypes was significantly smaller than expected (Table 6), indicating 
a broad host range for ecotype I and much smaller host ranges for the others. The most 
abundant host species in ecotype II, III and IV were roe deer, rodents and birds, respectively 
(Table 5). Visual inspection of the haplotype genealogies within ecotype I indicates a mixture 
of A. phagocytophilum samples of all kind of vertebrate species and I. ricinus, indicating 
transmission of A. phagocytophilum between these host species via I. ricinus. The presence 
of ecotypes in European countries were plotted to test whether the clustering could be 
explained by differences in geographic distribution. All four ecotypes were spread over 
Europe, and no geographic clustering of the ecotypes was observed (Figure 2).
Considerable sequence variation was found between and within ecotypes I, II and III. This 
prompted us to investigate whether this genetic marker could be used to detect changes 
in the population dynamics of A. phagocytophilum in the wild. The Ewens-Watterson test 
was performed separately on ecotypes I, II and III to infer the neutrality of the groEL marker 
[287-289]. It was not possible to apply the neutrality test for ecotype IV because only one 
haplotype was identified in this ecotype (Figure 1). The probability that two randomly 
chosen samples share the same haplotype (the F-values) agreed to the expectation of 
neutrality for ecotype III, but not ecotype I and II indicating that a particular haplotype was 
over-represented within each ecotype. Population expansion was tested using estimates of 
Fu’s Fs and Tajima’s D. Estimates of Fu’s Fs were significantly negative for ecotype I from the 
Netherlands and ecotype I from Europe (Table 7). These results demonstrate a large excess 
of rare genetic variants, over the expected genetic variants under the hypothesis of neutral 
selection and constant population size.
Figure 1: Genealogy of A. phagocytophilum haplotypes 
Only 228 isolates of out of 548, representing all 97 haplotypes are shown. Of each haplotype, only 
one isolate per host from each country is used. An open circle is a haplotype. It is colored by the 
isolation origin (host species) and drawn in proportion to the sample size. A small blue dot is a missing 
haplotype. A blue edge is a mutation. The haplotype genealogies were made using Haploviewer 
software [300]. Roman numerals label the four ecotypes, which were inferred from a phylogenetic 
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Table 5: Host distributions between ecotypes. 
European samples (All) and Dutch and Belgian samples (Part) are divided in the four ecotypes, which 
are derived from Figure 1. European samples included the Dutch and Belgian samples. Asterisks* 
indicate that the A. phagocytophilum samples were (partially) derived from ticks feeding on these 
hosts (Table 3). The most numerous ecotype in bold numerals indicate significant deviations from the 
hypotheses that ecotypes are evenly represented in that host species (P< 0.05). 
Ecotype I Ecotype II Ecotype III Ecotype IV
Animal All Part All Part All Part All Part Total
Bird 0 0 0 0 0 0 8* 6* 8
Rodent 0 0 3 0 27* 3* 0 0 30
Hedgehog 59* 7* 0 0 0 0 0 0 59
Cattle 5 0 0 0 0 0 0 0 5
Dog 9 0 0 0 0 0 0 0 9
Red fox 3 3 0 0 0 0 0 0 3
Goat & sheep 24* 11* 5 0 0 0 0 0 29
Horse 36 14 0 0 0 0 0 0 36
Moose 1 0 1 0 0 0 0 0 2
Mouflon 18* 14* 0 0 0 0 0 0 18
Red deer 45* 26* 2 0 0 0 0 0 47
Wild boar 3 2* 0 0 0 0 0 0 3
Roe deer 6 3 66 39 0 0 0 0 72
Human 34 0 0 0 0 0 0 0 34
I. persulcatus 0 0 12 0 3 0 0 0 15
I. ricinus 101 23 68 7 0 0 0 0 169
Deer ked 3 0 6 6 0 0 0 0 9
Total 347 103 163 52 30 3 8 6 548
Phylogenetic analyses of groEL sequences from all A. phagocytophilum samples (Table 
5) were performed as described in the Methods section. Roman numerals label the four 
ecotypes.
Figure 2: Geographic distributions of A. phagocytophilum ecotypes in Europe.
Countries in which one or more isolates from an ecotype are found are filled with grey. A country in 
which an ecotype was not detected or which was not sampled is depicted in white. Data are based on 
isolates from Table 5. Number of isolates per country can be found in Supplementary Table II.
Table 6: Host distributions within ecotypes. 
The expected and observed host range of the four ecotypes were calculated for the European samples 
(All) and Dutch and Belgium samples (Part). Observed: observed number of distinct host species. 
Expected: expected number of distinct host species given the sample size. Bold italic numerals indicate 
p-value < 0.025, hence observed host-species richness is significantly less than expectation from the 
ecotype I. Expected species richness and its p-value were computed using EstimateS (Version 9, R. K. 
Colwell, http://purl.oclc.org/estimates). 
Hosts (17) Ecotype I Ecotype II Ecotype III Ecotype IV
Sample All Part All Part All Part All Part
Size 347 103 163 52 30 3 8 6
Observed 14 9 8 3 2 1 1 1
Expected 14 9 12 8 8 2 5 4
Ecotype I Ecotype II
Ecotype III Ecotype IV
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Table 7: Summary of the population genetic test for A. phagocytophilum 
Ewens and Watterson is a test of neutrality. Bold numerals indicate p-values less than 0.05 indicating 
that a particular haplotype was identified in the ecotype more frequently than the expectation. This 
test returned Not applicable (NA) when only one haplotype is identified in the sample. Fu’s Fs statistic 
is a measure of a population expansion based on population genetics. Bold numerals indicate p-values 
less than 0.05, hence a significant evidence for a population expansion.
Cluster Ecotype I Ecotype II Ecotype III Ecotype IV
Sample All Part All Part All Part All Part
Ewens Watterson 0.19 0.10 0.18 0.48 0.18 NA NA NA
Tajima’s D -1.8 -0.18 -0.56 -1.45 -0.01 0.00 0.00 0.00
Fu’s Fs -25,47 -8,71 -1,48 -1,57 1.16 0.00 0.00 0.00
DISCUSSION
This study addressed the circulation of A. phagocytophilum in ticks and vertebrates. Our 
investigations only detected the DNA of this microorganism and not their viability or 
infectivity. However, previous studies implicate I. ricinus ticks as vectors and all investigated 
animals as potential hosts for A. phagocytophilum [36]. Therefore, the inability of a 
DNA-based detection method to asseverate infectiousness in host species is expected to 
be a minor issue in this study. In any case, we revealed the widespread circulation of A. 
phagocytophilum in enzootic cycles in Belgium and the Netherlands. In some cases, the 
infection status of hosts was inferred from the infection rate of infected tick feeding. 
Vertebrates were considered positive when the infection rate of engorged ticks was 
significantly higher than that of questing I. ricinus (Table 4). 
The absence of A. phagocytophilum in questing ticks in four out of 17 areas might be 
attributable to the relatively low number of ticks collected and tested (Table 1). Still, infection 
rates of A. phagocytophilum in questing ticks varied significantly between some geographic 
locations (Table 1), corroborating results from previous studies from other locations in 
Europe [36]. Knowledge on the ecological factors driving these differences is of relevance to 
public and animal health [290], but was not in the scope of this study. Significant differences 
between the infection rates of I. ricinus nymphs and adults were observed as well (Table 2). 
This may reflect that A. phagocytophilum ecotypes I and II cycle mainly between (infected) 
adults and nymphal I. ricinus, which become infected when feeding on larger vertebrates.
Also, in another study a small but significant proportion of I. ricinus larvae were found A. 
phagocytophilum-positive [40]. These larvae may have become positive due to transovarial 
transmission or due to drop-off from A. phagocytophilum-positive hosts after partial 
feeding and continued to quest as larvae. Transovarial transmission and whether A. 
phagocytophilum-positive larvae can transmit the microorganism to vertebrate hosts needs 
to be investigated. Together, these findings indicate that all three tick stages should be taken 
into account when calculating the acarological risk of a given area [38].
In terms of the risk for public health, not only the product of the density of questing ticks 
and their infection rate defines high or low risk areas, but also the zoonotic potential of 
the microorganism should be taken into account [38]. The identification of four different 
A. phagocytophilum ecotypes (Figure 1 and 2) with significantly different host ranges and 
zoonotic potential supports this. A significant correlation between the genetic clustering 
of groEL sequences and different host ranges was found (Table 5 and 6). Further genetic 
subclustering within ecotypes I, II and IV was also observed (Supplementary Figure 1). 
These subclusters could not be statistically linked to a further restriction in host ranges or 
to limitations in geographic distributions (not shown), probably due to lack of resolution in 
the groEL locus, and due to the limitations in the number and origin of the used samples, 
particularly of rodents and birds. 
Clustering of A. phagocytophilum isolates can also be achieved using other genetic loci, 
such as the ankA gene, which is presumably involved in host-specific adaptation [263, 291]. 
Combining several genetic loci, such as groEL and AnkA, in future analyses could reveal 
more refined host ranges, especially within ecotype I. Recently, a multilocus sequence 
typing scheme for A. phagocytophilum was presented, which was shown to be informative 
concerning host species, geographic distribution, and zoonotic potential [291]. The advent 
of this standardized multilocus sequence typing scheme and a freely available molecular 
epidemiological database (http://pubmlst.org/aphagocytophilum/) will facilitate more 
elaborate analyses in the future. 
Ecotype I had the broadest host range, but lacked birds and rodents, indicating that the latter 
two do not contribute directly to the transmission cycle. The generalist feeding behavior of I. 
ricinus nymphs and adults probably facilitates the continuous exchange of ecotype I between 
the different vertebrate species. All human isolates on the groEL-gene from Genbank and the 
literature [277-281] belong to ecotype I, demonstrating that members of this ecotype are 
zoonotic. Hence, ecotype I is the most plausible cause of infection regarding the one case of 
Human Granulocytic Anaplasmosis (HGA) in the Netherlands reported in 1999 [292]. Whether 
all or only a subset of the members of ecotype I are zoonotic remains to be examined [293]. 
In this study, ecotype II was found in roe deer, I. ricinus, and deer keds (Table 5). Therefore, 
ecotype II may circulate between roe deer via I. ricinus, or deer keds, or both. Whether 
deer keds may act as a host specific vector for ecotype II remains to be investigated [294, 
295]. When the generalist tick I. ricinus would transmit ecotype II, then the observed host 
specificity might be attributed to A. phagocytophilum and the possibility that the vectors play 
a role in host specificity could be excluded. Only three isolates belonging to ecotype III were 
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found in this study. One isolate was found in the spleen of a wood mouse. The kidney, liver 
and ear of this rodent were all A. phagocytophilum-positive, indicating a systemic infection 
of this wood mouse with A. phagocytophilum. Two isolates were found in two different tick 
species, I. trianguliceps and I. ricinus, feeding on one wood mouse. Ecotype III was not found 
in questing I. ricinus or in any other wildlife, except rodents (Table 5). Our finding supports 
the notion that ecotype III might be adapted to a life cycle involving exclusively some rodent 
species and a rodent specific vector, such as I. trianguliceps [260, 265, 296, 297]. Ecotype 
IV is most likely associated with one or more bird species, but not with other vertebrates. 
Ecotype IV was not found or in any other animal species. As ecotype IV was not found in 
questing I. ricinus either, it might be adapted to a life cycle involving exclusively birds and a 
bird-specific vector, such as I. frontalis. Although A. phagocytophilum was not detected in 
questing D. reticulatus or I. arboricola ticks, their role in the transmission of one or more A. 
phagocytophilum ecotypes cannot be excluded due to the relatively low numbers of ticks 
tested [298]. Although many ticks and animal samples have been included in this study, some 
animal species, particularly birds, rodents and carnivores, and some geographical locations 
(Figure 2) are underrepresented. Future studies should include broader and randomized 
sampling strategies. 
Before the considerable sequence variation between and within ecotype I and II in the groEL 
gene (Figure 1) could be used to address their population dynamics, several statistical tests 
were performed to address the neutrality of this genetic marker. The Ewens-Watterson test 
detected significant departure from neutrality for ecotype I. This outcome indicated that a 
particular haplotype was identified in ecotype I more frequently than the neutral expectation, 
indicating that this haplotype is under positive selection. Fu’s Fs statistic detected genetic 
traces of demographic changes for ecotype I in the Netherlands and Belgium. Fu’s Fs is more 
sensitive than Tajima’s D to an excess of rare genetic variants in the samples [299], and this 
has proved to be true for our datasets (Table 7). The increase in ecotype I population sizes 
might have occurred through an increase in either the population of ixodid ticks, or in the 
vertebrate host species, or in both [161, 253].
CONCLUSION
In conclusion, we identify the groEL gene as a suitable marker to discriminate between 
A. phagocytophilum ecotypes. These ecotypes can be linked to distinct host ranges. 
Furthermore, all three ecotypes have enzootic cycles in the Netherlands and Belgium. 
In these countries, ecotype I is expanding. This is probably caused by the increase in 
abundance (and activity) of their vertebrate hosts and vectors. Based on the analyses of 
the groEL marker, we infer that: 1. Ecotype I has the highest zoonotic potential, and 2. the 
acarological risk of exposure to A. phagocytophilum ecotype I has been increasing in time. 
However, future studies concerning the evolution, population dynamics, and ecology of 
naturally occurring A. phagocytophilum will shed light on identifying risks for public health.
Supplementary Table I: Geographic distributions of A. phagocytophilum ecotypes in Europe.
 Number of isolates per country.  Data are based on isolates from Table 3.



























































Supplementary Figure 1: Phylogenetic relationship of A. phagocytophilum
CHAPTER 5
Tick-borne encephaliTis virus in Ticks 
and roe deer, The neTherlands 
S. Jahfari, A. de Vries, J. M. Rijks, S. Van Gucht, 








Here we report the first evidence of tick-borne encephalitis virus (TBEV) in the Netherlands. 
A serological screening found TBEV-neutralizing antibodies in six roe deer, five of whom 
were from one national park. In addition, TBEV RNA was detected in two questing ticks 
from the same location. Enhanced surveillance and increased awareness among medical 
professionals should clarify the significance of this finding.
INTRODUCTION
Tick-borne encephalitis virus (TBEV) can infect humans causing febrile illness, with 
neurological complications including encephalitis in humans (TBE) [301]. TBEV is transmitted 
through a bite of infected ticks and small rodents are considered the main amplifying 
hosts, while larger animals including deer, serve as feeding hosts for the ticks [302, 303]. 
TBEV can be divided into three subtypes, the European (TBEV-Eu), Siberian (TBEV-Si) and 
Far Eastern (TBEV-Fe), and the clinical course of disease and prognosis depend on the 
subtype [304]. TBEV is endemic in 27 European countries, and therefore is considered an 
important public health concern [305]. The number of recognized human tick-borne TBE 
cases in endemic regions of Europe has increased in the last decades, and expansion TBEV 
subtypes northwards and to higher altitudes is reported in recent years, this expansion is 
thought to be related to climate change [306, 307]. No autochthonous human cases had 
been reported from the Netherlands or the neighboring country, Belgium [308]. However, 
recent reports from Belgium, where wildlife and ~ 3% of cattle have tested positive for TBEV 
with neutralizing antibodies, prompted us to reinvestigate the presence of TBEV in the 
Netherlands [309, 310]. 
METHODS
Collection of roe deer sera, antibody detection
Between January and September 2010, hunters collected 297 blood samples from roe deer 
(Capreolus capreolus) according to a sampling scheme designed to obtain a representative 
sample of the roe deer population from locations across the Netherlands. Serum samples 
were stored at -80ºC until testing. TBEV reactive IgG was detected in roe sera using a 
commercial ELISA based on inactivated TBEV for IgG detection in a range of hosts (All species 
ELISA- Progen, Heidelberg, Germany) according to the manufacturer’s recommendations. 
TBEV neutralizing antibody titration in the roe deer sera was performed at the Belgian 
Scientific Institute of Public Health, with the TBEV Neudörfl reference strain NCPV#848, 
which is considered a gold standard for TBE diagnosis as previously described [309].
Collection of tick samples, molecular detection and analyses
Ticks were collected by blanket dragging on seven locations in or close to the national park 
Sallandse Heuvelrug in September 2015. 1160 Ixodes ricinus nymphs and 300 adult ticks 
were collected. 
Pools of 5 nymphs or two adults were lysed and RNA was extracted as described with 
some modifications [311]. Collected ticks were ground up with Lysis matrix I (MPbio, 
USA) in a FastPrep FP120 homogenizer (Thermo Fisher, Waltham, MA, USA) for 40 
sec at speed 6.0. RT-qPCR reactions were done in a final volume of 20 μl with TaqMan® 
Fast Virus 1-Step Master Mix (Thermo Fisher scientific, USA), 5 μl of sample and 0.4 μM 
for all primers (TBpanFlavi-1 5’-TAYAACATGATGGGCAAGAGAGAGAA-3’, TBpanFlavi-2 
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5’-TATAACATGATGGGCAAAAGAGAGAA-3’, TBpanFlavi-3 5’-GTGTCCCAGCCAGCTGTGTCATC-3’, 
TBpanFlavi-4 5’-GTGTCCCATCCGGCTGTGTCGTC-3’) and 0.4 μM probe (TBpanFlavi-P 5’-FAM-
TGGTACATGTGGCTGGGGAG-BH1-3’). With 20 min reverse transcription step at 50°C, 
denaturation at 95°C for 30 s and 55 cycles of 95°C for 10 s and 60°C for 30 s. Amplification 
was performed on a Roche LightCycler 480 instrument. To obtain genomic sequences, 
primers and protocols were used as described previously [312]. Distance-based analyses 
were conducted using Kimura 2- parameters distance estimates and trees were constructed 
using the Neighbour-Joining (NJ) algorithm, implemented in the in Bionumerics 7.1. (Applied 
Math, Belgium). Bootstrap proportions were calculated by the analysis of 1000 replicates for 
NJ trees. 
RESULTS
TBEV reactive antibodies were detected in roe deer sera using a commercial ELISA based 
on inactivated TBEV (All species ELISA; Progen, Heidelberg, Germany). Serologic screening 
of roe deer sera by ELISA yielded six positive (VIEU/ml > 125) and eight borderline (VIEU/
ml 64-98) sera. To confirm these serological findings, all positive, and three negative sera 
were tested in a serum neutralization test (SNT) with the TBEV Neudörfl reference strain 
NCPV#848 [309]. Five out of six ELISA positive samples were confirmed positive by SNT. 
Interestingly, four out of five SNT-confirmed roe deer were shot at or near a popular 
recreation area, the national park Sallandse Heuvelrug (Figure 1). 
In response to the serological findings, ticks were collected by blanket dragging on seven 
locations at the national park in September 2015.
1160 Ixodes ricinus nymphs and 300 adult ticks were collected.  Pools of five nymphs or two 
adults were lysed and RNA was extracted as described [311]. The extracted RNA were tested 
for the presence of flavivirus RNA using a RT-qPCR.  RNA of a flavivirus was detected in two 
samples, one nymph pool and one pool of adult female ticks. To obtain sequences of the 
two qPCR-positive samples, primers and protocols were used as described previously [312]. 
Both sequences obtained from the tick lysates were identical. The sequences obtained in 
this study clustered within the TBEV-Eu subtype complex (Figure 2), but is different from the 
currently known TBEV-Eu sequences
Figure 1: Spatial distribution of TBEV-positive in roe deer sera. The spatial distribution of TBEV-ELISA 
test results are shown in the Netherlands (black dot, positive; grey dot, borderline; white dot, negative). 
The enlargement of the National Park Sallandse Heuvelrug area indicates the locations the TBEV-ELISA 
positive roe deer (black dots) in relation to the site with PCR positive ticks (black star) from 2015. 
Figure 2: Genetic cluster analysis of Dutch TBEV sequences. Genetic cluster analysis of Dutch TBEV 
sequences with tick-borne viruses. The description ‘salland’ being the obtained sequences from the 
questing ticks in the Netherlands. The sequence consists of one large fragment (3756 base pairs) of the 
first part of the genome, which includes the envelope gene. This fragment clusters with the TBEV-Eu. 
Distance-based analyses were conducted using Kimura 2- parameters distance estimates and trees were 
constructed using the Neighbour-Joining (NJ) algorithm, implemented in the in Bionumerics 7.1. (Applied 
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DISCUSSION
The presence of TBEV RNA in two questing ticks collected through surveillance in one 
national park confirms the presence of TBEV in the Netherlands. Serological evidence that 
roe deer from the same location had been infected with a flavivirus, most probably TBEV, 
five years prior to the detection of TBEV in ticks, suggests that TBEV has been endemic in 
the Netherlands for some time. In addition, the finding of at least one serologically positive 
roe deer south of the national park, suggests that TBEV is distributed more widely within the 
Netherlands. Disseminating information about the occurrence of TBEV in ticks and wildlife 
is important for both medical professionals and the general at large. In response to the 
current finding, the National Institute for Public Health and the Environment provided this 
type of information to medical professionals and the public at large. Within a week, this 
resulted in the report of an autochthonous TBE infection in the Netherlands (9). Further 
studies have been initiated to collect data on the circulation of TBEV in ticks and animals in 
other geographical areas in the Netherlands, while the prevalence of human infections will 
be assessed through increased surveillance of clinical cases with TBEV-like symptoms and 
serosurveillance of, for example, risk groups. 
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European hedgehogs (Erinaceus europaeus) are urban dwellers and host both Ixodes 
ricinus and Ixodes hexagonus. These ticks transmit several zoonotic pathogens like Borrelia 
burgdorferi sensu lato, Anaplasma phagocytophilum, Rickettsia helvetica, Borrelia miyamotoi 
and Candidatus Neoehrlichia mikurensis. It is unclear to what extent hedgehogs in (sub)
urban areas contribute to the presence of infected ticks in these areas, which subsequently 
pose a risk for acquiring a tick-borne disease. Therefore, it is important to investigate to 
what extent hedgehogs contribute to the enzootic cycle of these tick-borne pathogens, and 
to shed more light at the mechanisms of the transmission cycles involving hedgehogs and 
both ixodid tick species. 
Methods
Engorged ticks from hedgehogs were collected from (sub)urban areas via rehabilitating 
centers in Belgium. Ticks were screened individually for presence of Borrelia burgdorferi sensu 
lato, Borrelia miyamotoi, Anaplasma phagocytophilum, Rickettsia helvetica and Candidatus 
Neoehrlichia mikurensis using PCR-based methods. Infection rates of the different pathogens 
in ticks were calculated and compared to infection rates in questing ticks.
Results
Both Ixodes hexagonus (n = 1132) and Ixodes ricinus (n = 73) of all life stages were found 
on the 54 investigated hedgehogs. Only a few hedgehogs carried most of the ticks, with 6 
of the 54 hedgehogs carrying more than half of all ticks (624/1205).  Borrelia miyamotoi, 
Anaplasma phagocytophilum, Rickettsia helvetica and Borrelia burgdorferi genospecies 
(Borrelia afzelii, Borrelia bavariensis, and Borrelia spielmanii) were detected in both Ixodes 
hexagonus and Ixodes ricinus. Anaplasma phagocytophilum, Rickettsia helvetica, Borrelia 
afzelii, Borrelia bavariensis and Borrelia spielmanii were found significantly more in engorged 
ticks in comparison to questing Ixodes ricinus. 
Conclusions
European hedgehogs seem to contribute to the spread and transmission of tick-borne 
pathogens in urban areas. The relatively high prevalence of B. bavariensis, B. spielmanii, 
B. afzelii, A. phagocytophilum and R. helvetica in engorged ticks suggests that hedgehogs 
contribute to their enzootic cycles in (sub)urban areas. The extent to which hedgehogs can 
independently maintain these agents in natural cycles, and the role of other hosts (rodents 
and birds) remain to be investigated. 
BACKGROUND
The incidence of tick-borne diseases has increased the last decades and poses important 
economic and medical consequences [313]. Lyme borreliosis is the most prevalent tick-
borne disease in Europe and presents itself under a wide range of clinical manifestations. 
The most common and earliest manifestation is an expanding rash at the site of the tick 
bite (erythema migrans), and left untreated it can progress towards more severe disease 
manifestations. The disseminated infection can affect a patient’s nervous system, joints, 
lymph nodes, skin, and in rare cases the heart or eyes [10]. The causative agents of Lyme 
borreliosis are spirochetes belonging to the Borrelia burgdorferi sensu lato (s. l.) complex. 
They are generally transmitted by ticks of the Ixodes ricinus complex [15] and are maintained 
in enzootic cycles by different vertebrate hosts [16-18]. At least five genospecies of B. 
burgdorferi s. l. complex have been shown to be pathogenic to humans, namely B. burgdorferi 
sensu stricto (s. s.), B. afzelii, B. garinii, B.  spielmanii and B.  bavariensis [10, 19]. Each of 
these genospecies is maintained in nature through a distinct enzootic cycle involving ixodid 
ticks and vertebrates acting as reservoirs [33, 314]. The different Borrelia genospecies are 
generally associated with different clinical manifestations [19]. Current knowledge is that B. 
afzelii is predominantly involved in dermal infections (erythema migrans and acrodermatitis 
chronica atrophicans) [10] and is adapted to rodents and other small mammals [314, 315]. 
Borrelia garinii is associated with neurological manifestations and birds maintain most of 
the B. garinii strains [203, 271, 314]. Borrelia bavariensis is frequently found in rodents 
[316, 317] and hedgehogs [318] and is also associated with neuroborreliosis in humans [19]. 
Borrelia spielmanii infection in humans is rare, and only found in patients with erythema 
migrans. Its reservoir hosts are of the family Gliridae [319], but this Borrelia genospecies 
has also been detected in hedgehogs and their ticks [318, 320]. Besides the B. burgdorferi s. 
l. genospecies, other established pathogens circulate in enzootic cycles including the same 
ixodid ticks and vertebrate reservoirs, for example Anaplasma phagocytophilum, Rickettsia 
helvetica, Borrelia miyamotoi and Candidatus Neoehrlichia mikurensis. These pathogens 
can cause non-characteristic, viral-like symptoms in humans, and often confused with 
Lyme borreliosis [321]. Their infections are often self-limiting, but in immunocompromised 
patients, they can cause severe clinical manifestations [58, 68, 83, 95]. In the framework 
of human health, therefore, it is important to identify the different components of the 
enzootic cycle of these tick-borne diseases, and to shed more light at the mechanisms of 
the transmission cycles. 
The generalist tick species Ixodes ricinus actively quests in the vegetation for hosts to 
feed on and may readily bite humans, thereby possibly transmitting pathogens. Ixodes 
hexagonus is a host specialist, feeding primarily on hedgehogs. It shows an endophilic 
behavior preferring dark, humid places, and is usually found in the nests of its host species 
[322]. Besides hedgehogs, this tick species has been found to infest other host species as 
well [323]. Despite their nest dwelling behavior, it is known to occasionally bite humans 
and companion animals, even though less frequently than I. ricinus does [323, 324]. Both 
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ixodid species can be found on hedgehogs and are competent vectors for transmitting B. 
burgdorferi s. l. [325-327].
The European hedgehog (Erinaceus europaeus Linnaeus, 1758) is a nocturnal insectivorous 
mammal commonly found throughout Western Europe [328]. They seem to have adjusted 
to a wide variety of habitats and occur in rural, suburban, and urban areas but generally 
prefer grassland with sufficient edge habitats. Hedgehogs can reach up to nine times higher 
densities in urban areas with parks and garden, than in rural areas, with lowest densities in 
forests and open grassland fields and agricultural land without cover such as shrubs or dead 
wood [329-331]. Since they are one of the most successful urban adapters, hedgehogs and 
I. hexagonus could contribute to the spread and persistence of pathogens in a (sub)urban 
habitat via secondary enzootic cycles, even when the contact between I. hexagonus and 
humans is low [318, 332].
Only a few studies have been performed on the reservoir competence of the European 
hedgehog. These studies have shown that these mammals can be infected with different 
B. burgdorferi s. l. genospecies [318, 320, 322] as well as other tick-borne pathogens, 
such as A. phagocytophilum [333, 334], tick-borne encephalitis virus (TBEV) [327] and R. 
helvetica [335]. The role of the European hedgehog and both ixodid tick species feeding on 
it in the transmission cycle of many tick-borne pathogens like B. miyamotoi and Candidatus 
Neoehrlichia mikurensis is not completely illuminated, yet [336].
In this study we aim to investigate the prevalence of B. burgdorferi s. l. genospecies, B. 
miyamotoi, A. phagocytophilum, Candidatus Neoehrlichia mikurensis and R. helvetica in 
the different stages of the I. hexagonus and I. ricinus tick species sampled from European 
hedgehogs (E. europaeus) from Belgium. Furthermore, we aim to investigate the role of 
these tick species and that of the hedgehog in the enzootic cycle of the different disease 
pathogens. By using epidemiological analysis and comparing the infection prevalences 
of the different pathogens from engorged ticks collected from hedgehogs with questing 
nymphs from the vegetation, we aim to i) determine the reservoir status of the European 
hedgehog for B. burgdorferi s. l. genospecies, B. miyamotoi, A. phagocytophilum, Candidatus 
Neoehrlichia mikurensis and R. helvetica, and ii) find indications for the vector competence 
of I. hexagonus for tick-borne pathogens.
METHODS
Hedgehog and tick sampling
Since European hedgehogs are legally protected in Belgium, the current investigation 
was carried out on ticks sampled from hedgehogs that were brought to the rehabilitation 
centers of Herenthout and Heusen-Zolder in the Campine region, Belgium. In general, these 
hedgehogs were captured in gardens and urban areas by civilians. To grant the hedgehogs 
an easy and full recovery, removal of all ectoparasites upon arrival at the rehabilitation 
center is a standard procedure. For this study, attached ticks of all life stages were collected 
by the centers’ volunteers in 2014 (both centers) and 2015 (only Herenthout) between the 
end of April and the end of October. Tick specimens were stored in 70% ethanol at room 
temperature until further investigation. Ticks were identified to species and life stage [337]. 
The number of attached ticks (tick burden) was recorded for each hedgehog. Since only 
hedgehogs that harbored ticks were used in this study, there is no data on the percentage 
of hedgehogs that were infested by ticks. Age (adult or juvenile) was determined based on 
weight [318] for all hedgehogs, except two. The questing I. ricinus ticks, that were caught by 
drag-sampling the vegetation in the same region as where the hedgehogs were collected, 
are part of a previously published study [106].
Sample preparation and molecular detection of tick-borne pathogens 
All ticks were processed individually. Nucleic acids were extracted using the DNeasy Blood 
& Tissue Kit (Qiagen, Hilden, Germany), according to the manufacturer’s instructions. 
The extracted DNA was stored at -20 degrees Celsius until further use. Ticks were tested 
individually for presence of B. burgdorferi s. l., B. miyamotoi, A. phagocytophilum, 
Candidatus Neoehrlichia mikurensis and R. helvetica DNA using two separate multiplex real-
time PCR assays as described before [60, 106, 338, 339], followed by sequencing for species 
identification. For the identification of B. burgdorferi s. l. genospecies a conventional PCR 
assay targeting the 5S-23S intergenic region (IGS) was performed. Borrelia burgdorferi s. l. 
genospecies identification was determined by comparison of sequences to isolate in-house 
molecular databases [161]. As genospecies identification was successful for only 43.4% of 
the B. burgdorferi s. l. positive sequences, we proportionally assigned these unidentifiable 
sequences in each life stage per tick species to the different Borrelia burgdorferi s. l. 
genospecies present in stage, using the proportion of each genospecies detected in that 
stage as a weighting factor (Hofmeester et al., submitted). We assumed that the probability 
to successfully identify a particular genospecies is equal for all Borrelia burgdorferi s. l. 
genospecies. For confirmation of B. miyamotoi conventional PCR targeting glpQ gene was 
done [95]. The groEL gene of A. phagocytophilum was amplified and sequenced [39]. For 
all conventional PCR’s, both strands of PCR products were sequenced by BaseClear (Leiden, 
the Netherlands).
Statistical tests
All statistical tests were performed using R version 3.2.0 (R Core Team, 2016 [340]) and all 
graphs were made with the package ggplot2 [341]. To test the differences in distribution 
of tick species, tick burden and infection prevalence of the different pathogens in ticks on 
hedgehogs from different age classes, Kruskal-Wallis tests were employed. The number of 
mixed tick species infestations (both tick species on the same hedgehog) was compared 
to the number of single species infestations (only I. ricinus or I. hexagonus) with Pearson’s 
Chi-squared test. With the prop.test function, we tested if the pathogens in the ticks 
occurred more frequently alone or co-existing with a different pathogen in the same tick. 
Afterwards we compared the infection prevalence of the pathogens in I. hexagonus with 
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the prevalence in I. ricinus. Finally, to assess the transmission capabilities of the hedgehog 
for each pathogen, we compared the infection prevalence in the engorged ticks collected 
from hedgehogs with the infection prevalence in questing I. ricinus from the same region 
[106], and used this as a proxy to evaluate the reservoir status of the hedgehog. In order to 
evaluate the reservoir status of a host species, it is best to compare engorged I. ricinus larvae 
with questing I. ricinus larvae and nymphs. As the amount of engorged I. ricinus larvae is 
too low to perform these analyses (n = 7), we decided to compare the infection prevalence 
of each pathogen in engorged I. ricinus larvae and nymphs collected from hedgehogs with 
the infection prevalence in host-seeking I. ricinus nymphs and adults. This way, we compare 
ticks that fed once (engorged larvae and questing nymphs) or twice (engorged nymphs and 
questing adults), and omit ticks that had the chance to feed three times (engorged adults). 
Engorged adults have a higher chance to be infected than a questing tick anyway, that has 
never fed more than twice. The difference between the pathogen communities in engorged 
and questing ticks is thus that the engorged ticks will have certainly fed, at least once, on 
hedgehogs, while the chance that the questing ticks will have fed on hedgehogs is rather low. 
Differences between the infection prevalence of the pathogens in engorged and questing 
ticks may then reflect the importance of the hedgehog in the transmission of pathogens. A 
higher infection prevalence of a certain pathogen in engorged larvae and nymphs will then 
suggest that the hedgehog has an important role in the transmission of that pathogen.
RESULTS
Of the 54 hedgehogs investigated, 24 were adults and 28 were juveniles. For two hedgehogs, 
age was not determined. Both I. hexagonus and I. ricinus ticks of all life stages were found on 
the hedgehogs. The number of ticks per hedgehog ranged from one to 167. Most hedgehogs 
in our study carried only few ticks, while only few individuals harbored the majority of 
the ticks. Six of the 54 hedgehogs carried more than half of all ticks (624/1205) and only 
15 hedgehogs carried 25 or more ticks. Tick burden did not significantly differ between 
hedgehog age classes (p = 0.97). In total, we collected 1205 ticks and found significantly 
more I. hexagonus (n = 1132) than I. ricinus (n = 73) (p < 0.05). The most common life stage 
of I. hexagonus retrieved from the hedgehogs were nymphs (n = 586) (p = 0.03). Of I. ricinus, 
all life stages were equally common (p = 0.07, Figure 1). Some hedgehogs were found to 
harbor both species of ticks (n = 10), but infestations with only one tick species were more 
common (n = 44, p < 0.05). 
Figure 1: The distribution of the different life stages of Ixodes ricinus (IR) and Ixodes hexagonus (IH) 
collected from 54 hedgehogs in the Campine region, Belgium (mean ± S.E.)
Of the 1205 collected ticks, two got lost during sample preparation, hence the molecular 
analyses were performed on 1203 ticks. A total of 859 (71.4%) ticks was infected with at 
least one of the tested pathogens. Of these infected ticks, 524 (61%) had a single infection, 
and 335 ticks (39%) were infected with more than one pathogen of another genus. The 
number and percentage of infected I. ricinus and I. hexagonus ticks per life stage can be 
found in Table 1. A more detailed overview, including the different Borrelia burgdorferi s. l. 
genospecies, is provided in Additional file 1. Anaplasma phagocytophilum and R. helvetica 
were the two most common pathogens and occurred in 466 ticks (38.7% of all analyzed ticks 
or 54% of all infected ticks) coming from 34 hedgehogs and in 481 ticks (40% of all analyzed 
ticks or 56% of all infected ticks) coming from 37 hedgehogs, respectively. An infection 
with Borrelia burgdorferi s. l. occurred in 297 ticks (24.7% of all analyzed ticks or 34.6% 
of all infected ticks) from 28 hedgehogs. We were able to identify the B. burgdorferi s. l. 
genospecies in 129 (43.4%) of these infected ticks, of which B. afzelii (n = 80), B. spielmanii 
(n = 28) and B. bavariensis (n = 17) were the most common. Borrelia turdi occurred once in 
both tick species and Borrelia garinii and B. valaisiana each in one I. ricinus tick. An infection 
with B. miyamotoi occurred in 20 ticks from five hedgehogs. Only three Ixodes ricinus ticks 
from two hedgehogs were infected with Candidatus Neoehrlichia mikurensis. The pathogen 
prevalence per tick species is depicted in Figure 2. Ixodes ricinus seems to be more likely 
infected with at least one pathogen (59/72, 81.9%) than I. hexagonus (800/1131, 70.7%) 
but the difference between the two tick species was only marginally significant (p = 0.06). 
More specifically, the infection prevalence of A. phagocytophilum, Candidatus Neoehrlichia 
mikurensis, B. afzelii, B. garinii, B. valaisiana and B. turdi was highest in I. ricinus while 
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infection with R. helvetica was highest in I. hexagonus (p < 0.05). For the infection prevalence 
of B. miyamotoi, B. spielmanii and B. bavariensis, no difference between the tick species 
could be observed. There was no difference in infection prevalence between adult and 
juvenile hedgehogs for any of the detected pathogens (p > 0.05).
Table 1: The number (#) of Ixodes ricinus and Ixodes hexagonus ticks infected with a certain pathogen, 
for all life stages together or for larvae (L), nymphs (N) or adults (A) separately, and the percentage (%) 
of infected ticks of the two species on all analyzed ticks from that species per life stage.










































I. hexagonus L # 3 2 10 2 0
% 6.3 4.2 20.8 4.2 0
N # 166 8 192 279 1
% 28.4 1.4 32.8 47.7 0.2
A # 91 7 267 137 0
% 18.3 1.4 53.6 27.5 0
all # 260 17 469 418 1
% 23 1.5 41.5 37 0.09
I. ricinus L # 1 0 0 3 0
% 14.3 0 0 42.9 0
N # 20 0 3 23 2
% 71.4 0 10.7 82.1 7.1
A # 16 3 9 22 0
% 43.2 8.1 24.3 59.5 0
all # 37 3 12 48 2
  % 51.4 4.2 16.7 66.7 2.8
Figure 2: The prevalence of the distinct pathogens in Ixodes ricinus and Ixodes hexagonus ticks 
collected from hedgehogs (mean ± S.E.).
Co-infections of other pathogens with B. burgdorferi s. l. were investigated. For I. ricinus, 
37 of the 59 infected ticks (62.7%) carried two (n=31) or three (n=6) pathogens. The most 
common co-infection in I. ricinus (24/37) was with B. burgdorferi s. l. and A. phagocytophilum. 
Of the 800 infected I. hexagonus ticks, 298 (37.3%) had a co-infection composed of two 
(n=232) or three (n=65) pathogens. Co-infections of A. phagocytophilum and R. helvetica 
(102/298), A. phagocytophilum and B. burgdorferi s. l. (86/298) and A. phagocytophilum, R. 
helvetica and B. burgdorferi s. l. (64/298) occurred most often. One I. hexagonus tick was 
infected with four pathogens: A. phagocytophilum, R. helvetica, B. burgdorferi s. l. and B. 
miyamotoi. All pathogens were found more often co-existing with another pathogen in a 
tick, than as the single pathogen infecting the tick (p < 0.05). 
Ixodes ricinus larvae and nymphs from hedgehogs were infected more often (28/35) than 
questing I. ricinus nymphs and adults (367/1874) (p < 0.05). We could not detect any 
difference in prevalence of R. helvetica, B. miyamotoi, B. garinii and B. valaisiana. For all 
other pathogens, infection prevalence was significantly higher in the engorged ticks from 
the hedgehogs (p < 0.05). 
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Afterwards we repeated these analyses for I. hexagonus collected from hedgehogs and 
compared the larvae and nymphs of this tick species with the questing I. ricinus nymphs and 
adults collected from the vegetation. This enables us to interpret more comprehensively 
the reservoir role of the hedgehog for the different pathogens, and the vector competence 
of I. hexagonus. We observed that B. garinii and B. valaisiana were more prevalent in the 
questing I. ricinus ticks. No significant difference in infection prevalence between questing 
or engorged ticks could be detected for Borrelia turdi, B. miyamotoi and Candidatus 
Neoehrlichia mikurensis. The prevalence of all other pathogens, including R. helvetica, is 
higher in the engorged than the questing ticks. Furthermore, when comparing just the ticks 
collected from hedgehogs that carried 25 or more ticks, we obtain the same outcome.
For A. phagocytophilum, R. helvetica, B. bavariensis and B. miyamotoi, the distribution of 
the infections was clustered in some hedgehogs, with most hedgehogs harboring no, or 
only few infected ticks, while only few hedgehogs were responsible for the majority of the 
infected ticks. This is visualized in Figure 3. Twelve of the 17 ticks infected with Borrelia 
bavariensis and 16 of the 20 ticks infected with B. miyamotoi came from one individual 
hedgehog (hedgehog #18). Hedgehog #33 harbored a total of 125 ticks of which 118 were 
infected with A. phagocytophilum (25.3% of all A. phagocytophilum infections). Still, there 
are hedgehogs that harbor many ticks, while no or few or these ticks are infected with one 
of these pathogens (Figure 3).
Of the A. phagocytophilum positive ticks, 43 were sequenced of which 33 I. hexagonus 
and 10 I. ricinus from 18 different individual hedgehogs. All the groEL sequences of the A. 
phagocytophilum isolates clustered with the zoonotic ecotype, ecotype I (not shown [39]).  
Figure 3: The tick burden per hedgehog with the number of ticks per hedgehog harboring infection 
with Anaplasma phagocytophilum, Rickettsia helvetica, Borrelia bavariensis and Borrelia miyamotoi.
DISCUSSION
Our results confirm that hedgehogs are a host of all three stages of I. hexagonus and I. 
ricinus. Still, more I. hexagonus were found feeding on hedgehogs than I. ricinus ticks (Figure 
1). The aggregation of ticks on hedgehogs varied vastly between the individual hedgehogs, 
as only a few hedgehogs were recorded to carry most of the ticks (Figure 3). This means that 
just a few hedgehogs contribute to tick maintenance, similar to what is seen on rodents 
[342]. This seems to be especially the case for I. hexagonus, and to a lesser extend for I. 
ricinus, since the burdens of I. ricinus on hedgehogs appears to be relatively low. Moreover, 
it is less likely that hedgehogs can maintain the I. ricinus life cycle as the sole host species 
because, even though it can feed all life stages of this generalist tick species, hedgehog 
densities in forested areas, the preferred habitat of I. ricinus, are too low [329, 330]. Namely, 
if all I. ricinus stages should rely only on the hedgehog to feed on, many ticks would starve 
and perish since the amount of encounters with this host would be low. We believe, rather, 
that a host community without large mammals but composed only of small or medium sized 
hosts such as rodents, birds and hedgehogs (like in (sub)urban area’s and parks), can already 
be sufficient to complete the life cycle of I. ricinus. This because, as we show, large mammals 
are not the only hosts adult I. ricinus ticks feed on. More research is needed, however, to 
elucidate the role of hedgehogs in the life cycle of this generalist tick species.
Since 71.4% of the ticks retrieved from hedgehogs were infected by at least one pathogen, 
hedgehogs can be considered as amplifying hosts and epidemiologically important wildlife 
species. Moreover, 39% of all infected ticks carried more than one pathogen of another 
genus. High prevalence of tick-borne pathogens B. bavariensis, B. spielmanii, B. afzelii, A. 
phagocytophilum and R. helvetica in engorged I. hexagonus and I. ricinus ticks obtained from 
E. europaeus, indicates that hedgehogs contribute to pathogen maintenance in natural cycles 
in urban and suburban areas. For B. bavariensis, B. spielmanii, B. afzelii, A. phagocytophilum 
and R. helvetica, the infection prevalence was higher in the engorged ticks of both species, 
in comparison to the infection rates in questing ticks from the same region (Figure 2). This 
indicates that the hedgehog is a possible reservoir host of these pathogens and contributes 
to their enzootic cycle. On the other hand, Candidatus Neoehrlichia mikurensis infection 
rate was not significantly higher in questing I. ricinus ticks than in engorged hedgehog ticks, 
indicating that hedgehogs do not play a main role in the maintenance of the enzootic cycle 
of this pathogen. 
Engorged I. ricinus ticks tend to be more infected with any pathogen in comparison to 
engorged I. hexagonus, except for R. helvetica which was significantly more prevalent in I. 
hexagonus ticks. Perhaps this observation can be subscribed to transmission pathway of R. 
helvetica, which occurs transovarially as well as transstadially. Therefore, ticks in nature are 
usually thought to be the main reservoir and vectors of R. helvetica [105]. However, since 
transovarial transmission rates are less than 100%, vertebrate hosts like the hedgehog can 
act as an amplifier of this pathogen, playing a vital role in transmission cycles. The pathogens 
that are present in engorged I. ricinus ticks can originate from a previous blood meal from 
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another host species, while the pathogens I. hexagonus carries are most probably coming 
from the hedgehog, since hedgehogs are their preferred host species. This way infection 
prevalence in engorged I. ricinus can be higher than engorged I. hexagonus, when they fed 
in a previous stage on a host species that functions as an efficient reservoir species for some 
of the investigated pathogens, such as small rodents or birds.
Remarkably, the infection of some pathogens such as B. bavariensis, B. miyamotoi, R. 
helvetica and A. phagocytophilum seem to be clustered per individual hedgehog, meaning 
that only a few hedgehogs contribute to the gross of the infected ticks. Borrelia  miyamotoi is 
known to give short-term systemic infection in rodents, therefore making rodents excellent 
but transitory amplifying hosts of this bacterium [61]. Vertebrates other than rodents 
may also become infected: B. miyamotoi DNA was also found in the tissue of an European 
greenfinch and a great tit [89]. The clustering of infected fed ticks on only one hedgehog 
in this study indicate that B. miyamotoi might result in a short-term systemic infection in 
hedgehogs as well. The role of these animals in the transmission cycle is not clear; they 
could be transitory hosts. Another possible explanation for the fact that many ticks were 
infected with the same pathogen on the same hedgehog could be co-feeding transmission 
[343, 344]. With this route of transmission, no systemic infection of the vertebrate host is 
necessary. The host is only a transient bridge, bringing together infected and uninfected 
ticks in both space and time, thereby facilitating pathogen exchange. The host does not 
necessarily have to be infected himself [343, 344]. The bird associated Borreliae, B. garinii 
and B. valaisiana, were each detected in one I. ricinus adult tick, and B. turdi occurred in 
one I. hexagonus female and one I. ricinus nymph. We can thus confirm the indication that 
hedgehogs are no reservoir hosts for the bird associated, only for the rodent-associated, B. 
burgdorferi s. l. genospecies [318].
Hedgehogs and their host-specific parasite I. hexagonus seem to play a role in maintaining 
some pathogens, like B. bavariensis, B. spielmanii, and A. phagocytophilum in cryptic cycles. 
The generalist feeding behavior of I. ricinus and the low prevalence of these pathogens 
in questing I. ricinus suggest that they do not play a main role in the maintenance of the 
enzootic cycle of these pathogens. However, when feeding on hedgehogs I. ricinus may 
still be infected by I. hexagonus-associated pathogens and transmit them to humans. 
Borrelia bavariensis can cause neurological disease in humans [19], and B. spielmanii has 
been linked to EM in humans. Both pathogens have already been linked to hedgehogs 
[318, 320]. Moreover, co-infection of R. helvetica and B. burgdorferi s. l. has been shown 
in neuroborreliosis patients [118]. Also, co-infections are thought to affect the severity of 
disease and influence clinical outcomes in some cases [155].  Since hedgehogs seem to 
be large contributors to co-infection rates in ticks, this poses an increased health risk. The 
variant of A. phagocytophilum detected in these samples were all linked to human cases of 
anaplasmosis (ecotype I) [39]. 
CONCLUSIONS
From these findings we conclude that hedgehogs are important components in the enzootic 
cycle of a diverse set of human pathogens, thereby contributing to the maintenance of 
various tick-borne diseases in (sub)urban areas. Humans are likely to come into contact with 
ticks infected with one or several of these pathogens while gardening or recreating in parks 
[345]. This poses a potential human health risk. Most hedgehogs, however, carry only few 
ticks and hedgehog densities are relatively low, thus hedgehogs will probably infect only few 
ticks with a certain pathogen. 
Further research is necessary to elucidate the interaction between hedgehog densities, tick 
burden and tick infection prevalence and to assess the precise impact of hedgehogs on the 






Enzootic origins for clinical 
manifEstations of lymE borrEliosis
S. Jahfari, A. Krawczyk, E. C. Coipan, M. Fonville, 
J. Hovius, H. Sprong, K. Takumi
Journal of Molecular Epidemiology and 
Evolutionary Genetics of Infectious Diseases (2016)
118  




Both early localized and late disseminated forms of Lyme borreliosis are caused by Borrelia 
burgdorferi senso lato. Differentiating between the spirochetes that only cause localized skin 
infection from those that cause disseminated infection, and tracing the group of medically-
important spirochetes to a specific vertebrate host species, are two critical issues in disease 
risk assessment and management. Borrelia burgdorferi senso lato isolates from Lyme 
borreliosis cases with distinct clinical manifestations (erythema migrans, neuroborreliosis, 
acrodermatitis chronica atrophicans, and Lyme arthritis) and isolates from Ixodes ricinus 
ticks feeding on rodents, birds and hedgehogs were typed to the genospecies level by 
sequencing part of the intergenic spacer region. In-depth molecular typing was performed 
by sequencing eight additional loci with different characteristics (plasmid-bound, regulatory, 
and housekeeping genes). The most abundant genospecies and genotypes in the clinical 
isolates were identified by using odds ratio as a measure of dominance. Borrelia afzelii was 
the most common genospecies in acrodermatitis patients and engorged ticks from rodents. 
Borrelia burgdorferi senso stricto was widespread in erythema migrans patients. Borrelia 
bavariensis was widespread in neuroborreliosis patients and in ticks from hedgehogs, 
but rare in erythema migrans patients. Borrelia garinii was the dominant genospecies in 
ticks feeding on birds. Spirochetes in ticks feeding on hedgehogs were overrepresented 
in genotypes of the plasmid gene ospC from spirochetes in erythema migrans patients. 
Spirochetes in ticks feeding on hedgehogs were overrepresented in genotypes of ospA 
from spirochetes in acrodermatitis patients. Spirochetes from ticks feeding on birds were 
overrepresented in genotypes of the plasmid and regulatory genes dbpA, rpoN and rpoS 
from spirochetes in neuroborreliosis patients. Overall, the analyses of our datasets support 
the existence of at least three transmission pathways from an enzootic cycle to a clinical 
manifestation of Lyme borreliosis. Based on the observations with these nine loci, it seems 
to be justified to consider the population structure of B. burgdorferi senso lato as being 
predominantly clonal.
INTRODUCTION
Lyme borreliosis is one of the vector-borne disease with the highest incidence in Europe [14]. 
The most common manifestation of Lyme borreliosis is erythema migrans, an expanding 
skin lesion occurring after several days or weeks at the site of the tick bite. Medical 
guidelines advise antibiotic treatment of erythema migrans, as it commonly prevents the 
development of late and more severe disease stages [10]. The disseminated and more severe 
manifestations of Lyme borreliosis can involve a patient’s nervous system (neuroborreliosis), 
joints (Lyme arthritis), skin (acrodermatitis chronica atrophicans), and in rare cases heart 
(Lyme carditis), ocular and lymph nodes (borrelial lymphocytoma). These disseminated 
manifestations seldom occur simultaneously in individual patients. Epidemiological surveys 
from Germany and the Netherlands found that 89-95% of the reported Lyme borreliosis 
cases had erythema migrans, 2-5% Lyme arthritis, 2% (early) neuroborreliosis, 0.4-2% 
borrelial lymphocytoma, 0.9-1% acrodermatitis chronica atrophicans, 0.1% Lyme carditis, 
and 0.1% ocular manifestations [25, 346]. 
Lyme borreliosis is caused by spirochetes belonging to the B. burgdorferi sensu lato 
(s. l.) complex. These bacteria have a high genetic diversity, at intergenospecies and 
intragenospecies level. It has been postulated that this genetic diversity is at the base of 
the multiple clinical manifestations that infection with these bacteria can display [347-349]. 
At least five of the more than 19 known genospecies of B. burgdorferi s. l. are commonly 
associated with Lyme borreliosis in Europe: B. afzelii, B. garinii, B. burgdorferi sensu stricto (s. 
s.), B. spielmanii, and B. bavariensis [350]. Other Borrelia genospecies, such as B. lusitaniae, 
have occasionally been found to cause disease as well [20-23]. All the five pathogenic 
genospecies are able to cause erythema migrans [351]. Although there is not a clear-cut 
differentiation between genospecies and disseminated disease manifestations, current 
knowledge is that B. afzelii is predominantly associated with acrodermatitis, B. garinii and 
B. bavariensis with neurological manifestations, and B. burgdorferi s. s. with Lyme arthritis 
[10, 19]. Remarkably, not all the Borrelia genotypes within the pathogenic genospecies can 
cause Lyme borreliosis [117]. Genotype is a subset of spirochetes belonging to the same 
genospecies which share an identical sequence. From the 251 multilocus sequence types 
(MLST) that were identified in a study investigating 775 B. burgdorferi s. l. isolates from 
various sources, only six sequence types significantly associated to clinical manifestations 
in humans [19]. In Northern America, B. burgdorferi s. s. has some major sequence types of 
the outer surface protein C (ospC) and certain sequence types of 16S-23S rRNA intergenic 
spacer that are more frequently found in disseminated cases of Lyme borreliosis [347-349]. 
Furthermore, significant associations between clusters of multilocus sequence types (clonal 
complexes) of B. burgdorferi s. s. and localized or disseminated forms of Lyme borreliosis 
have been found [352]. What genetic information determines the differential invasiveness 
of Borrelia genospecies, but also of genotypes within a genospecies is not known.
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Ixodes ricinus is the main vector of B. burgdorferi s. l. in Western Europe [353], although 
other tick species, such as I. hexagonus, I. uriae and I. frontalis might be able to transmit B. 
burgdorferi s. l. as well [322, 354, 355]. Ticks become infected during a blood meal on an 
infected vertebrate host or when co-feeding near an infected nymph [356, 357]. Many small 
mammals, birds and lizards act as transmission and/or amplification hosts for B. burgdorferi 
s. l. [358]. Interestingly, ungulates are among the few vertebrates known as incompetent 
for transmission of B. burgdorferi s. l. [359, 360]. The full range of transmission and/or 
amplification hosts and their relative contribution to the generation of infected ticks has not 
been well understood for all Borrelia genospecies. It has been hypothesized that the genetic 
diversity of B. burgdorferi s. l. is maintained by a multiple-niche polymorphism balancing 
selection [361]. This seems to be the case at the genospecies level: Small mammals 
mainly transmit B. afzelii, while B. garinii is mainly transmitted by birds [201, 203, 361]. 
There is evidence that this is also the case within the genospecies: In the United States, 
four important host species of B. burgdorferi s. s. were infected with different sets of ospC 
major groups [362]. Furthermore, different host species differ in their ability to transmit B. 
burgdorferi s. s. [363]. Whether this is also the case for two major Borrelia genospecies in 
Europe, B. afzelii and B. garinii, needs further investigation [364]. 
This study aims to directly link a transmission and/or amplification host for B. burgdorferi s. 
l. to a clinical manifestation of Lyme borreliosis. We hypothesize that a transmission cycle 
for a genotype is one factor that determines the clinical manifestation of Lyme borreliosis. 
We test this hypothesis by a quantitative molecular epidemiologic approach. Our sample 
collection covers both clinical sources (Lyme borreliosis patients having erythema migrans, 
neuroborreliosis, acrodermatitis, or Lyme arthritis) and field sources (ticks feeding on birds, 
rodents and hedgehogs). Plasmid, regulatory, house-keeping and neutral genetic loci from a 
number of samples are input to the statistical test of the hypothesis.
MATERIAL AND METHODS
Borrelia samples
For this study, 183 previously described isolates [19] of B. burgdorferi s. l. which were 
derived from Lyme borreliosis cases across Europe (Austria, Switzerland, Denmark, Spain, 
Finland, France, Germany, Hungary, Italy, Netherlands, Portugal, Slovenia, Sweden), with 
distinct clinical manifestations were used. In addition, 26 isolates of B. burgdorferi s. l. from 
questing I. ricinus and 184 B. burgdorferi s. l. positive lysates of questing I. ricinus from the 
Netherlands were used. Ixodes ricinus ticks that had fed on rodents (n=217), birds (n=153) 
and hedgehogs (n=28) from the Netherlands were used. Ticks of all stages were included in 
this study. 
DNA extraction, screening of samples, target gene amplification
Upon arrival in the laboratory, the ticks were identified by an experienced technician using 
morphological keys [224, 365]. Only Ixodes ricinus tick were used for further analysis. 
DNA extraction from the individual questing ticks was done by alkaline lysis in ammonium 
hydroxide, as described previously [51], while the DNA extraction from the bacterial isolates 
and fed ticks was performed using DNeasy® Blood & Tissue Kit (QIAGEN N.V., Venlo, the 
Netherlands). Screening of the questing and fed ticks for B. burgdorferi s. l. was done by 
qPCR, as described [271]. 
For all the Borrelia positive samples, we performed PCR targeting the variable 5S–23S rDNA 
intergenic spacer region (IGS), to determine and type the genospecies of the Borrelia. The 
PCR was performed according to the protocol described before [161]. All B. burgdorferi s. 
l. samples were sequenced using the 5 regulatory virulence -associated genes (bosR, rrp2, 
rpoS and rpoN) and 3 plasmid genes (ospC, ospA and dbpA). The gene rpoN is involved 
in the regulation of plasmid genes [366-368]. The genes bosR, rpoS, and rrp2 are located 
downstream of rpoN [369, 370]. Furthermore, these genes are thought to be involved in the 
uptake of essential metal and ions from the surroundings, which is important for survival of 
the spirochetes in the host [371]. PCR procedure and primers as described in Table A of the 
supplementary data. All 8 genes were amplified and subsequently sequenced in forward 
and reverse directions. Trimming and manual cleaning of sequences was performed in 
Bionumerics 7.1. (Applied Math, Belgium). Genes ospC, ospA and dbpA available in Genbank 
were downloaded and used for the analyses.
Molecular epidemiological database
Borrelia burgdorferi s. l. ospC, ospA and dbpA DNA sequences with the geographical origin 
(country) and the host species from which the isolate originated were also downloaded 
from the Entrez Nucleotide Database (GenBank, NCBI). A sequence was excluded if its host 
species was unknown or it did not originate from Europe. Sequences that were too short 
to cover regions of variation were also excluded from further analysis. DNA sequences and 
epidemiological data used for this study are given in Supplementary material.
Genetic analyses
DNA sequences for each gene were aligned using MAFFT version 7.271 [372] with the 
option localpair turned on and the option maxiterate set to 1000. A phylogenetic tree was 
estimated using raxml version 8.1.17 [373]. We set an option for a general time reversible 
model of DNA evolution and CAT approximation for a gamma model of rate heterogeneity 
(-m GTRCAT). We also set an option for rapid bootstrap analysis and maximum likelihood 
tree search (-f a) to compute confidence values for each internal node. We collapsed the 
internal nodes in the estimated maximum likelihood tree for which a confidence value was 
less than 80% using a program Python (2.7.10 Release) and importing a module Phylo [374].
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We estimated association between a particular source and a genotype or a genospecies 
as odds ratio, using Fishers Hypergeometric distribution [375] by means of the maximum 
likelihood method. Three outcomes are possible: (a) a particular source is overrepresented 
in a genospecies (odds ratio > 1), (b) present evenly in each genospecies (odds ratio = 1), 
and (c) underrepresented in a particular genospecies (odds ratio < 1). P-value for odds ratio 
was calculated based on the likelihood ratio test with 1 degree of freedom. When P-value is 
greater than 0.05, we interpret that the estimated odds ratio is not equal to 1.
Plasmid, regulatory, and house-keeping genes are analyzed for identification of a possible 
virulent cluster. Each internal node in a gene tree was examined for virulence by depth-
first search, by estimating Bayes factor [376] at each internal node. This calculation was 
based upon Dirichlet compound multinomial distribution [377] with a flat prior. Null 
hypothesis is that the observed numbers of eight sources (Lyme borreliosis patients having 
erythema migrans, neuroborreliosis, acrodermatitis, or Lyme arthritis, questing ticks and 
engorged ticks from birds, rodents and hedgehogs) within a cluster are congruent with the 
proportions of eight sources in the whole gene tree. Alternative hypothesis is that observed 
numbers within a cluster are better explained by assigning cluster-specific proportions. 
Estimated Bayes factors are translated into decision categories following a classification 
scheme [376]. Category ‘Decisive’ supports that some source is overrepresented within the 
cluster. All other decision categories are deemed insufficient support and we discard them 
for subsequent steps in the analyses.
A ‘Decisive’ clusters could indicate significant excess in any of the eight sources of our 
sample collection. Our primary interest is one of four clinical sources. To find out which, 
we calculate a distance from a cluster to each of four clinical sources. Mathematically, we 
assemble observed numbers of eight sources into a data matrix, where ‘Decisive’ clusters 
are rows and eight distinct sources are columns (Supplementary material Table B). Then 
we identify the top two principal components by applying singular value decomposition 
[378] to the data matrix. Cosine similarity defines the distance between a cluster and a 
clinical source. After identifying the shortest distance, we label a cluster by the matching 
clinical source. We checked the result by examining the number of sequences with regard 
to the matching clinical source (Supplementary material Table B). In case of failure to check, 
the cluster remains unlabeled. Failure is often due to the absence of any clinical source, or 
unusual amount of excess or deficit in one of field sources.
A test on nine genetic markers is performed to divide the markers into two subgroups based 
on odds ratio. Genetic markers are ordered by the estimated odds ratio values, then they 
are split into a high odds ratio group and a low odds ratio group. Each arrangement is tested 
based on the likelihood ratio test against the null hypothesis: all genes are equal in odds 
ratio. We choose the arrangement for which the P-value is: (1) the lowest among all eight 
splits, and (2) less than the threshold value (p = 0.05). A test on genospecies and the genetic 
markers is performed similarly.
Depth-first tree-traversal and Dirichlet compound multinomial distribution are implemented 
using Python (2.7.10 Release) and importing two modules Phylo [374] and Scipy [379]. Odds 
ratio calculation and singular value decomposition are implemented using Mathematica 
10.4.1.0 (Wolfram Research, Inc., Campaign, IL). 
RESULTS
Genospecies frequencies based on IGS
A set of 467 samples from seven sources (four clinical manifestations and three field 
sources) were typed to the genospecies level using the intergenic spacer region (IGS, Table 
1,[161]). Clinical sources were Lyme borreliosis patients having erythema migrans (n=136), 
acrodermatitis (n = 36), neuroborreliosis (n=9) and Lyme arthritis (n = 1). Six patients 
developed both erythema migrans and neuroborreliosis, and their Borrelia sequences were 
added once to both clinical manifestations for further analyses. Field sources were engorged 
ticks from birds (n = 51), engorged ticks from hedgehogs (Erinaceus europaeus; n = 182), and 
engorged ticks from rodents (Apodemus sylvaticus and Myodes glareolus; n = 56). The most 
common genospecies was B. afzelii (n = 329: 133 clinical and 205 field isolates), followed 
by B. garinii (n = 59: 23 clinical and 35 field), B. spielmanii (n = 40: 3 clinical and 37 field), 
B. bavariensis (n = 27: 7 clinical and 20 field), and B. burgdorferi s. s. (n = 12: 10 clinical and 
2 field). Borrelia valaisiana was identified only once in a tick feeding on a hedgehog, and 
ignored in further analyses. Since it is the feeding tick nymph, it is possible that the tick was 
infected in a previous developmental stage.
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Table 1: Summary of intergenic spacer region sequences by isolate origin and genotype. Each row lists 
the numbers of successful sequencing products using the specified isolate. Columns are organized 
according to Borrelia genotypes. 
Afzelii Bavariensis Senso 
stricto
Garinii Spielmanii Valaisiana Total
Acrodermatitis 
chronica atrophicans
35 0 1 0 0 0 36
Lyme arthritis 1 0 0 0 0 0 1
Erythema migrans 97 1 9 20 3 0 130
Neuroborreliosis 0 3 0 0 0 0 3
Erythema migrans & 
neuroborreliosis
0 3 0 3 0 0 6
Engorged bird tick 17 0 0 34 0 0 51
Engorged hedgehog 
tick
122 20 2 1 37 1 182
Engorged rodent tick 56 0 0 0 0 0 56
Unknown/Others 1 0 0 1 0 0 2
Total 329 27 12 59 40 1 467
Genospecies association with clinical manifestations
Based on IGS genetic typing, B. afzelii was the dominant genospecies identified from 
acrodermatitis patients as measured by odds ratio (OR = 17, Table 2). Borrelia burgdorferi 
s. s. (OR = 8) was overrepresented in erythema migrans patients. B. bavariensis was 
the dominant genospecies in patients with neuroborreliosis (OR = 35), and it was 
underrepresented in erythema migrans patients (OR = 0.4). Borrelia afzelii was absent and 
therefore underrepresented in neuroborreliosis patients (OR = 0). 
Genospecies association with enzootic cycles
Borrelia afzelii was the dominant genospecies in engorged ticks from rodents (OR = 29, Table 
2), whereas B. garinii was the dominant genospecies in engorged ticks from birds (OR = 29). 
B. bavariensis was overrepresented in engorged ticks from hedgehog (OR = 3).
Frequencies of nine other genetic markers
Next to IGS, one or more loci (Table 3) were obtained from a larger subset of the sample 
collection (n = 966). These loci complement IGS as additional genetic markers for this study 
because of their potent roles in a sequelae following an acute Borrelia infection [370, 380-
383]. Between 500 and 700 sequences were located on plasmids (dbpA, ospA and ospC, 
Table 3). Between 200 and 300 sequences were loci from regulatory genes (bosR, rpoN, 
rpoS, and rrp2, Table 3), and approximately 700 sequences were located on house-keeping 
genes (clpA and clpX, Table 3).
Table 2: Estimates for odds ratio values by genotype. Numerals are bold when P-value is less than 0.05: 
Odds ratio is not equal to 1.





17 0 1 0 0 0
Lyme arthritis 0.4 0 0 0 0 0
Erythema migrans 1 0.4 8 2 0.2 0
Neuroborreliosis 0 35 0 4 0 0
Engorged bird tick 0.2 0 0 29 0 0
Engorged hedgehog 
tick
0.7 3 0.3 0 24 2
Engorged rodent tick 29 0 0 0 0 0
Table 3: Summary of isolates and sequences in this study. Each row lists the numbers of successful 
sequencing products using the specified isolate. Columns are organized according to plasmid, 
regulatory and MLST genes.
Plasmid Regulatory MLST
dbpA ospA ospC bosR rpoN rpoS rrp2 clpX clpA
Acrodermatitis 33 35 36 36 36 36 35 38 38
Lyme arthritis 2 3 3 1 1 1 1 2 2
Erythema migrans (EM) 125 152 127 126 129 128 128 162 163
Neuroborreliosis (NB) 28 42 44 3 3 3 3 19 22
NB and EM 6 6 6 6 6 6 6
Vegetation tick 98 335 217 27 31 61 29 514 494
Engorged bird tick 46 40 14 49
Engorged hedgehog tick 15 9 3
Engorged rodent tick 101 40 99 56
Unknown/Others 233 27 8 1 2 1 1
Total 672 655 581 199 220 344 203 735 719
Association of genetic markers with clinical manifestations
Sequences of each of the nine genetic markers grouped into clusters by genetic similarity 
(Supplementary material Table B). The number of genetic clusters was the lowest for the 
regulatory gene (9 clusters, bosR) and the highest for the plasmid gene (108 clusters, ospC). 
One or more clusters were identified in each genetic marker, which contain an excess of 
isolates from neuroborreliosis patients (Supplementary material Table B), as supported by 
OR estimates, all exceeding 1 (Table 4). A likelihood test on the set of nine genetic markers 
supported that eight markers were statistically equal in OR and ospA was significantly lower 
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than the rest (Table 4). Distinct clinical clusters were identified for acrodermatitis in all nine 
genetic markers as well (Supplementary material Table B). Excess of acrodermatitis in the 
identified clusters were quantified in OR estimates (Table 4). Seven genetic markers were 
statistically equal in OR and dbpA and ospC were lower than the other seven markers (Table 
5). Erythema migrans clusters were only identified in ospC (Supplementary material Table 
B). OR estimate for the erythema migrans clusters (Table 6) was a factor ten lower than the 
estimates for neuroborreliosis and acrodermatitis (Table 4 and 5).
Association of genetic markers with enzootic cycles
We investigated whether spirochetes from ticks feeding on a particular host species appear 
exceedingly often in the genotypes of the nine markers from spirochetes in neuroborreliosis 
patients (Supplementary material Table B), or that their occurrence follows the expectation 
(2.5 Statistical analyses). Spirochetes from ticks feeding on birds were overrepresented in 
the genotypes of the three genetic markers from spirochetes in neuroborreliosis patients, 
as supported by the estimated OR values significantly exceeding the value one at these loci 
(dbpA, rpoN, rpoS in Table 4). No evidence was found for the association of the spirochetes 
in ticks feeding on hedgehog with the neuroborreliosis, i.e. estimated OR values for ospC 
and rpoS in Table 4 are not significantly different from one.
Similar analysis was performed regarding the genotypes of the nine markers of spirochetes 
in acrodermatitis patients (Supplementary material Table B). Spirochetes from ticks 
feeding on rodents were overrepresented in the acrodermatitis patients: the estimated OR 
significantly exceeded the value one at three genetic markers (dbpA, ospA, and rpoS in Table 
5). Spirochetes from ticks feeding on hedgehog were overrepresented in acrodermatitis: 
estimated OR using ospA significantly exceeded one (Table 5).
Spirochetes from ticks feeding on hedgehogs (OR = 4.6) and on rodents (OR = 2.7) were 
overrepresented in the genotypes of spirochetes from erythema migrans patients (Table 6). 
No evidence was found for the association of spirochetes from ticks feeding on birds with 
erythema migrans patients (Table 6).
OR estimates were calculated so far separately for association of genospecies and genetic 
markers with clinical manifestations and enzootic cycles. We applied the likelihood ratio 
test to the separate cases with the aim to identify main contributing factors. Genospecies 
B. afzelii and the seven genetic markers equally predicted the excess of acrodermatitis. 
Genospecies B. bavariensis and the eight genetic markers equally predicted the excess of 
neuroborreliosis. Genospecies B. burgdorferi s. s. was better predictor for the excess of 
erythema migrans than the specific genotype of the plasmid gene ospC.
Table 4: Estimates for odds ratio support neuroborreliosis clusters in three plasmid four regulatory and 
two MLST genes. Rows list plasmid, regulatory and house-keeping genes. A cell contains estimated 
odds ratio (see Method for detail). Numerals are bold when P-value is less than 0.05. A subgroup of 
genes having higher estimated odds ratio values is identified by applying the likelihood ratio test. The 
members are indicated by the + symbol in the class column.






Plasmid dbpA + 92 7 0.3
ospA 9
ospC + 30 0.3 0.6 0.04
Regulatory bosR + 36
rpoN + 35 55
rpoS + 28 7 1.4 0.04
rrp2 + 53
MLST clpA + 58
clpX + 53
Table 5: Estimates for odds ratio support acrodermatitis clusters in in three plasmid four regulatory 
and two MLST genes. See Table 4 for detail.






Plasmid dbpA 11 0.1 40
ospA + 37 15 4
ospC 5 0.6 1.5 0.8
Regulatory bosR + 13
rpoN + 18 0.03
rpoS + 14 0.1 0.7 25
rrp2 + 13
MLST clpA + 39
clpX + 42
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Table 6: Estimates for odds ratio support erythema migrans clusters in only one plasmid gene. See 



















From a public health perspective, it is important to be able to differentiate between the 
pathogenic and non-pathogenic Borrelia spirochetes and to differentiate between the 
genotypes that only cause localized infections and the ones that are able to cause more 
disseminated, and consequently more severe disease manifestations. Discriminating 
between these types and linking them to specific vertebrate hosts could also be useful for 
disease risk assessment and management. From the medical perspective, the development 
of more accurate diagnostic tools, and effective treatment regimens require knowledge on 
the diversity and etiology of the different Borrelia genospecies and genotypes, which can be 
identified based on IGS [161].
Our quantitative molecular epidemiological approach based on genospecies level testifies 
that hedgehogs are a host of B. bavariensis and that this genospecies is widespread in 
neuroborreliosis patients but rare in patients with erythema migrans. Birds are a host of B. 
garinii. While rodents are a host of B. afzelii and this genospecies is strongly associated with 
acrodermatitis. Borrelia burgdorferi s. s. is widespread in erythema migrans, and its host 
could not be identified in our sample collection. Statistical support (odds ratio) for these 
links are substantial. The results in this study express the currently prevailing hypotheses in 
a more precise and quantitative manner.
The same quantitative approach based on the set of nine genetic markers revealed extra 
links on top of those identified by the genospecies-based analyses (Figure 1). Based on 
the significant associations found in these analyses, tentative transmission pathways 
of B. burgdorferi s. l. were identified in a number of situations: (1) from hedgehogs to 
erythema migrans patients based on the genetic similarity of the plasmid gene ospC, (2) 
from hedgehogs to patients with acrodermatitis using the plasmid gene ospA, (3) from birds 
to neuroborreliosis patients using the plasmid gene dbpA and two virulence-associated 
regulatory genes rpoN and rpoS, and (4) from rodents to patients with erythema migrans 
using ospC as a marker. Overall, the analyses of our datasets support the existence of at 
least three transmission pathways from an enzootic cycle to a clinical manifestation of Lyme 
borreliosis (Figure 1). Nevertheless, these pathways are not mutually exclusive and overlap 
to some extent. All three clinical manifestations could be traced by one of those pathways 
to hedgehogs. We are aware that more transmission pathways exist, and that not all of 
them were identified in this study. Two primarily limiting factors are; the lack of a significant 
statistical support and, the lack of samples from more vertebrate hosts species from which 
engorged tick were analyzed (limited dataset). For example, the lack of B. burgdorferi s. 
s. from vertebrate hosts (Table 3) might be masking a medically important transmission 
pathway of this genospecies from an unknown enzootic cycle to erythema migrans. Due to 
these factors, the understanding of Borrelia transmission pathways at this stage (illustrated 
by Figure 1) is incomplete. We contemplate that a more comprehensive picture would 
emerge when further B. burgdorferi s. l. sequences become available from increasing 
number of a variety of amplification hosts and human Lyme borreliosis patients.
Borrelia bavariensis was identified both in neuroborreliosis and in erythema migrans patients. 
Interestingly, this genospecies seems to be abundant in neuroborreliosis patients, but rare 
in erythema migrans patients (Table 2), and rare in questing Ixodes ricinus ticks [38, 384, 
385]. All sequences of the nine genetic markers from neuroborreliosis patients genetically 
cluster together with at least one sequence from Borrelia isolates from erythema migrans 
patients (Supplementary material Table B). If we maintain the evidence solely on the basis 
of genetic identity, the hypothesis that erythema migrans always precedes neuroborreliosis 
is supported by our data. An alternative argument can be made based on the number of 
sequences in combination with the genetic identity. A high propensity of this genospecies to 
manifest neuroborreliosis in a patient, and to a significantly lesser extent erythema migrans, 
is consistent with the high odds ratio in neuroborreliosis and the low odds ratio in erythema 
migrans, while both clinical manifestations co-exist within the same genetic cluster. Medical 
guidelines advise antibiotic treatment of erythema migrans, as it commonly prevents the 
development of late and more severe disease stages [10]. Based on our observations, this 
strategy does not seem to work well for the prevention of neuroborreliosis caused by B. 
bavariensis, because of the scarcity of B. bavariensis infections causing erythema migrans. 
Our analysis attests that all the nine genetic markers except ospA are equally suitable 
candidate marker for neuroborreliosis. Equality among the majority of genetic markers 
applies to the other severe sequela, acrodermatitis. Odds ratio estimates exceeding the 
baseline (= 1) by a wide margin (Table 4 and 5) can be explained by high disequilibrium among 
the plasmid and chromosomal loci, whose phenotypes are associated to regulatory and 
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house-keeping tasks. These results are less compatible with the possibilities that multiple 
Borrelia genotypes exchange a virulent plasmid gene by horizontal gene transfer. For the 
purpose of disease risk assessment and management, it might be justified to consider the 
population structure of B. burgdorferi s. l. as being predominantly clonal.
Figure 1: Schematic drawing illustrating the genetic linkages from engorged Ixodes ricinus ticks on 
distinct wild animal species to different clinical outcomes of Lyme borreliosis. Square boxes represent 
clinical and field sources of the sample collection in this study. A Borrelia gene overrepresented in a 
source is listed in the box. Directed edges between two boxes represents the routes identified in this 
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Tick-borne diseases are the most prevalent vector-borne diseases in Europe. Knowledge on 
the incidence and clinical presentation of other tick-borne diseases than Lyme borreliosis 
and tick-borne encephalitis is minimal, despite the high human exposure to these pathogens 
through tick bites. Using molecular detection techniques, the frequency of tick-borne 
infections after exposure through tick bites was estimated. 
Methods
Ticks, blood samples and questionnaires on health status were collected from patients that 
visited their general practitioner with a tick bite or erythema migrans in 2007 and 2008. The 
presence of several tick-borne pathogens in 314 ticks and 626 blood samples of this cohort 
were analyzed using PCR-based methods. Using multivariate logistic regression, associations 
were explored between pathogens detected in blood and self-reported symptoms at 
enrolment and during a three-month follow-up period.
Results
Half of the ticks removed from humans tested positive for Borrelia burgdorferi sensu lato, 
Anaplasma phagocytophilum, Candidatus Neoehrlichia mikurensis, Rickettsia helvetica, 
Rickettsia monacensis, Borrelia miyamotoi and several Babesia species. Among 92 Borrelia 
burgdorferi s. l. positive ticks, 33% carried another pathogen from a different genus. In blood 
of sixteen out of 626 persons with tick bites or erythema migrans, DNA was detected from 
Candidatus Neoehrlichia mikurensis (n=7), Anaplasma phagocytophilum (n=5), Babesia 
divergens (n=3), Borrelia miyamotoi (n=1) and Borrelia burgdorferi s. l. (n=1). None of 
these sixteen individuals reported any overt symptoms that would indicate a corresponding 
illness during the three-month follow-up period. No associations were found between the 
presence of pathogen DNA in blood and; self-reported symptoms, with pathogen DNA in 
the corresponding ticks (n=8), reported tick attachment duration, tick engorgement, or 
antibiotic treatment at enrolment.
Conclusions
Based on molecular detection techniques, the probability of infection with a tick-borne 
pathogen other than Lyme spirochetes after a tick bite is roughly 2.4%, in the Netherlands. 
Similarly, among patients with erythema migrans, the probability of a co-infection with 
another tick-borne pathogen is approximately 2.7%. How often these infections cause 
disease symptoms or to what extend co-infections affect the course of Lyme borreliosis 
needs further investigations.
AUTHORS SUMMARY 
Two most common tick-borne diseases in Europe are Lyme borreliosis and tick-borne 
encephalitis. Ticks transmit many more pathogens, causing neglected diseases such as 
anaplasmosis, babesiosis, rickettsiosis and neoehrlichiosis. These diseases are seldom 
diagnosed, due to their mild and non-characteristic symptoms, but also due to lack of 
awareness and availability of diagnostic tests. Using molecular detection techniques 
(polymerase chain reaction or PCR), we estimated the frequency of tick-borne infections 
in humans after a tick bite and in patients with the first symptoms of Lyme borreliosis, an 
erythema migrans. About half of the ticks that fed on humans carried one or more tick-borne 
pathogens, and approximately 2.5% of people that were bitten by ticks were infected with a 
tick-borne pathogen other than Lyme borreliosis or tick-borne encephalitis. Co-infections of 
a tick-borne pathogen in patients with an erythema migrans was also approximately 2.5%. 
Based on these findings, we estimated the incidence of tick-borne infections other than 
Lyme borreliosis in the Netherlands. How often these infections cause disease or to what 
extend co-infections affect the course of Lyme borreliosis needs further investigations.
INTRODUCTION
Lyme borreliosis is the most prevalent tick-borne disease in humans, and is caused by 
spirochetes of the Borrelia burgdorferi sensu lato complex [10, 350, 386]. The most 
common clinical manifestation of early localized Lyme borreliosis is erythema migrans (EM), 
an expanding skin lesion occurring after several days or weeks at the site of the tick bite. 
Other sporadically reported symptoms in this early stage of disease are malaise and viral-
like symptoms. Disseminated Lyme borreliosis displays more severe manifestations that 
can involve a patient’s nervous system, joints, skin, and in rare cases the heart [10, 350, 
386]. Tick-borne encephalitis (TBE) is the most common tick-borne central nervous system 
infection caused by the tick-borne encephalitis virus (TBEV). Its clinical spectrum ranges 
from fever to mild meningitis and severe meningoencephalitis with or without paralysis 
[387]. 
In several European countries, there have been marked increases in the incidence of 
Lyme borreliosis and TBE over the past ten to twenty years [12-14]. In the Netherlands, 
a retrospective study among general practitioners has shown a continuing increase in 
consultations for tick bites and EM between 1994 and 2009 [9, 24]. The increasing number of 
tick bites, adding up to 1.1 million tick bites in 2009 [9], poses a growing risk of disseminated 
Lyme borreliosis and perhaps also of other tick-borne diseases. In the Netherlands, Ixodes 
ricinus ticks transmit several Borrelia burgdorferi s. l. genospecies, but are also infected 
with a variety of established or potentially pathogenic microorganisms, such as Borrelia 
miyamotoi, Anaplasma phagocytophilum, Candidatus Neoehrlichia mikurensis, several 
Babesia species, Rickettsia helvetica, R. monacensis and TBEV [38, 60, 103, 120, 177, 388]. 
These ticks often carry multiple pathogens; at least one-third of the I. ricinus ticks carrying 
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B. burgdorferi s. l. are co-infected with one or more pathogens from a different genus [38], 
implying frequent exposure and possibly subsequent infection with several pathogens when 
humans are bitten by ticks.  
Remarkably, little is known about the incidences and clinical presentations of other tick-
borne diseases than Lyme borreliosis and TBE. In general, disease caused by these other 
tick-borne pathogens, are associated with febrile illnesses with fever, headache, myalgia 
and malaise [36, 73, 83, 95, 122, 389]. However, in immunocompromised patients chronic 
infections with severe clinical manifestations and even mortality have been described [73, 
95, 122, 390]. In the Netherlands, one single case of anaplasmosis has been reported in 
1999 [45], and one case of B. miyamotoi disease in an immunocompromised patient in 2012 
[95]. It has been suggested that the severity of disease in Lyme borreliosis is affected by co-
infections with other tick-borne pathogens [11, 155, 166, 391, 392]. Therefore, co-infections 
of B. burgdorferi s. l. with different tick-borne pathogens may possibly contribute to the high 
variety of clinical manifestations that are associated with Lyme borreliosis. 
Several reasons can be appointed for the absence in reporting of tick-borne diseases other 
than Lyme borreliosis and TBE, and the diagnosis of co-infections with other pathogens in 
Lyme borreliosis patients. Firstly, most of these infections might be self-limiting without 
overt or characteristic symptoms, often a clear-cut case definition of patients infected with 
one of these pathogens has not been established yet. Secondly, a poor performance or non-
existence of supportive laboratory tests in routine medical microbiological settings. Thirdly, 
the lack of awareness among health professionals. 
Here, we aim to investigate i) whether infection with tick-borne pathogens other than B. 
burgdorferi s. l. can be shown in patients with early localized Lyme borreliosis and in people 
exposed to tick bites in the Netherlands, and to determine ii) the clinical picture of patients 
with DNA of tick-borne pathogens in their blood.
Our approach is to test for the presence of nucleic acid (DNA/RNA) of the specific pathogens 
in human blood through amplification with PCR, especially since currently; there is no other 
specific laboratory diagnostic to detect infection with most of these tick-borne pathogens. 
Compared to DNA amplification with PCR, available serological tests generally have a low 
specificity and or sensitivity, particularly during the early phase of infection. In addition, 
although culturing is considered the most reliable method in proving the presence of 
microorganisms, it is time consuming, costly and often not possible for all pathogens.
MATERIAL AND METHODS
Study design, ticks, human samples and questionnaires
Ticks, EDTA-blood and questionnaire data were available from a nationwide prospective 
observational study among patients who consulted one of 307 enrolling general practitioners 
for a tick bite or EM between May 2007 and December 2008 in the Netherlands, as described 
in detail [254]. All participants gave written informed consent, all minors who participated 
in the study had consent given from a parent/guardian, and the study protocol (number 
07-032/K) was approved by the medical ethics committee of the University Medical Centre 
in Utrecht, the Netherlands. Patients were not eligible for participation when they were 
younger than six years of age, or when the tick bite had occurred outside the Netherlands. 
At enrolment, participants received the first set of study materials, containing a brochure 
about the study, an enrolment questionnaire, and materials for collection and mailing of 
first blood samples and removed ticks. Ticks removed from the skin were submitted in a 
small tube with 70% ethanol. In total, 314 ticks were obtained from 293 participants, of 
which 278 patients consulted their physician for a tick bite, and fifteen patients consulted 
their physician with an EM. Four ticks (1%) were larvae, 167 (53%) nymphs, 135 (43%) adult 
ticks, and for eight ticks, the developmental stage could not be determined, as they had 
been damaged too much during removal from the patient’s skin. No other tick species than 
I. ricinus were identified. At enrolment, two tubes of blood were collected, 7 ml in a serum 
tube and 5 ml in an EDTA tube. Three months after enrolment, follow-up questionnaires and 
a consecutive 7 ml serum sample was collected from the tick bitten patients and from the 
EM patients after standard antibiotic treatment [254, 393]. Seven patients who consulted 
their physician for a tick bite and in whom EM developed within the three month follow-
up duration of the prospective study, were categorized in EM patient-group of the current 
study. EDTA-blood samples were available for molecular testing from 335 tick bitten patients 
and 291 EM patients.
Tick analyses for detection of tick-borne pathogens
After arrival at the laboratory, ticks were stored at –20°C in ethanol. DNA was extracted using 
the DNeasy Blood and Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer’s 
instructions extraction for ticks. After total DNA extraction from ticks and amplification 
by PCR, reverse line blotting (RLB) was performed for Borrelia-, Ehrlichia-, Anaplasma-, 
Rickettsia- and Babesia-species. Further identification by DNA sequencing was performed 
as described [104, 177]. PCR products that specifically reacted to the generic (“catch all”) 
probes, but that could not be further specified to the (geno)species level were designated 
as “untypeable”. Furthermore, our RLB analysis could not distinguish between B. garinii 
and B. bavariensis [38]. The presence of B. miyamotoi in ticks was tested by a real-time 
PCR amplification in 302 ticks, and Candidatus Neoehrlichia mikurensis in 312 ticks. The 
presence of TBEV RNA could not be screened in the tick samples, since only DNA had been 
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extracted from these samples. Individual test results of the tick analyses were not reported 
to the participants or their physicians, in accordance with the informed consent form. 
Molecular analyses for detection of tick-borne pathogens in EDTA-blood
Extraction of whole nucleic acid of the EDTA-blood samples were performed using robot-
extraction (MagNA Pure Compact Extraction Robot; Roche, Basel, Switzerland) from 400 
µL of EDTA-plasma (Nucleic Acid Isolation Kit I; Roche) according to the manufacturer’s 
instructions in a diagnostic laboratory setting. All 626 samples were analyzed with different 
real-time PCRs based on various genes specific for the microorganism of interest namely; 
B. burgdorferi s. l., B. miyamotoi, A. phagocytophilum, Candidatus Neoehrlichia mikurensis, 
spotted fever Rickettsia’s carried out on a LightCycler 480 (Roche Diagnostics Nederland 
B.V, Almere, the Netherlands). For primers and probes, see supplementary data, Table 1. 
Reactions were done in a final volume of 20 μl with iQ multiplex Powermix, 3 μl of sample and 
0.2 μM for all primers and different concentrations for probes. Positive plasmid controls and 
negative water controls were used on every plate tested. For detection of TBEV, multiplex 
a reverse transcription real-time PCR was performed as described before [394]. In brief, 
reactions were done in a final volume of 20 μl with TaqMan Fast Virus 1-Step Master Mix 
(Thermo Fisher scientific, USA), 5 μl of sample and 0.2 μM for all primers and 0.2 μM probes 
(Table 1 of the supplementary data) were added to the master mix and internal control 
was added to all the samples. With 20 min reverse transcription step at 50°C, denaturation 
at 95°C for 30 s and 50 cycles of 95°C for 10 s and 60°C for 30 s. The amplification was 
performed on a Roche LightCycler 480 instrument. For Babesia genospecies, we performed 
a conventional PCR targeting the 18S rRNA gene on all the blood samples [177], followed by 
sequencing. To minimize cross contamination and false-positive results, negative controls 
were included in each batch tested by PCR. In addition, DNA/RNA extraction, PCR mix 
preparation, sample addition, and PCR analyses were performed in separated air locked 
dedicated labs. On all samples that were found positive in the real-time PCR, conventional 
PCRs were performed for confirmation on one or more targets followed by Tris-Borate-EDTA-
agarose gel-electrophoresis. PCR products were sequenced, and these were compared with 
reference sequences from Genbank using Unweighted Pair Group Method with Arithmetic 
Mean-based (UPGMA) hierarchical clustering. Individual test results of these molecular 
analyses on EDTA-blood were not reported to the participants or their physicians, in 
accordance with the informed consent form. 
Statistical analyses
The prevalence of microorganism DNA detection in ticks and in EDTA-blood was calculated 
with 95% confidence intervals (95%CI) based on mid-P exact. Characteristics of persons with 
or without DNA detected in blood by PCR were compared in Chi-square or Fisher’s exact 
test. We looked for associations between DNA detected in EDTA-blood by PCR and DNA 
detected in available ticks from the participants, tick engorgement, patient-reported tick 
attachment duration, antibiotic treatment at enrolment, and patient-reported symptoms 
at enrolment and after three months. Using multivariate logistic regression, we explored 
for associations between DNA detected in blood by PCR and self-reported symptoms at 
enrolment and follow-up. All reported clinical symptoms (at enrolment and follow-up) were 
included as predictive variables in the multivariate logistic regression models, after which 
the models were optimized using backwards elimination, until all predictive variables that 
were maintained in the model were statistically significant contributors (p<0.05). Statistical 
analyses were performed with SAS 9.4 (SAS Inc.)
RESULTS
Tick-borne pathogens in ticks removed from humans
Table 1 shows the number of DNA sequences of the pathogens detected in 314 ticks 
obtained from 293 participants. Borrelia burgdorferi s. l. DNA was detected in 92 (29%) ticks, 
as published earlier [254]. The ticks contained DNA of Candidatus Neoehrlichia mikurensis 
(5.4%), A. phagocytophilum (1.0%), Rickettsia species (22%), Babesia species (3.5%). and 
B. miyamotoi (2.3%). DNA of microorganisms of two or more genera were detected in 34 
ticks (11%). Among the 92 B. burgdorferi s. l. positive ticks, 30 (33%) also carried a pathogen 
of a different genus. About half of the ticks (149/314, 47%) tested negative for all genera. 
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Table 1: Detected DNA sequences in 314 ticks obtained from 293 participants. The results on B. 
burgdorferi s. l. have been published by Hofhuis et al. 2013 [254]. 




1.1 million tick 
bites
      Borrelia burgdorferi sensu lato [254] 92/ 314 29.3% (24.5%-34.5%) 322293
      B. afzelii [254] 36/ 314 11.5% (8.3%-15.4%) 126115
      B. garinii [254] 11/ 314 3.5% (1.9%-6.0%) 38535
      B. burgdorferi senso stricto [254] 7/ 314 2.2% (1.0%-4.4%) 24522
B. valaisiana [254] 4/ 314 1.3% (0.4%-3.0%) 14013
Untypeable* Borrelia burgdorferi  [254] 36/ 314 11.5%
Borrelia miyamotoi 7/ 302 2.3% (1.0%-4.5%) 25497
Babesia spp 11/ 314 3.5% (1.8%-6.0%)
B. microti 6/ 314 1.9% (0.8%-3.9%) 21019
B. venatorum (B. EU1) 4/ 314 1.3% (0.4%-3.0%) 14013
B. divergens 1/ 314 0.3% (0.0%-1.6%) 3503
Ehrlichia spp / Anaplasma spp 8/ 314 2.5% (1.2%-4.8%)
A. phagocytophilum 3/ 314 1.0% (0.2%-2.6%) 10510
Untypeable* Ehrlichia / Anaplasma spp 5/ 314 1.6%
Candidatus Neoehrlichia mikurensis 17/ 312 5.4% (3.3%-8.4%) 59936
Spotted fever rickettsia’s 70/ 314 22.3% (18.0%-27.2%)
R. helvetica 59/ 314 18.8% (14.8%-23.4%) 206688
R. monacensis 1/ 314 0.3% (0.0%-1.6%) 3503
Untypeable* Rickettsia spp 10/ 314 3.2%
Co-infections with B. burgdorferi sensu 
lato**
30 105096
Babesia spp 3/ 314 1.0% (0.2%-2.6%)
Ehrlichia / Anaplasma spp 
Candidatus Neoehrlichia mikurensis
10/ 314 3.2% (1.6%-5.6%)
Spotted fever rickettsia’s 21/ 314 6.7% (4.3%-9.9%)
Borrelia miyamotoi 1/ 302 0.3% (0.0%-1.6%)
Using the observed prevalence of tick-borne pathogens in 314 ticks, national annual numbers of 
human exposure were estimated among 1.1 million tick bites in the Netherlands [9].
* PCR products that specifically reacted to the generic (“catch all”) probes, but that could not be 
further specified to the (geno)species level were designated as Untypeable. Within B. burgdorferi s. l., 
RLB analysis could not distinguish between B. garinii and B. bavariensis [254].
** these categories of co-infections with B. burgdorferi s. l. are not mutually exclusive.
Tick-borne pathogens in human EDTA-blood
Table 2 shows the prevalence of DNA detection of tick-borne pathogens in EDTA-blood 
samples of 335 tick bitten patients and 291 EM patients, using various (real-time) PCRs. Only 
one (0.2%) of 626 blood samples tested positive for B. burgdorferi s. l. and one (0.2%) for B. 
miyamotoi in the real-time PCRs multiplex, both with high Ct values. In another multiplex, 
five blood samples (0.8%) were positive for A. phagocytophilum and seven (1.1%) for 
Candidatus Neoehrlichia mikurensis. Three (0.5%) blood samples for Babesia genospecies 
yielded a sequence in conventional PCR, in which genetic analyses showed to be B. divergens. 
None of the samples were found positive for spotted fever Rickettsia’s or TBEV. 
All seven of the Candidatus Neoehrlichia mikurensis sequence yielded a partial groEL 
sequence and five out of seven could also be confirmed on a separate gene, namely gltA. 
The seven groEL are 100% identical to each other as were the five gltA sequences (Figure 1). 
Four out of five A. phagocytophilum positives yielded a partial groEL sequence after nested 
PCR. The four groEL are almost identical to each other, with just one or two mismatches. 
Nevertheless, all four sequences are part of zoonotic variant of the A. phagocytophilum, 
ecotype I [39]. Three of the tested blood samples for Babesia genospecies yielded a 
sequence in conventional PCR for the ribosomal 18S rRNA gene, and showed to be identical 
to B. divergens sequences. Extensive efforts to generate a B. miyamotoi sequence failed. 
Accession numbers of the obtained sequences are: LC167302, LC167303, LC167304, 
LC167305.
Table 2: Prevalence of DNA detection of tick-borne pathogens in blood of persons with tick bites or 














n % n % n % (95%CI) n
Borrelia burgdorferi s. l. 1 0.3% 0 - 1 0.2% (0.0% - 0.8%) 1757
Borrelia miyamotoi 1 0.3% 0 - 1 0.2% (0.0% - 0.8%) 1757
Anaplasma phagocytophilum 2 0.7% 3 0.9% 5 0.8% (0.3% - 1.8%) 8786
Candidatus Neoehrlichia mikurensis 4 1.4% 3 0.9% 7 1.1% (0.5% - 2.2%) 12300
Babesia divergens 1 0.3% 2 0.6% 3 0.5% (0.1% - 1.3%) 5272
Spotted fever Rickettsia species 0 - 0 - 0 0.0% (0.0% - 0.5%) -
Tick-borne encephalitis virus 0 - 0 - 0 0.0% (0.0% - 0.5%) -
Total (excluding B. burgdorferi  s. l.) 8 2.7% 8 2.4% 16 2.6% (1.5% - 4.0%) 28115
142  
CHAPTER 8  Molecular detection of tick-borne pathogens in humans with tick bites and erythema migrans
 143
8
Figure 1: Phylogenetic tree of the sequences obtained from human blood samples. 
PCR and sequencing was performed on the real-time PCR-positive blood samples. Sequences were 
clustered with (reference) sequences from Genbank. The evolutionary distance values were determined 
by Kimura method, and the tree was constructed according to the neighbor-joining method. A.) 
Anaplasma phagocytophilum: Phylogenetic tree of partial heat shock protein gene groEL of Anaplasma 
phagocytophilum of the four, one sequences is slightly different by couple of mismatches. All four are 
part of zoonotic variant of Anaplasma phagocytophilum. B.) Babesia genospecies: Three of the tested 
blood samples for Babesia genospecies yielded a sequence for the ribosomal 18S rRNA gene, and 
showed to be identical to B. divergens sequences. C.) Candidatus Neoehrlichia mikurensis: Five out 
of seven Candidatus Neoehrlichia mikurensis yielded a partial sequence of the citrate synthase gene 
gltA. D.) Candidatus Neoehrlichia mikurensis: All seven Candidatus Neoehrlichia mikurensis yielded a 
partial sequence of the heat shock protein gene groEL.
EDTA blood samples testing were tested in various (real-time) PCRs for the presence of 
tick-borne pathogens. Using the observed prevalence of infection with tick-
borne pathogens, national numbers of infections per year were estimated 
among 1.1 million tick bites in the Netherlands [9]. Note that the prevalence of 
DNA confirmed Borrelia burgdorferi s. l. detection in blood is a small fraction of 
the number of manifest borreliosis cases. For explanation, see results section. 
95%CI = 95% confidence intervals.
Characteristics of 16 participants with DNA of tick-borne pathogens detected in blood
The prevalence of DNA of a tick-borne pathogen other than B. burgdorferi s. l. detected 
in blood from persons after a tick bite was 2.4% (Table 2), this number was similar to 
EM patients (2.7%). In the blood of one person DNA of both A. phagocytophilum and B. 
divergens were detected. Altogether, DNA of tick-borne pathogens was detected in the 
blood of sixteen persons. The characteristics of these sixteen participants are summarized 
in Table 3, with regard to age, gender, self-reported clinical symptoms, antibiotic treatment 
and tick exposure at enrolment and during the three month follow-up period. Eight of the 
sixteen cases had submitted ticks at enrolment. Among these eight ticks, six ticks tested 
negative in PCR, and in two ticks DNA was detected of a different genus than the tick-borne 
pathogens that had been detected in the EDTA-blood of the corresponding participants 
(Table 3). We did not observe associations between detection of tick-borne pathogen DNA 
in EDTA-blood and; patient-reported tick attachment duration, with tick engorgement, with 
antibiotic treatment at enrolment. Seven out of sixteen cases reported clinical symptoms 
at enrolment or during the three month follow-up period, such as myalgia (3 cases), skin 
rash (2 cases), tingling sensations in limbs (2 cases), fatigue, arthralgia, headache, pain in 
limbs, and gastrointestinal symptoms/vomiting. Using multivariate logistic regression, we 
compared the prevalence of self-reported symptoms, tick attachment duration and tick 
engorgement among cases with and without DNA of tick-borne pathogens detected in 
blood. Compared to the cases that tested negative by PCR, the cases with DNA of tick-borne 
pathogens detected in their blood sample were not more likely to report any of the named 
clinical symptoms at enrolment or at follow-up.
DISCUSSION
In this study, DNA of tick-borne microorganisms was detected and identified in ticks and 
human blood samples (Table 1 and 2). The limitations of this methodology are well known; 
hence, the interpretation of these results should be done with caution [2]. In order to 
unequivocally prove the presence of the corresponding infectious agents in ticks or blood, 
their viability should be tested by in vitro culture or infection experiments of laboratory 
animals. Also, the absence of DNA of a pathogen cannot be interpreted as the absence of the 
infectious agent. Besides the technical detection limits of PCR-based methods, the timing of 
sample collection after a tick bite and start of an antibiotic treatment, as well as the tissue 
tropism of the pathogen strongly affect the ability of pathogen detection [395, 396]. The 
latter is corroborated in this study: Only in one out of the 291 patients with an erythema 
migrans (EM) -a skin infection caused by B. burgdorferi s. l. - the DNA of this pathogen was 
detected in blood (Table 2). This finding confirms that the chance of detecting B. burgdorferi 
s. l. DNA in blood samples of confirmed Lyme borreliosis patients is very low [395]. Rickettsia 
helvetica and R. monacensis were both not detected in the 626 blood samples whereas, 
recently molecular evidence for their presence in cerebrospinal fluid of neuroborreliosis 
patients and in a skin sample of an EM patient was found [117, 118]. The absence of TBEV in 
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blood samples can further be explained by its extremely low infection rates in ticks and focal 
geographic distribution in the Netherlands [388]. Candidatus Neoehrlichia mikurensis, A. 
phagocytophilum, B. miyamotoi and Babesia species are all pathogens that can be expected 
in blood because of their biology and tissue tropism [36, 58, 83, 119].
The tick samples were screened by a different method (RLB) than the blood samples (real-
time PCR). In 314 ticks removed from humans a wide variety of tick-borne pathogens 
were detected namely, Borrelia afzelii, Borrelia garinii, Borrelia burgdorferi sensu stricto, 
Borrelia valaisiana, Babesia microti, Babesia venatorum, Babesia divergens, Anaplasma 
phagocytophilum, Candidatus Neoehrlichia mikurensis, Rickettsia helvetica, Rickettsia 
monacensis and Borrelia miyamotoi. All these pathogens have been found in questing ticks 
from field studies in the Netherlands before [84, 161, 397]. The infection rate of tick-borne 
pathogens other than B. burgdorferi s. l. varied from 0.3% (B. divergens and R. monacensis) 
up to 18.8% (R. helvetica). With an estimated incidence of 1.1 million tick bites per year, 
human exposure to a tick-borne pathogen other than B. burgdorferi s. l. and TBEV varies 
from roughly 3500 for B. divergens, and 3500 for R. monacensis to 207,000 persons for R. 
helvetica. Among the 322,000 persons exposed to B. burgdorferi s. l. through a tick bite, 
roughly 105,000 are simultaneously exposed to another pathogen. In addition, exposure to 
more than one tick-borne pathogen can occur when people have more than one tick bite at 
once or several consecutive tick bites.
Clearly, not all exposure to tick-borne pathogens results in human infection. Based on the 
development of an EM or seroconversion, the risk of infection with B. burgdorferi s. l. after 
tick bites was estimated to be 5.1% [254]. In this study, evidence for infection comes from 
the detection of Candidatus Neoehrlichia mikurensis, A. phagocytophilum, B. divergens, B. 
miyamotoi and B. burgdorferi s. l. DNA in the blood of sixteen individuals after exposure to a 
tick bite. None of these cases reported to be immunocompromised, and all the EM patients 
were treated with antibiotics according to the guidelines for treatment of Lyme borreliosis 
[393]. Mild clinical symptoms were reported by seven out of sixteen PCR-positive cases. 
However, using multivariate logistic regression, we did not detect associations between DNA 
detected in blood and self-reported symptoms at enrolment and follow-up. Furthermore, 
we did not find associations between detection of DNA of tick-borne pathogens in blood 
and; PCR positive ticks, patient-reported tick attachment duration, tick engorgement, and 
antibiotic treatment at enrolment. The lack of statistically significant associations may be due 
to the mildness of symptoms amongst immune-competent patients, and to a lesser degree 
due to insufficient numbers of PCR-positive cases per pathogen genus in our analyses. 
In this study, Candidatus Neoehrlichia mikurensis infection was observed in 1.1% (95%CI 
0.5% - 2.2%). Candidatus Neoehrlichia mikurensis infections have been described in 
immunocompromised patients [398], and more recently in immune-competent patients 
with relatively mild symptoms in China, Poland, and Sweden [74, 76, 77, 399]. Anaplasma 
phagocytophilum infection was found in 0.9% (95%CI 0.3% - 2.0%) of the persons exposed 
to tick bites in the Netherlands (Table 2). Genetic analyses of the DNA sequences showed 
the highest similarity to the zoonotic A. phagocytophilum ecotype I [39]. Evidence for A. 
phagocytophilum infection is primarily based on its molecular, microscopic or serological 
detection most disease cases [1, 36]. There is serological evidence that A. phagocytophilum 
infection occurs in the absence of disease symptoms [400]. Babesia divergens infection was 
observed in 0.5% (95%CI 0.1% - 1.3%) of the persons exposed to tick bites. In Europe, only 
two cases of human babesiosis have been reported in immune-competent patients, one due 
to B. divergens [126]. Only one patient with EM was possibly infected with B. miyamotoi 
0.2% (95%CI 0.0% - 0.8%). The presence of B. miyamotoi DNA could only be determined 
by real-time PCR, and several attempts to confirm this finding by conventional PCR was 
unsuccessful. This patient had received antibiotic treatment at enrolment for his EM, so a low 
bacterial load in blood due to the treatment could be an explanation for the high Ct value. 
Evidence for infection with B. miyamotoi in Europe comes from one immunocompromised 
case [95], and a seroprevalence study in people exposed to tick bites [401]. 
Altogether, the probability of infection with a tick-borne pathogen other than Lyme 
spirochetes after tick bites in the Netherlands is roughly 2.4% (95%CI 1.1% – 4.5%). This 
number is similar to the probability of a co-infection with another tick-borne pathogen in 
patients with EM (2.7%, 95%CI 1.3% – 5.2%). Interestingly, one patient in this study had 
a co-infection with A. phagocytophilum and B. divergens. The severity of self-reported 
symptoms of the seven EM patients with a co-infection was indistinguishable from patients 
only having EM. No indications were found that infection with a tick-borne pathogen other 
than B. burgdorferi s. l. caused overt symptoms that would indicate a corresponding illness. 
The low number of persons with a tick bite or EM that were identified with an tick-borne 
pathogen infection other than B. burgdorferi s. l., in combination with the limited medical 
assessments, and the used method of pathogen detection are not sufficient to infer how 
often tick-borne pathogens other than B. burgdorferi s. l. (and TBEV) cause disease. Also, to 
what extend they affect the diagnoses and the etiology of Lyme borreliosis. Furthermore, 
the ability for a pathogen to cause disease depends also on extrinsic factors for example the 
immune status of its host. 
The high exposure to tick-borne pathogens other than B. burgdorferi s. l. and TBEV, and 
their ability to cause infection in the general population, warrants increased awareness, 
knowledge, improvement of diagnostic tests and a clear-cut clinical case definitions in 
an European setting. Only when better laboratory tests are available for these tick-borne 
diseases, their impact as a co-infection with Lyme borreliosis can be assessed.
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Supplementary Table 1. 
Microorganism Target 
gene












groEL GroEL-F2a 5’-CCTTGAAAATATAGCAAGATCAGGTAG-3’  [60] 
GroEL-R2a 5’-CCACCACGTAACTTATTTAGCACTAAAG-3’
GroEL-P2a 5’-X-CCTCTACTAATTATTGCtGAAGAT














TGCTGAI CA-Pho-3’       X = BHQ-1-dT
Legend for Table 3
EM: erythema migrans.
t=0: time of enrolment, at the time of blood sample collection for PCR-testing.
t=12: twelve weeks after enrolment. 
b.i.d.: bis in die.
q.i.d.: quarter in die.
* PCR products from tick analyses that specifically reacted to the generic (“catch all”) probes, but 
that could not be further specified to the (geno)species level were designated as ‘Untypeable’.
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Babesia species 18S rRNA Bath-F 5’-TAAGAATTTCACCTCTGACAGTTA-3’
Bath-R 5’-ACACAGGGAGGTAGTGACAAG-3’
CHAPTER 9
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Ixodes ticks transmit Borrelia burgdorferi sensu lato (s. l.), the causative agent of Lyme 
borreliosis (LB). These tick species also transmit Borrelia miyamotoi, which was recently 
found to cause infections in humans. We were interested in the prevalence of B. miyamotoi 
infection in ticks and natural hosts in the Netherlands, and to what extent ticks are co-
infected with B. burgdorferi. In addition, erythema migrans has been sporadically described 
in Borrelia miyamotoi infected patients, but these skin lesions might as well represent co-
infections with B. burgdorferi s.l. We therefore investigated whether B. miyamotoi was 
present in LB-suspected skin lesions of patients referred to our tertiary Lyme disease clinic.
 
Methods 
3360 questing Ixodes ricinus nymphs as well as spleen tissue of 74 rodents, 26 birds and 
10 deer were tested by PCR for the presence of B. miyamotoi. Tick lysates were also tested 
for the presence of B. burgdorferi s. l.. Next, we performed a PCR for B. miyamotoi in 31 
biopsies from LB-suspected skin lesions in patients visiting our tertiary Lyme center. These 
biopsies had been initially tested for B. burgdorferi s. l. by PCR, and the skin lesions had been 
investigated by specialized dermatologists.
Results 
Out of 3360 unfed (or questing) nymphs, 313 (9.3%) were infected with B. burgdorferi s. l., 70 
(2.1%) were infected with B. miyamotoi, and 14 (0.4%) were co-infected with B. burgdorferi 
s. l. and B. miyamotoi. Co-infection of B. burgdorferi s. l. with B. miyamotoi occurred more 
often than expected from single infection prevalences (p=0.03). Both rodents (9%) and birds 
(8%) were found positive for B. miyamotoi by PCR, whereas the roe deer samples were 
negative. Out of 31 LB-suspected skin biopsies, 10 (32%) were positive for B. burgdorferi s. 
l. while none were positive for B. miyamotoi. 
Conclusion
The significant association of B. burgdorferi s. l. with B. miyamotoi in nymphs implies the 
existence of mutual reservoir hosts. Indeed, the presence of B. miyamotoi DNA indicates 
systemic infections in birds as well as rodents. However, their relative contributions to the 
enzootic cycle of B. miyamotoi requires further investigation. We could not retrospectively 
diagnose Borrelia miyamotoi infection using biopsies of LB-suspected skin lesions, supporting 
the hypothesis that B. miyamotoi is not associated with LB-associated skin manifestations. 
However, this warrants further studies in larger sets of skin biopsies. A prospective study 
focused on acute febrile illness after a tick bite could provide insight into the incidence and 
clinical manifestations of Borrelia miyamotoi infection in the Netherlands. 
INTRODUCTION
Borrelia miyamotoi is a tick-borne relapsing fever (TBRF) spirochete in Ixodes ticks, the same 
vector that transmits Borrelia burgdorferi s. l. and a range of other tick-borne pathogens. The 
prevalence of B. miyamotoi in reservoir hosts, as well as the reservoir host range in nature, 
is yet scarcely described, but points towards small rodents and certain bird species being 
infected [406-411]. Interestingly, B. miyamotoi can cause short-term systemic infection in 
rodents, and it is experimentally shown that ticks can acquire this pathogen from rodents 
[61].  While B. burgdorferi s. l. causes Lyme borreliosis (LB), B. miyamotoi was recently found 
to cause infections in humans [412]. The incidence of Borrelia miyamotoi infection in humans 
is yet unknown. Two studies have described the prevalence of Borrelia miyamotoi in febrile 
patients suspected of a tick-borne infection, which found 97/11,515 (0.84%) of patients in 
north-eastern United States and 51/302 (16.9%) of hospital-admitted Russian patients to be 
PCR positive for B. miyamotoi on blood [412, 413]. Borrelia miyamotoi infection presents 
around two weeks after a tick bite with a high fever and viral-like symptoms such as headache, 
myalgia, arthralgia and malaise [412-414]. In two patients with severe immunodeficiency, 
including one case in our tertiary Lyme clinic (AMLC, Amsterdam, The Netherlands), B. 
miyamotoi infection was found to cause a chronic meningoencephalitis [415, 416]. Several 
studies have described Borrelia miyamotoi infected patients presenting with erythema 
migrans (EM), a classical symptom of early LB. In one study, 9% of Russian patients with 
Borrelia miyamotoi infection presented with EM, and it was hypothesized that EM was 
a sign of co-infection with B. burgdorferi s. l. rather than a true manifestation of Borrelia 
miyamotoi infection [412]. A study in North America revealed several Borrelia miyamotoi 
infected patients to be co-infected with B. burgdorferi s. l., one of which presenting with an 
EM [413]. Furthermore, a study in Japan described two febrile Borrelia miyamotoi infected 
patients that presented with EM and were shown to have antibodies against B. burgdorferi 
s. l. antigens, suggesting co-infections with both B. burgdorferi s. l. and B. miyamotoi [417]. 
In the Netherlands, exposure levels to B. miyamotoi as measured by serology showed that 
risk groups such as forestry workers (10%) had higher seroprevalence levels than the control 
group. In the same study, B. miyamotoi antibodies were also found in patients suspected of 
human granulocytic anaplasmosis (HGA) (14.6%), suggesting that B. miyamotoi infections 
occur in Dutch high-risk populations and that they could be misdiagnosed [418]. However, 
thus far only one PCR-confirmed patient has been described in the Netherlands, suggesting 
under-diagnosis due to a lack of awareness, lack of severe symptoms, lack of widely 
available diagnostic tools and/or misdiagnosis. A Russian study recently revealed a relatively 
high transmission efficiency of B. miyamotoi by adult I. persulcatus ticks to humans (~8%), 
and B. miyamotoi was recently demonstrated to be transmitted by I. ricinus larvae, bites of 
which would likely go unnoticed in humans [419, 420]. Indeed, a Russian study described 
B. miyamotoi to be under-diagnosed, leading to relapses in the absence of adequate 
antibiotic treatment [421].  Because no routine diagnostics are currently performed for B. 
miyamotoi in our (tertiary) multidisciplinary Lyme disease center, we aimed to investigate 
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if (co-) infections with B. miyamotoi were missed over the past years. Thus, in the current 
study, we performed B. miyamotoi-specific real-time PCR on ticks and in spleen samples 
from potential reservoir hosts in nature and in LB-suspected human skin biopsies, which 
were previously tested for B. burgdorferi s. l. by PCR.  
METHODS
Collection of ticks and vertebrate hosts
Questing ticks were collected by blanket dragging at 11 different forested areas throughout 
the Netherlands in 2014-2015. Spleen tissues were collected from different species of 
rodents, roe deer and birds (table 2) at several sites in the Netherlands. The obtained spleen 
samples of roe deer, birds as well as the capturing of wild rodents have been described 
elsewhere [422, 423]. Spleen samples were kept frozen (-80 °C) until testing. DNA from 
tissue samples was extracted using the Qiagen DNeasy Blood & Tissue Kit according to 
manufacturer’s protocol. Based on morphological criteria, tick species and stages were 
identified, and DNA from I. ricinus nymphs was extracted by alkaline lysis [162].
Polymerase chain reactions and sequencing of DNA from ticks and vertebrate hosts
At the beginning of the extraction process, an internal amplification and extraction control 
(IAC) consisting of a random DNA sequence in the Invitrogen pCR(tm)2.1-TOPO® vector was 
added to the samples. All samples were screened for the presence of B. miyamotoi DNA with 
a real-time polymerase chain reaction (RT-PCR) targeting portion of the flagellin gene. We 
used 200 nM forward primer (5’-AGA AGG TGC TCA AGC AG-3’) and 200 nM reverse (5’-TCG 
ATC TTT GAA AGT GAC ATA T-3’) primer, 200 nM probe (5’-Atto647N-AGC ACA ACA GGA GGG 
AGT TCA AGC-BHQ2-3’), and 3 to 8 µl of template DNA [95]. Samples with doubtful qPCR-
results were re-tested with 3 µl sample volume, to reduce the contribution of inhibitory 
factors, and with 8 µl sample volume, to (slightly) increase the detection limit of the test.
RT-PCR -positive samples were analyzed further with primers targeting a fragment of a 
700bp fragment of the glycerophosphodiester phosphodiesterase (glpQ) gene. The PCR was 
performed with the HotStarTaq master mix (Qiagen, Venlo, the Netherlands) using forward 
5’-ATG GGT TCA AAC AAA AAG TCA CC-3’ and reverse primers 5’-CCA GGG TCC AAT TCC ATC 
AGA ATA TTG TGC AAC-3’ under the following conditions: 15 min 94°C, then 40 cycles of 30 s 
94°C, 30 s 53°C, 90 s 72°C and finishing with 10 minutes at 72°C.The sequences were stored 
and analyzed in Bionumerics (Version 7.1, Applied Math, Belgium), after subtraction of the 
primer sequences. Of all the B. miyamotoi positive tick samples (n=70), 30 were sequenced 
for the glpQ and/or p66 gene. A total of 22 yielded a sequence 100% identical to Genbank 
accession numbers: AB824730.1, AB824731.1, AB824855.1, AB824856.1, confirming 
amplification of the gene of interest. 
LB-suspected skin lesions 
In our tertiary Lyme center, we offer more extensive diagnostic service than primary care 
centers will perform based on the current Dutch national guideline for LB (CBO richtlijn 
Lyme,www.nvvg.nl/images/stories/Richtlijn_lymeziekte_definitief_18_juli_2013.pdf). 
Occasionally, biopsies of skin lesions are taken to confirm or rule out LB, which enabled us 
to retrospectively investigate the presence of B. miyamotoi in these lesions. Biopsies from 
skin lesions in patients suspected to have LB were in retrospect analyzed for the presence 
of B. miyamotoi. Our dermatology department gathered 4 mm skin biopsies under local 
lidocaine anesthesia from 34 patients between 2009 and 2013, which were taken from the 
edge of suspected (atypical) EM lesions or central in suspected acrodermatitis chronica 
atrophicans (ACA) lesions. Biopsies were used for PCR and sent for pathologic examination 
when clinically indicated according to the treating dermatologist. A B. burgdorferi s. l.-
specific PCR was initially performed, and 31/34 extracted DNA samples were included, while 
three DNA samples and corresponding patient cases were excluded from analysis due to 
RT-PCR inhibition. Patient records and PCR results were retrospectively reviewed to obtain 
a final diagnosis and to categorize the skin lesions into: 1. EM; 2. Multiple EM; 3. ACA; 4. LB-
suspected skin lesion after previous treatment for LB, but active LB excluded 5. LB-suspected 
skin lesion without previous treatment for LB, but active LB excluded. C6 enzyme-linked 
immunofluorescence assays and RT-PCR for B. burgdorferi s. l. and B. miyamotoi were 
performed as previously described [416, 424].  
Statistical analysis
Confidence intervals (95%) were calculated using a Fisher’s exact test. The Chi-square test 
was used to assess the correlation between B. miyamotoi infections and B. burgdorferi s. 
l. infection in ticks based on a 2x2 contingency table with B. miyamotoi infection and B. 
burgdorferi s. l. infection as determining binary conditions.   
RESULTS
Ticks
Questing I. ricinus nymphs (n=3360) were collected from 11 different areas in the 
Netherlands between 2014 and 2015. Of these nymphs 313 (9.3%) were positive for B. 
burgdorferi s. l. only and 70 (2.1%) were positive for B. miyamotoi only, while 14 nymphs 
(0.4%) were co-infected with both pathogens (Table 1). Thus, 14/327 (4.3%) B. burgdorferi 
s. l. positive nymphs were also positive for B. miyamotoi, and co-infection of B. burgdorferi 
s. l. with B. miyamotoi occurred significantly (p=0.03) more often than expected, suggesting 
the existence of mutual reservoir hosts. 
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Seven out of 74 (9%) examined rodent spleens were RT-PCR positive for B. miyamotoi. 
Three out of 21 (14%) wood mice (Apodemus sylvaticus), one out of 8 (13%) common voles 
(Myodes arvalis) and 3 out of 34 (9%) bank voles (M. glareolus) (Table 2) were found to be 
infected with B. miyamotoi. All 10 roe deer spleen samples were negative for B. miyamotoi 
DNA (Table 2). Two out of 26 studied birds (8%) were found RT-PCR positive for B. miyamotoi, 
namely a great tit (Parus major) and a European greenfinch (Carduelis chloris) (Table 2). 
LB-suspected skin biopsies
Nine out of 31 (29%) patients with LB-suspected skin lesions who were referred to our 
tertiary LB center were PCR positive for B. burgdorferi s. l. in a skin biopsy: 3 patients were 
diagnosed as having ACA, 1 as multiple EM and 5 were diagnosed with definite EM (table 
3). One patient was PCR-negative (possibly because the biopsy was taken after initiation 
of doxycycline treatment), but clinically diagnosed with EM by the dermatologist. None of 
these biopsies were taken from febrile patients, and none were concurrently positive for B. 
miyamotoi. In seven patients that had previously been diagnosed with LB, who were now 
presenting with persisting skin conditions, active LB was excluded by PCR and pathology. 
In three of these patients, another dermatological diagnosis could be made (progressive 
purpura pigmentosa, nummular eczema and morphea cutis). In none of these patients, 
B. miyamotoi could be identified as the cause of the symptoms. Finally, the remaining 14 
patients with LB-suspected skin lesions tested negative for B. burgdorferi s. l., but combined 
with pathology results, other dermatological diagnoses were made in 11 patients (angioma 
serpiginosum, contact dermatitis, toxicodermia, granuloma annulare, pityriasis lichenoides 
chronica, dermatomycosis corporis, eczematous dermatitis, chilblain lupus, erythema 
annulare centrifugum, and hypersensitivity to a tick bite and a spider bite). These, including, 
the five patients without a definite diagnosis all retrospectively tested negative for B. 
miyamotoi (Table 3). 
Table 1: Borrelia burgdorferi s. l. and B. miyamotoi infection in questing Ixodes ricinus nymphs 
Ixodes ricinus (n=3360) Positive (n) Percentage (CI)
B. burgdorferi s. l. 327 10% (9-11% CI*)
B. miyamotoi 84 2.5% (2-3% CI*)
B. burgdorferi s. l. and B. miyamotoi co-infection 14 0.4% (0.2-0.7% CI*)
*CI: 95% confidence interval
Table 2: Borrelia miyamotoi in spleen tissue from different rodents, roe deer and bird species
Species Total (n) Positive (n) Positive (%)
Apodemus flavicollis 2 0 0
Apodemus sylvaticus 21 3 14
Cocidura russula 4 0 0
Myodes arvalis 8 1
Myodes glareolus 34 3
Sorex araneus 5 0 0
Capreolus capreolus 10 0 0
Carduelis chloris 4 1 25
Coccothraustes coccothraustes 2 0 0
Fringilla coelebs 3 0 0
Parus major 2 1 50
Phylloscopus trochilus 1 0 0
Pyrrhula pyrrhula 1 0 0
Turdus iliacus 5 0 0
Turdus merula 2 0 0
Turdus philomelos 6 0 0
Table 3: Borrelia miyamotoi detected retrospectically in skin lesion biopsies from suspected Lyme 
borreliosis patients 

















EM 6 5 0 5 0 0/5**
Multiple EM 1 0 0 1 0 1/1
ACA 3 2 0 3 0 3/3
LB- suspected skin lesion after 
previous treatment for LB; Ac-
tive LB excluded 
7 1 0 0 0 4/7
LB- suspected skin lesion with-
out previous treatment for LB; 
Active LB excluded 
14 8 1 0 0 1/12
Total 31 16 1 9 0 9/28
* n/N: positive/total tested. Not all samples were analyzed with ELISA 
** 1/5 dubious. 2/5 were re-tested at a later stage, both of which seroconverted
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In this study we have evaluated the prevalence of B. miyamotoi in I. ricinus ticks, wild animals 
and LB-suspected skin lesions in the Netherlands. Previous studies in the Netherlands 
revealed that 2-4%    [84, 95] of questing I. ricinus ticks were infected with B. miyamotoi, and 
around 4% [85] of ticks that were collected from humans, which corresponds well with the 
incidence in other endemic areas [406]. We found that B. miyamotoi infection in I. ricinus 
nymphs was present more often when ticks were infected with B. burgdorferi s. l. than in 
B. burgdorferi s. l. uninfected ticks (4.3% versus 2.3%, p=0.03), suggesting similar reservoir 
hosts. Indeed, we identified B. miyamotoi in rodents (9%) and birds (8%). The role of these 
animals in the transmission cycle is not clear; they could be amplifying hosts, a transitory or 
dead-end host for this spirochete, warranting further investigation. 
Previously, several studies have shown wild rodents and small mammals to be infected with 
B. miyamotoi in up to 3.7% of animals [409-411]. Because of vertical transmission, larvae 
can be infected with B. miyamotoi and are thought to play an important role in transmission 
[407, 425]. Indeed, we have recently described field-collected I. ricinus larvae to be able 
to transmit B. miyamotoi to laboratory-bred Naval Medical Research Institute (NMRI) mice 
[420]. In addition to vertical transmission, the relative contribution of mammalian reservoir 
hosts to the transmission cycle is not fully understood. Mice seem to clear B. miyamotoi from 
their blood by VMP-specific antibodies, and only SCID mice have so far been demonstrated 
to experience persistent spirochetemia [426, 427]. 
Interestingly, we identified two B. miyamotoi infected birds, namely a great tit and a 
European greenfinch. Previous studies revealed a high prevalence (58%) of B. miyamotoi 
in wild Tennessee turkeys (Meleagris gallopavo), while experimental infection with field-
collected I. ricinus nymphs did not succeed in common European songbirds (Parus major) 
[408, 428]. Further studies should reveal which bird species are susceptible to B. miyamotoi 
infection, the relationship between species-specific complement sensitivity and the 
ecological implications of bird infections.  
After establishing the presence of B. miyamotoi in ticks and wild animals from the 
Netherlands, we investigated if B. miyamotoi infections were missed in patients previously 
examined in our tertiary LB clinic. Borrelia miyamotoi was not found as a co-infection or 
primary explanation for 31 LB-suspected skin lesions examined in our clinic. These patients 
were mostly afebrile, while Borrelia miyamotoi infection is currently characterized by fever 
and generalized symptoms several weeks after a tick bite [412, 413, 417, 429, 430] or by 
chronic meningoencephalitis in immunocompromised patients [415, 416]. Unfortunately, 
due to the retrospective nature of our study, no blood samples were available to establish 
serologic evidence or absence of infection with B. miyamotoi, and Borrelia miyamotoi 
infection in these patients can therefore not be definitely excluded. Nonetheless, this is the 
first study investigating the presence of B. miyamotoi DNA in LB- suspected skin biopsies, 
and our findings support the hypothesis that B. miyamotoi is not associated with LB-related 
skin manifestations. However, more studies, with larger patient populations and with 
multiple body fluids and tissues, should be performed to corroborate our findings. 
Considering the 2.5% B. miyamotoi prevalence in ticks in the present study, combined with 
over a million tick bites per year in the Netherlands [431], an estimated 8% transmission 
efficiency to humans, elevated seroprevalences in Dutch high-risk populations and the 
incidence of  Borrelia miyamotoi infection described in prospective studies in Russia and 
the U.S.A., we postulate that the diagnosis Borrelia miyamotoi infection is currently being 
missed in Dutch patients [412, 413, 418, 419]. Therefore, we suggest that a prospective 
clinical study in Dutch patients presenting with fever after a tick bite is needed in order to 
assess the incidence of Borrelia miyamotoi infection and the occurrence of B. miyamotoi in 
blood and other tissues or body fluids of these patients. 
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Substantial exposure to Borrelia miyamotoi occurs through bites from Ixodes ricinus ticks 
in the Netherlands, which also transmit Borrelia burgdorferi sensu lato and Anaplasma 
phagocytophilum. Direct evidence for Borrelia miyamotoi infection in European populations 
is scarce. A flu-like illness with high fever, resembling Human Granulocytic Anaplasmosis, 
has been attributed to Borrelia miyamotoi-infections in relatively small groups. Borrelia 
miyamotoi-infections associated with chronic meningoencephalitis have also been described 
in case reports. Assuming that an IgG antibody response against Borrelia miyamotoi antigens 
reflects (endured) infection, the seroprevalence in different risk groups was examined. 
Sera from nine out of ten confirmed Borrelia miyamotoi infections from Russia were found 
positive with the recombinant antigen used, and no significant cross-reactivity was observed 
in secondary syphilis patients. The seroprevalence in blood donors was set at 2.0% (95% CI 
0.4–5.7%). Elevated seroprevalences in erythema migrans patients 5.6% (3.0-9.2%) and in 
individuals with serologically confirmed 7.4% (2.0-17.9%) or unconfirmed 8.6% (1.8-23%) 
Lyme neuroborreliosis were not significantly different from blood donors. The prevalence of 
anti-Borrelia miyamotoi antibodies among forestry workers 10% (5.3-16.8%) and in patients 
with serologically unconfirmed but suspected Human Granulocytic Anaplasmosis 14.6% 
(9.0-21.8%) were significantly higher compared the seroprevalence in blood donors. Our 
findings indicate that infections with Borrelia miyamotoi occur in tick-exposed individuals in 
the Netherlands. In addition, Borrelia miyamotoi infections should be considered in patients 
reporting tick bites and febrile illness with unresolved etiology in the Netherlands, and other 
countries where Ixodes ricinus ticks are endemic.
INTRODUCTION
Borrelia miyamotoi belongs to the relapsing fever group of the Borrelia genus [432]. 
Agents of relapsing fever spirochetes are transmitted between vertebrates by different 
vectors for instance; Borrelia duttonii and Borrelia hermsii are transmitted by soft ticks and 
Borrelia recurrentis is transmitted by the human body louse [407, 433, 434]. Interestingly, 
B. miyamotoi is transmitted by the same vectors as Borrelia burgdorferi senso lato. and 
Anaplasma phagocytophilum, the causative agents of Lyme borreliosis (LB) and Human 
Granulocytic Anaplasmosis (HGA), respectively [407, 425]. In Europe, Asia and North America, 
B. miyamotoi infection rates in Ixodes persulcatus, I. scapularis, I. pacificus and I. ricinus 
range between 0.5% and 5% [425, 432, 435-439]. In the Netherlands, the infection rate of I. 
ricinus is 2.4-4.7% in all three life-stages [440]. The presence of B. miyamotoi in wild rodents 
indicates enzootic circulation in the Netherlands (unpublished observations). Furthermore, 
a recent study estimated that in the Netherlands annually, approximately 200.000 people 
are bitten by ticks infected with B. burgdorferi s. l. and 36.000 by B. miyamotoi infected ticks 
[440]. Additionally, exposure to both Lyme and relapsing fever Borrelia by co-infected ticks 
occurs in at least 9,000 people annually. This substantial exposure raises the question to 
what extent B. miyamotoi leads to human disease in the general population.
Currently, the clinical symptoms of B. miyamotoi-infections are not well-known, and well-
defined and validated supportive laboratory diagnostic tests are lacking. Infections with 
other members of the relapsing fever Borreliae are characterized by influenza-like illness 
and one or more relapse episode(s) of bacteraemia and fever. Borrelia miyamotoi infections 
in humans were first reported in Russian patients suspected of LB (Table 1). Fifty-one LB-
suspects had amplifiable B. miyamotoi DNA in venous blood samples, and most tested 
positive by commercial IgM and IgG serology assays used for LB diagnosis. This test consisted 
of a mixture of whole cell antigens from B. afzelii, B. burgdorferi, and B. garinii [412]. A 
potentially severe complication of B. miyamotoi infection is meningoencephalitis. The first 
American and European meningoencephalitis case reports of well-documented B. miyamotoi 
infection were described in severely immune-compromised patients [415, 416] and B. 
miyamotoi was detected in cerebrospinal fluid with the use of microscopy and polymerase-
chain-reaction (PCR) assays. In another study, two cases of B. miyamotoi infection were 
initially mistaken for HGA [430] on the basis on their clinical manifestations after a tick-bite 
(Table 1). Taken together, disease caused by an infection with B. miyamotoi may be confused 
with other tick-borne pathogens, either because of its comparable symptoms or because of 
misinterpretation of a serological reaction against a (endured) co-infection. 
Patient categories that have an (endured) infection with this relapsing fever spirochete will 
have a higher seroprevalence than the general population. For other relapsing fever Borreliae 
the majority of antibodies are directed towards the Variable Major Proteins (VMP) [441]. 
However, antibodies to VMP have been described to be cross-reactive to B. burgdorferi s. l. 
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antigens. Furthermore, VMP is a highly variable protein that could give false-negative results 
in serological tests [441]. On the other hand, Glycerophosphodiester phosphodiesterase 
(GlpQ) appears to be highly conserved among all members of the relapsing fever Borreliae, 
including B. miyamotoi, but distinct for the spirochetes causing LB and their near relatives. 
In addition, GlpQ is immunogenic in humans and shows negative results when testing sera 
from LB and syphilis patients [441-445]. More recently, an American study showed that 
serum samples from 1 to 3% of residents of New England were reactive in an experimental 
serologic assay targeting the B. miyamotoi GlpQ antigen [414]. 
The long-term objective of our studies is to gain more insight in the public health risk of B. 
miyamotoi. As a first attempt to describe the exposure of B. miyamotoi in the Netherlands, 
using a newly developed serological assay based on the GlpQ antigen, we determined 
here the seroprevalence of anti-B. miyamotoi antibodies in different risk groups within the 
general population. Apart from important epidemiologic insights, our findings will facilitate 
the future identification of the clinical symptoms of B. miyamotoi infections and might serve 
as a starting point for further development of serological assays.
MATERIAL AND METHODS
Antigen preparations and biochemicals 
A DNA sequence encoding for the Borrelia miyamotoi GlpQ protein was amplified from 
an Ixodes ricinus lysate, cloned, sequence-verified, expressed and purified from an E. coli 
construct (Scottish Biomedical, Glasgow, United Kingdom). Purified GlpQ was coupled to 
activated carboxylated microspheres by using a two-step carbodiimid reaction with an 
antigen to bead ratio of 50 μg/6.25×106 [446]. The beads were incubated in the dark under 
constant rotation at 25 rpm for 2h at room temperature. The beads were washed three 
times with PBS and stored in 500 μl PBS containing 0.05% (w/v) sodium azide and 1% (w/ 
v) BSA at 4 °C in the dark until used [447-449]. Biochemicals and reagents used were from 
Sigma (St. Louis, MO), Pierce (Rockford, IL), Bio-Rad Laboratories (Hercules, CA) and Merck 
(Darmstadt, Germany) and were used in the highest purity available.
Serum samples
Sera from 150 blood donors were used as negative controls to determine the background 
in the general Dutch population. Ten sera of PCR-confirmed B. miyamotoi patients were 
used as positive controls and were described previously [412]. These sera were also 
positive in a anti-glpQ serologic assay developed and performed in Russia (not shown). Sera 
from patients infected with Treponema pallidum were included to test for possible cross-
reactivity [450]. In total 120 serum samples from forestry workers were used as a group with 
high exposure to tick bites [451, 452]. Other serum specimens from patients were obtained 
from the residuals of sera submitted to the RIVM for routine microbiological investigations, 
Table 1: Case reports of Borrelia miyamotoi infections associated with disease.
Reference Methods Patient description Erythema 
migrans
Clinical manifestations
Russia [412] PCR, 
IgM-positive
(n=51) 4/51 Fever, headache, chills, 
fatigue, vomiting and 
myalgia.
USA [414]  Seroconversion Previously healthy 
individuals (n=3)




abdominal pain, a 
cough, a sore throat, 
and right inguinal 
lymphadenopathy
USA [415] PCR, microscopy 80-yr women, (treated) 
non-Hodgkin’s lymphoma 
0/1 Meningoencephalitis, 
progressive decline in 
mental status, wobbling 
gait, and difficulty 
hearing, weight loss.





and arthralgia, pain 
across the chest, 
muscles were 
tightening, sweats and 
episodes of fever with 
shaking chills
USA [430] PCR 87-yr male, previously 
healthy
0/1 Severe fatigue, malaise, 
short of breath with 
activities, chills, fever 
and loss of appetite.
Netherlands 
[416]
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provided patients did not object to this use by indicating this on the diagnostic request form. 
Sera with no or doubtful epidemiological data and repetitive sera were excluded. Selected 
sera were divided in different patient groups: 251 individuals with erythema migrans 
(EM), 54 individuals with serologically confirmed Lyme neuroborreliosis (LNB) based on 
the detection of local antibody production in the paired liquor sample and 35 individuals 
with serologically unconfirmed LNB. In addition, 130 samples from patients sent in to our 
laboratory for HGA serology, but who tested negative for IgG and IgM-specific HGA, were also 
examined. Serological confirmation for Lyme borreliosis was based on positive test results 
of Borrelia burgdorferi s. l. Immunoblot (in house), and C6-ELISA (Immunetics, Boston, MA). 
Immunofluorescence assays against Anaplasma phagocytophylum and Ehrlichia chaffeensis 
(Focus Technologies, Cypress, CA) were used. Serological unconfirmed was defined as 
negative test results in these serological assays.
Serological analysis
Antibodies to the GlpQ protein of B. miyamotoi were determined by an in house Luminex-
assay. Serum-dilutions and conjugate concentrations in the Luminex-assay were optimized 
using checkerboard titrations. Sera, positive and negative control samples were tested in 
duplicate or triplicate and were diluted 1:200 in 25ul PBS containing 0.1% (v/v) Tween-20 
and 3% (w/v) BSA. Serum samples were mixed with an equal volume of GlpQ-conjugated 
microspheres (4000 beads/region/well) in a 96-well Multiscreen HTS filter plate (Millipore 
Corporation, Billerica, MA) and incubated on a plate shaker at 600 rpm in the dark for 45 min 
at room temperature. Blank and control sera were included on every plate. The beads were 
collected by filtration using a vacuum manifold and washed three times with 100 μl PBS. 
To each well 50 μl of a 1:200 dilution of R- phycoerthyryn-conjugated goat anti-human IgG 
(Jackson ImmunoResearch Laboratories, Westgrove, PA) in PBS was added and the plate was 
incubated for 30 min with continued shaking. After a second wash, the beads were mixed 
in 100 μl PBS and shaken before analysis with a Bio-Plex 200 in combination with Bio-Plex 
Manager software version 4.1.1 (Bio-Rad Laboratories). 
Statistical analysis
The Kolmogorov-Smirnov test was used to test null hypotheses that the LogOD values of 
different groups were normally distributed. Fisher’s exact test was used to calculate the 
95% confidence intervals. A one-tailed Fisher’s exact test was used to compare pairwise the 
frequency of B. miyamotoi seropositive and seronegative subjects in different groups. The 
level of significance was set at p < 0.05. Moreover, Taylor series was used to calculate Odds 
Ratio with a 95% confidence limits testing.
RESULTS
All serum samples (n=764) were tested for their reactivity against the GlpQ protein of the 
European B. miyamotoi. The LogOD values of the samples from 150 blood donors were 
normally distributed (p=0.56), whereas the LogOD values of 590 samples from the risk 
groups were not (p<0.004), indicating that the latter distribution is the mixture of two 
distributions (Figure 1). In order to strive for a relatively high specificity, a cut-off value of 
two standard deviations above the average of the blood donor group (n=150) was chosen. 
This is in line with recommendations by the Centres for Disease Control (CDC) to confirm 
the diagnosis of Tick Borne Relapsing Fever (TBRF) in the USA. With this chosen cut-off 
(LogOD 3.50), the seroprevalence of B. miyamotoi IgG antibodies in blood donors was 2.0% 
(Table 2) and nine out of the ten sera from confirmed B. miyamotoi-infected patients from 
Russia were also serologically positive. Only one out of 24 serum samples from patients 
infected with an unrelated spirochete, Treponema pallidum, showed reactivity against the 
GlpQ-antigen, and the seroprevalence in this category was comparable to that of the blood 
donors. Although an increase in seroprevalence was observed comparing blood donors to 
EM patients, confirmed and unconfirmed LNB patients, these seroprevalences did not differ 
significantly from the blood donors (Table 2). In the serologically unconfirmed but suspected 
HGA group a significantly higher seroprevalence was observed compared to that in the 
blood donor panel. In addition, the seroprevalence in forestry workers was significantly 
higher than the seroprevalence in blood donors (Table 2).
Table 2: Seroprevalences against Borrelia miyamotoi GlpQ.



































EM patients 251 14 5,6% 3,0% 9,2% 0.067 2.90 0.82 10.24
LNB; serologically 
confirmed
















24 1 4.2% 0.2% 18.9% 0.45
Significant p-values (Fisher’s exact test, level of significance was set at p < 0.05 ) and Odds Ratio’s 
(Taylor series, with 95% confidence limit)  in bold. NA; not applicable. 
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This study provides serological evidence of B. miyamotoi exposure in humans in the 
Netherlands using the GlpQ antigen of the B. miyamotoi in a newly developed Luminex-
assay. Based on the significantly higher anti-B. miyamotoi antibodies in forestry workers and 
the serologically unconfirmed but suspected HGA group, B. miyamotoi infection appears 
not only to occur in immunocompromised patients - as has recently been described in the 
Netherlands [416]- but also seems to affect populations without underlying or chronic 
disease, which is in line with recent studies [412, 414, 430]. 
The seroepidemiology of the prevalence of IgG antibodies against B. miyamotoi as evidence 
for (endured) infection was examined in this study. Therefore, the study was setup to 
determine the seroprevalence in the different populations at a given moment, a so-called 
cross-sectional design, determining B. miyamotoi exposure rather than infection. No 
discrimination between endured or active infection was made, we did not determine a 
rise, decline or persistence of specific antibody production in these individuals nor did we 
determine the presence of anti-B. miyamotoi IgM antibodies. According to the Centers for 
Disease Control, to confirm the clinical diagnosis of other Tick Borne Relapsing Fever (TBRF) 
caused by B. hermsii, B. parkerii or B. turicatae, specific antibody titers should increase 
4-fold between acute and convalescent serum samples. Because of the cross-sectional 
design of this study, no convalescent serum samples were tested and therefore we were not 
able to assess the course of the serological response over time. Patients with other TBRF 
may have false-positive tests in indirect immunofluorescence assay (IFA) or whole lysate 
enzyme-linked immunosorbent assay (ELISA) for LB because of the similarity of proteins 
between the two organisms. Because of this cross-reactivity and the fact that cultivating B. 
miyamotoi - as a definite proof of a B. miyamotoi infection - has been a genuine challenge 
until now, a serological test such as the one we describe here is an important step towards 
a new diagnostic tool.
Our aim was to identify risk groups with significant more exposure that the general 
population. As recommended by the CDC we used a cut-off two standard deviations above 
the average of the blood donor group in order to strive for a relatively high specificity. This 
is higher than the mathematical optimal cut-off value (LogOD 3.45), which gives the best 
discrimination between positive and negative serum samples, yet without taking false-
positivity into account (data not shown). Nonetheless, assays for exposure to B. miyamotoi, 
such as described here and for other recombinant GlpQ antigen ELISA and immunoblot 
described before [414], need to be more extensively validated and tested to determine the 
extent of cross-reactivity and sensitivity. In the Netherlands, we have not identified another 
relapsing fever spirochete other than B. miyamotoi in ticks obtained from the environment, 
thus far. Therefore, we assume cross-reactivity between different relapsing fever GlpQ [441] 
has no or an insignificant influence in the Dutch setting. In addition, no significant cross-
reactivity was observed with Treponema pallidum positive patients. 
An increased seroprevalence was observed in EM patients and unconfirmed and confirmed 
LNB patients, which might be attributed to exposure to ticks infected with both B. burgdorferi 
s. l. and B. miyamotoi [416, 440]. Whether co-infection with B. miyamotoi exists and may 
alter the clinical manifestations of LB or LNB remains to be answered, our serological 
evidence suggests that it can occur in the same patients, assuming patients were diagnosed 
correctly. From our data we cannot conclude whether these were concomitant or serial 
infections. It should be mentioned that, in analogy to B. burgdorferi s.l. infection in Europe, 
it might also be that anti-B. miyamotoi antibodies are a result of a previous asymptomatic 
infection. To answer these questions a longitudinal approach would be required. 
Previous studies conducted in the Netherlands showed that forestry workers have an 
increased risk of acquiring infections transmitted by ticks [451-454]. In this study, 11.6% (6.5-
18.8%) of the forestry workers tested positive for anti-B. miyamotoi IgG antibodies. These 
findings indicate that in addition to LB and other tick-borne pathogens, forestry workers also 
run an occupational risk of acquiring infection with B. miyamotoi or at least exposed to this 
tick-borne pathogen. Furthermore, based on the findings presented here, demonstrating 
that the HGA suspected group of patients have a significantly higher seropositivity compared 
to blood donors, suggests that B. miyamotoi might also cause a febrile illness comparable 
to HGA. This is in line with previous case reports [430]. Indeed, the clinical manifestations 
of HGA might be similar to those caused by B. miyamotoi infection, including (high-grade) 
fever, chills, myalgia, nausea and headache a few weeks after a tick bite. Therefore, clinicians 
should include B. miyamotoi in the differential diagnosis of patients with a febrile illness 
caused by an unknown etiological agent when there is evidence of tick exposure.
In conclusion, a Luminex-assay was developed for seroepidemiologic screening of 
IgG antibodies against the GlpQ protein of B. miyamotoi. We observed an increase in 
seroprevalence from blood donors, to EM patients and unconfirmed and confirmed 
LNB patients. However, only the forestry workers and the serologically unconfirmed but 
suspected HGA group consistently showed significantly higher seroprevalence compared 
to the blood donor panel. It could be that some patients identified as having LB and 
definitely some that were suspected of having HGA, substantiated in part by nonspecific 
serological tests such as a whole cell ELISA or not substantiated at all, may actually have 
been infected with this relapsing fever spirochetes. Furthermore, our study suggests that 
individuals that are (occupationally) exposed to ticks in the Netherlands, such as forestry 
workers, are potentially at risk for B. miyamotoi infection. Interestingly, in light of the 
popularity of outdoor recreational activities among Dutch people, it is to be expected 
that this will certainly predispose a large number of people to the risk of infection with B. 
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miyamotoi, amongst other tick-borne pathogens. Therefore, B. miyamotoi infection should 
be included in the differential diagnosis when forestry workers or patients who engage in 
outdoor recreational activity present with fever after a tick-bite. In addition, in patients with 
unexplained fever or HGA-like symptoms after exposure to ticks physicians should consider 
B. miyamotoi infection. Until better validated diagnostic tests become available it should 
be recommended to consult academic referral centers when there is a suspicion on B. 
miyamotoi infection.
Figure 1: Distribution of LogOD-values
A: Serum samples (n=590) from the five risk groups. B: Serum samples from only blood donors. Red 
line depicts the selected cut-off value.
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There have been marked increases in the incidence of Lyme borreliosis and tick-borne 
encephalitis over the past ten to twenty years, in most European countries [12-14]. In the 
Netherlands, this upsurge has been evident from both a continuing increase in consultations 
for tick bites and erythema migrans [9, 24]. In addition, substantial disease burden is caused 
by either Lyme borreliosis or Lyme borreliosis related manifestations. Patients with Lyme-
related persisting symptoms are the majority of this burden [455]. The increasing number 
of tick bites reflects a growing risk of humans contracting Lyme borreliosis, but also other 
of tick-borne diseases. Still, these other tick-borne diseases are rarely diagnosed in the 
Netherlands. The results presented in this thesis, provide insights into presence and public 
health risk of other tick-borne diseases and could be used for public health decision-making, 
disease risk assessment and risk management in the field of tick-borne diseases.   
In part I, the different tick-borne pathogens in the Netherlands are studied; several 
knowledge gaps about their enzootic cycles are filled in. In Chapter 2, we calculated the 
prevalence of the different tick-borne pathogens in ticks, while we tested whether these 
pathogens might share similar enzootic cycles. We studied patterns of co-infection and 
spatial and seasonal dynamics of infection in questing Ixodes ricinus nymphs. Rickettsia 
helvetica (31.1%) and Borrelia burgdorferi sensu lato (11.8%) had the highest overall 
prevalence and were detected in all areas. Candidatus Neoehrlichia mikurensis (5.6%), 
Anaplasma phagocytophilum (0.8%), and Babesia species (1.7%) were detected in most, 
but not all areas. The prevalence of pathogens in ticks varied among the study areas from 
0 to 64%, while the density of questing ticks varied from 1 to 179/100 m2. Overall, 37% of 
the ticks were infected with at least 1 pathogen, and 6.3% with more than 1 pathogen. One-
third (1/3) of the Borrelia-positive ticks were infected with at least one other pathogen. 
Coinfection of Borrelia afzelii with Candidatus Neoehrlichia mikurensis and with Babesia 
species occurred significantly more often than expected, implying shared reservoir hosts for 
these pathogens. Conversely, coinfection of Rickettsia helvetica with either Borrelia afzelii 
or Candidatus Neoehrlichia mikurensis occurred significantly less frequent than expected.
In Chapter 3, we focused on the prevalence of Candidatus Neoehrlichia mikurensis in 
different tick species in Europe. By using an in-house developed real-time PCR assay, we 
showed that Candidatus Neoehrlichia mikurensis is present in questing Ixodes ricinus ticks 
throughout the Netherlands, Belgium, and other European countries but described under 
different names. In addition, we further characterized this emerging pathogen molecularly 
by using groEL, 16S rRNA and gltA as molecular markers. We propose that Ixodes ricinus can 
transstadially but not transovarially transmit this microorganism and that different small 
mammal species act as reservoir hosts. Our data imply that humans are frequently exposed 
to Candidatus Neoehrlichia mikurensis-infected ticks through tick bites. 
178  
CHAPTER 11  Synthesis.  Ticking all the boxes: from ticks, pathogens, vertebrate host to human disease.
 179
11
In Chapter 4, we showed that Anaplasma phagocytophilum has at least four differential 
enzootic cycles (ecotypes), and that the groEL gene is a suitable molecular marker to identify 
these different clusters. All human cases described clustered in only one of these ecotypes 
(ecotype I), suggesting that only one ecotype is zoonotic. Furthermore, the zoonotic ecotype 
has the broadest range of wildlife hosts. The significant population expansion – as shown by 
sequencing – of the zoonotic A. phagocytophilum ecotype indicates a recent increase of the 
acarological risk of exposure of humans and animals. 
To date, tick-borne encephalitis virus (TBEV) was never shown to occur in the Netherlands. 
By using roe deer as sentinels and screening their sera for neutralizing TBEV antibodies, and 
using molecular methods in questing ticks in Chapter 5, we showed that there is at least one 
region in the Netherlands where tick-borne encephalitis is endemic. 
In Chapter 6, we assessed the relative contribution of one of the most common animal urban 
dwellers - the European hedgehog - in the maintenance of several tick-borne pathogens 
and their enzootic cycles in (sub)urban areas. We conclude that hedgehogs and their 
ticks contribute to transmission and spreading of Borrelia bavariensis, Borrelia spielmanii, 
Borrelia afzelii, Anaplasma phagocytophilum and Rickettsia helvetica in (sub)urban areas. 
In part II, we aimed to translate these environmental findings of tick-borne pathogens, 
to human exposure, infection and disease. There are two critical issues in disease risk 
assessment and risk management for Lyme borreliosis; 1) differentiating between the 
spirochetes that only cause localized skin infection from those that cause disseminated 
infection, 2) and tracing the group of medically important spirochetes to a specific vertebrate 
host species. In Chapter 7, we directly link a transmission and/or amplification host for 
Borrelia burgdorferi s. l. to specific clinical manifestations of Lyme borreliosis. To show 
this, isolates from Lyme borreliosis cases with distinct clinical manifestations (erythema 
migrans, Lyme neuroborreliosis, acrodermatitis chronica atrophicans, and Lyme arthritis) 
and isolates from Ixodes ricinus ticks feeding on rodents, birds and hedgehogs were typed to 
the genospecies level by sequencing part of the intergenic spacer region. In addition, more 
in-depth molecular typing was performed by sequencing eight additional loci with different 
characteristics (plasmid-bound, regulatory, and housekeeping genes). We showed that 
Borrelia afzelii was the most common genospecies in acrodermatitis patients and engorged 
ticks from rodents. Borrelia burgdorferi sensu stricto was widespread in erythema migrans 
patients. Borrelia bavariensis was widespread in neuroborreliosis patients and in ticks 
from hedgehogs, but rare in erythema migrans patients. Borrelia garinii was the dominant 
genospecies in ticks feeding on birds. Spirochetes in ticks feeding on hedgehogs were 
overrepresented in genotypes from spirochetes in erythema migrans and acrodermatitis 
patients. Spirochetes from ticks feeding on birds were overrepresented in genotypes from 
spirochetes in neuroborreliosis patients. Overall, the analyses of our datasets support the 
existence of at least three transmission pathways (1. ticks feeding on hedgehogs and Lyme 
neuroborreliosis patients, 2. ticks feeding on birds and Lyme neuroborreliosis patients, 3. 
and ticks from rodents and hedgehogs and acrodermatitis chronica atrophicans patients) 
from an enzootic cycle to a clinical manifestation of Lyme borreliosis. 
In Chapter 8, in search of indirect proof of human exposure to, and infection with other 
tick-borne pathogens, we tested ticks that fed on humans. And blood of a cohort study of 
humans with tick-bites and/or erythema migrans, for the presence of Borrelia burgdorferi s. 
l., Borrelia miyamotoi, Anaplasma phagocytophilum, Candidatus Neoehrlichia mikurensis, 
spotted fever Rickettsia’s, tick-borne encephalitis virus and Babesia genospecies using 
molecular detection techniques. Half of the ticks removed from humans tested positive for 
Borrelia burgdorferi s. l., Anaplasma phagocytophilum, Candidatus Neoehrlichia mikurensis, 
Rickettsia helvetica, Rickettsia monacensis, Borrelia miyamotoi and several Babesia species. 
Among the Borrelia burgdorferi s. l. positive ticks, 33% carried another pathogen from a 
different genus.  Based on molecular detection techniques, the probability of infection 
with a tick-borne pathogen other than Lyme spirochetes after a tick bite is roughly 2.4% 
in the Netherlands. Similarly, among patients with erythema migrans, the probability of a 
co-infection with another tick-borne pathogen was approximately 2.7%. Collectively, these 
data show that exposure to pathogens other than Borrelia burgdorferi s. l. and co-infections 
are more common than assumed and warrant further investigation. 
In Chapter 9, we investigated a new kid on the block, the relapsing fever spirochetes Borrelia 
miyamotoi in more detail. We showed significant association of Borrelia burgdorferi s. l. with 
Borrelia miyamotoi in nymphs implying the existence of mutual reservoir hosts. Indeed, 
we demonstrated the presence of Borrelia miyamotoi DNA in different organs of rodents, 
suggesting systemic infections. On top of this, we showed that birds also can be infected with 
this pathogen. It has been postulated that Borrelia miyamotoi is able to cause an erythema 
migrans-like skin lesion. Another, perhaps more plausible, hypothesis is that patients with 
Borrelia miyamotoi disease - characterized by fever, malaise and myalgia - with a skin lesion 
are co-infected with Borrelia burgdorferi s. l.. We did however, not find evidence for Borrelia 
miyamotoi infection when testing biopsies of Lyme borreliosis-suspected skin lesions, 
suggesting that Borrelia miyamotoi is not associated with Lyme borreliosis-associated skin 
manifestations. 
Based on the infection rate of Ixodes ricinus ticks with Borrelia miyamotoi in the 
Netherlands, we hypothesized that various populations are exposed to Borrelia miyamotoi. 
Therefore, in Chapter 10, we serologically tested the exposure of different risk groups to 
Borrelia miyamotoi in the Netherlands, by an in-house developed Luminex assay using a 
fragment of glycerophosphodiester phosphodiesterase (GlpQ) as antigen. Assuming that 
an IgG antibody response against Borrelia miyamotoi antigens reflects (endured) infection, 
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the seroprevalence in different risk groups was examined. Sera from nine out of ten 
PCR-confirmed Borrelia miyamotoi infections from Russia were found positive with the 
recombinant antigen used, and no significant cross-reactivity was observed in secondary 
syphilis patients. The seroprevalence in blood donors was set at 2.0% (95% CI 0.4–5.7%). 
The seroprevalence of antibodies to Borrelia miyamotoi GlpQ was elevated in erythema 
migrans patients 5.6% (3.0-9.2%) and in individuals with serologically confirmed 7.4% (2.0-
17.9%) or unconfirmed 8.6% (1.8-23%) Lyme neuroborreliosis, but these rates were not 
significantly higher than the percentage blood donors testing positive. The prevalence of 
anti-Borrelia miyamotoi antibodies among forestry workers 10% (5.3-16.8%) and in patients 
with serologically unconfirmed but suspected Human Granulocytic Anaplasmosis 14.6% 
(9.0-21.8%) were significantly higher compared to the seroprevalence in blood donors. Our 
findings indicate that infections with Borrelia miyamotoi occur in tick-exposed individuals in 
the Netherlands. In addition, Borrelia miyamotoi infections should be considered in patients 
reporting tick bites and febrile illness with unresolved etiology in the Netherlands, and other 
countries where Ixodes ricinus ticks are endemic. 
GENERAL DISCUSSION
The findings presented in this thesis contribute to a better understanding of the complicated 
relationship between ticks, pathogens, vertebrate hosts, and human infection, filling in 
several important knowledge gaps. However, I realize that the research presented in my 
thesis is only a small part of a larger puzzle. There is much research to be done, many stones 
are left unturned. In this synthesis, I will put my findings into a perspective, discuss their 
relevance and relate to previously published work. I start with discussing my findings on 
different tick-borne pathogens in the Netherlands, and then continue to discuss the most 
prevalent tick-borne disease: Lyme borreliosis and linking the causative agent Borrelia 
burgdorferi s. l. in relationship to vertebrate hosts and human disease. Second, I connect 
vertebrate host to ticks and pathogens in section 3 and 4. In the following section, I continue 
arguing how disease risk and surveillance in the field of tick-borne pathogens can be used 
in public health strategies. In section 6, I discuss my findings on human exposure, infection 
and disease of different tick-borne pathogens. In my concluding remarks, I recommend and 
speculate about policy and future research. 
1. Ticks and Pathogens: Ticks contain more pathogens than Lyme spirochetes alone
As described in this thesis, also in the Netherlands, Ixodes ricinus is not only the transmitter of 
Borrelia burgdorferi s. l., but also of other tick-borne pathogens, namely Borrelia miyamotoi, 
Anaplasma phagocytophilum, Candidatus Neoehrlichia mikurensis, Rickettsia helvetica, 
Rickettsia monacensis, several Babesia species and tick-borne encephalitis virus. To study 
and understand the biology, disease dynamics and human health risk of tick-borne diseases, 
a multidisciplinary approach is required, studying 1) the composition and prevalence of 
pathogens carried by the vector in the different life stages, 2) the different animal reservoirs 
and their contribution in the maintenance of the pathogen, and 3) exposure, infection and 
importantly disease in humans.
The risk of human infection with tick-borne pathogens after an I. ricinus bite depends to a 
large extent on the prevalence and phenotypic but also genetic make-up of the different 
pathogens in the different stages of the tick, and abundance and distribution of the reservoir 
host at a geographical location. By determining the prevalence and distribution of tick-borne 
microbes in questing ticks, linking that to reservoir hosts and enzootic cycles, we can get 
an insight into the biological and ecological drivers of these pathogens. Connecting this to 
epidemiological data on human exposure, infection and disease can give an insight into risk 
on a population scale, and possibly find novel ways to control the disease.
In the Netherlands, more than one-third of questing ticks harbored one or more of the tested 
tick-borne pathogens consisting of B. burgdorferi s. l., R. helvetica, Candidatus Neoehrlichia 
mikurensis, A. phagocytophilum and Babesia species. Furthermore, these pathogens have 
a ubiquitous distribution in the Netherlands, in a variety of habitats, from open areas such 
as dune and heather to deciduous or coniferous forests (chapter 2). This same pattern of 
distribution was seen in the relatively newly discovered pathogen, B. miyamotoi (chapter 9). 
Evidently, the presence of I. ricinus is inherently linked to the presence of these pathogens. 
In addition, we show that some pathogens share the same reservoir host by using data 
on mixed infections in questing ticks. Some combinations of mixed infection in a tick are 
found at significantly higher rates than others, indicating a common reservoir host. The 
idea that some pathogens have a common reservoir host, was confirmed by experimental 
studies, where infected wild rodents have proven to be competent hosts that can transmit 
Candidatus Neoehrlichia mikurensis, as well as B. miyamotoi to laboratory ticks [61].  
2.  Connecting Borrelia burgdorferi sensu lato to vertebrate host and human disease
Lyme borreliosis can be considered a collective name for different clinical manifestations and 
diseases in humans caused by spirochetes from the B. burgdorferi s. l. complex. At least five 
genospecies of B. burgdorferi s. l. complex have been shown to be pathogenic to humans, 
namely B. burgdorferi s. s., B. afzelii, B. garinii, B.  spielmanii and B.  bavariensis [10, 19]. 
The wide variety of clinical outcomes is related to genetic variation of the spirochetes of the 
B. burgdorferi s. l. ([456] chapter 7). It has been postulated that this genetic diversity is at 
the base of the multiple clinical manifestations that infection with these bacteria can cause 
[347-349]. This was shown in chapter 7 and in other research we have conducted [19]. 
Not all the Borrelia genotypes within the known pathogenic B. burgdorferi s. l. genospecies 
can cause Lyme borreliosis [117]. What genetic information determines the differential 
invasiveness of Borrelia genospecies, but also of genotypes within a genospecies is not 
known. Successful colonization of the human host by bacterial pathogens, like Bordetella 
pertussis, Streptococcus mutans and Neisseria meningitidis requires that bacteria overcome 
limitations in iron and other essential elements imparted by the host [457, 458]. Based on 
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the knowledge that genes involved in efficient uptake of metals and ions from the host 
are responsible for virulence and pathogenesis, a set of genes involved in the regulation of 
genes located on plasmids [383, 459, 460] and chromosomal virulence genes were selected 
and characterized to look for possible explanations for the observed clinical differences 
[369, 370, 380]. We could not prove this by the chosen approach, as the data showed that 
the differences in pathogenicity and clinical manifestations of the Lyme spirochete are 
not associated with genetic differences in the virulence genes and plasmid-based genes. 
Second, we hypothesized that a zoonotic transmission cycle for a genotype is one factor 
that determines the clinical manifestation of Lyme borreliosis. Indeed, we showed that 
clinical outcomes could be linked to different zoonotic transmission cycles characterized 
by a defined genotype-host association: each B. burgdorferi s. l. genospecies able to cause 
Lyme borreliosis is maintained in nature through a distinct enzootic cycle with different 
vertebrates acting as reservoirs. This knowledge about enzootic cycles and the different 
clinical consequences that each B. burgdorferi s. l. genospecies is associated with, can prove 
to be helpful in disease risk assessment and risk management. 
Yet we could not link all B. burgdorferi s. l. genospecies (B. spielmanii and B. burgdorferi s. 
s.) to an enzootic cycles. We did detect B. spielmanii genospecies in hedgehogs and their 
ticks (chapter 6), while  small rodent of the Gliridae family (which are extremely rare in 
the Netherlands) have been described in the literature as the main reservoir hosts [319]. 
Infection with B. spielmanii in humans, however, is rare and therefore we could not study 
the host reservoir relationship for this pathogen. Thus far, B. spielmanii was only found in 
patients with erythema migrans [19].
Interestingly, in hedgehogs we found all mammal reservoir-associated B. burgdorferi s. l. 
genospecies except for B. burgdorferi s. s.. In North America the B. burgdorferi s. s. causes 
Lyme arthritis and rodents are its reservoir host. For the European strains of B. burgdorferi s. 
s. we did not find the same clinical manifestations (e.g. causing Lyme arthritis) and rodents 
as reservoir hosts (chapter 7, [19]). To be more specific, no other genospecies than B. afzelii 
are detected in ticks from rodents in the Netherlands, in the more than thousand rodent 
samples tested to date (data not shown). This suggests that there is a real difference in 
maintenance of B. burgdorferi s. s. in nature between the two continents. In addition, the 
low prevalence of B. burgdorferi s. s. (0.2%) in chapter 2 suggest that this genospecies is 
either maintained in a cryptic cycle involving a vector other than I. ricinus, or has a specific 
reservoir host that is not very abundant in the Netherlands and/or was not include in our 
study. This discrepancy of prevalence in questing ticks and presence in human disease is 
most obvious in the case of B. bavariensis, with less than 1% of the questing I. ricinus ticks 
being positive for this genospecies but almost 60% of all the Lyme neuroborreliosis cases we 
tested. In addition, since our findings indicate that neuroborreliosis caused by B. bavariensis 
will not always be preceded by erythema migrans as a first symptom of infection, the 
current medical guidelines may need to be re-evaluated. Current recommendation advises 
antibiotic treatment of erythema migrans, as it commonly prevents the development of late 
and more severe disease stages [10], but this approach will not prevent all cases of Lyme 
neuroborreliosis. Clinicians should therefore be aware of this finding. That said, treating all 
patients that present with a tick bite with antibiotics, will lead to overtreatment and is not 
desirable in this era where antibiotics-resistance is one of our main public health challenges. 
There is another side of the Lyme borreliosis coin, genetic variation of the pathogen, and 
reservoir host association alone cannot fully explain the observed variation in the clinical 
manifestations observed in humans. The ability to cause disease depends not only on 
the genetic make-up of the Lyme borreliosis spirochetes, but also on extrinsic factors, for 
example genetic factors, the immune status of its host and the human immune responses. 
Indeed, most if not all tissue damage results from host inflammatory reactions. The intensity 
of the inflammatory response varies according to the B. burgdorferi s. l. genospecies that 
causes an infection [461, 462]. Host genetic factors have an important role in the expression 
and severity of infection in animals, host factors being certain SNP’s Toll-like receptors, NOD-
like receptors [463], as well as HLA-DR allele associated differences in the development of 
antibiotic refractory Lyme arthritis [464]. Thus, the extensive array of disease manifestations 
in Lyme borreliosis patients reflects most probably the interplay between B. burgdorferi s .l. 
genospecies virulence and host immune responses.
3. Vertebrate host their ticks and pathogens
The role of hedgehogs and Ixodes hexagonus in pathogen maintenance and transmission 
to Ixodes ricinus 
Other tick species maintain their specific set of pathogens in enzootic cycles. However, they 
may still play a key role in transmitting those pathogens to the generalist feeder I. ricinus via 
a shared vertebrate host. As I. ricinus is a generalist feeder, it shares vertebrate hosts with 
other tick species. Ixodes ricinus ticks are therefore exposed to other tick-borne pathogens, 
and could be able to transmit these pathogens to humans or animals (Figure 1). Ixodes 
hexagonus is a host specialist, feeding primarily on hedgehogs. Despite this, it is known to 
occasionally bite humans, companion animals and other hosts [323, 324]. In chapter 6 we 
show that hedgehogs and I. hexagonus contribute to the spread and persistence of ticks and 
their pathogens in a (sub)urban habitat via secondary enzootic cycles. This is especially of 
significance since hedgehogs are one of the most successful urban adapters and can reach 
up to nine times higher densities in urban areas with parks and garden, than in rural areas 
[329-331].
The presence of different Borrelia genospecies in ticks from hedgehogs (chapter 6) indicates 
that infection rates of questing ticks are possibly higher in areas where hedgehog densities 
are high - like in (sub)urban areas -  in comparison to other areas like in forests and rural 
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areas [329-331]. As hedgehogs carried many adult I. ricinus ticks, it might very well be that a 
host community composed only of small or medium sized vertebrates such as rodents, birds 
and hedgehogs (such as in (sub)urban area’s and parks) is already sufficient to complete 
the life cycle of I. ricinus. Therefore, the general idea that ticks cannot be sustained in 
(sub)urban areas is not accurate and this should be considered in design of disease risk 
and control models. These models should incorporate the effect of individual variation on 
disease emergence and super spreader effects of hosts [465, 466]. 
In chapter 7, we show by using quantitative molecular epidemiologic approach that 
hedgehogs have significant associations with the clinical Lyme borreliosis manifestations 
erythema migrans, acrodermatitis chronica atrophicans and Lyme neuroborreliosis. Dr. 
Coipan suggests in her thesis that mammal-associated B. burgdorferi s. l.  genospecies, such 
as B. afzelii, B. bavariensis, and B. spielmanii, are more often isolated from patients than 
avian-associated Borrelia genospecies (B. garinii and B. valaisiana) [19]. She hypothesizes 
that the reason why mammal associated Borrelia are significantly more often retrieved from 
humans than bird-associated Borrelia is that transmission of the bacteria is easier between 
vertebrates of the same class (i.e. mammals) than between vertebrates of different classes 
(i.e. birds and mammals). The factors that trigger the specificity of Borrelia for small 
rodents could be the same ones that are responsible for facilitating the establishment of 
localized infection with these bacteria in humans, for instance outer surface protein B and 
other factors [467]. Since we show that B. afzelii, B. bavariensis, and B. spielmanii are all 
associated with hedgehogs, this hypothesis that mammal-associated pathogens are more 
likely to infect humans than pathogens associated with ectothermic animals, could also very 
well hold true for hedgehog-associated pathogens including A. phagocytophilum and R. 
helvetica. More research is needed, however, to elucidate the role of hedgehogs in the life 
cycle of I. ricinus, and its role in the epidemiology of human tick-borne diseases especially 
in (sub)urban area’s and parks. 
4. Connecting pathogens to vertebrate hosts 
To survive in the different environments of a tick vector and of a vertebrate host, tick-borne 
pathogens undergo substantial selection pressures. In the tick, pathogens must survive 
great fluctuations in pH, temperature, and other factors related to biology of the tick [468], 
and in the host, pathogens must survive immunological and inflammatory defenses [469]. 
Strain diversity is likely to be an outcome of this selective pressure. Diversity allows the 
pathogen to evade immune responses of the host and also increases the number of different 
host species that can be infected [155]. Therefore, we were interested in strain diversity of 
Anaplasma phagocytophilum, an established tick-borne pathogen. 
Figure 1. The cryptic cycle of human pathogens via Ixodes hexagonus and its host, the hedgehog. 
When feeding on an infected hedgehog, the generalist tick Ixodes ricinus gets infected with pathogens 
and transmits them to another host species, for example humans. L/N is larva/ nymph and N/A is 
nymph/ adult.
Strain diversity of Anaplasma phagocytophilum 
Various reservoir hosts are implicated to play a role in the maintenance of the endemic life 
cycle of A. phagocytophilum in nature. The animals identified as reservoir hosts range from 
domestic and wild ungulates, to small mammals like rodents and insectivores, to birds and 
lizards [1, 36]. To study the enzootic cycles of A. phagocytophilum in nature, different genetic 
markers are used in literature. Sequences of the groEL gene (part of the heat-shock protein 
operon) have shown more clearly delineated genetic variants of A. phagocytophilum than 
have sequences of other genes [470]. Using this genetic marker, in chapter 4 we show four 
different ecotypes of A. phagocytophilum in vertebrates and vectors in Europe, each with 
their particular enzootic cycle. We hypothesize that each of these ecotypes has its own main 
vector and therefore its own ecological niche and that these ecotypes are maintained in their 
own cycle. Vectors and pathogens have coevolved with specific host species, and therefore 
these host species are likely to be the preferred hosts for both vector and pathogen. We 
hypothesize that: 1) The main vector of ecotype II, could be the deer-ked or another deer 
specific ecto-parasite. Alternatively, I. ricinus could still be the main vector for this ecotype 
Ixodes hexagonus (N/A)
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since, the chance of feeding on roe deer in a subsequent life stage is fairly high [18]. 2) The 
main vector of the rodent ecotype (ecotype III) is Ixodes trianguliceps species that feeds only 
on rodents and shrews and is thought to be a driver of A. phagocytophilum and B. microti 
[247, 471] and 3) Ecotype IV, the bird associated type has the Ixodes frontalis as its main 
vector. The notion of different ecotypes is supported by experimental findings that point to 
variations in the susceptibility of different mammalian species to A. phagocytophilum strains 
[47]. The generalist I. ricinus tick species and (perhaps the hedgehog tick I. hexagonus) is the 
main vector for ecotype I, the only ecotype that is considered zoonotic (chapters 4 and 8). It 
is possible that ecotype I is zoonotic due to the great strain diversity, because this diversity 
could allow the pathogen to evade immune responses of the host and also increases the 
number of different host species that can be infected, a strategy used by numerous so called 
multihost pathogens, like influenza A and Salmonella typhimurium [472, 473]. Alternately 
and equally possible is that the strain diversity of this ecotype is a reflection of to population 
expansion. This particular ecotype showed significant population expansion, implying 
that either expansion occurred in the vector, or the vertebrate host, with a third option 
of expansion occurring in both the vector as the vertebrate host, which in turn could also 
explain strain diversity. Whether the other ecotypes can cause infection in humans remains 
to be determined. 
Other tick-borne pathogen in which strain diversity could play a role in virulence and 
the ability to cause human disease is R. helvetica. As shown in chapter 2, R. helvetica is 
widespread in the questing tick population, with infection rates ranging from 3% to 64%, 
with an overall average of 31%. These numbers suggest that there is considerable exposure 
to R. helvetica after a tick bite. Still, only a few human cases have been described so far, 
in the Netherlands. Rickettsia helvetica was identified using serological and molecular 
methods in skin biopsies of erythema migrans patients. In addition, co-infection with R. 
helvetica, was also found in Lyme neuroborreliosis patients [117, 118]. Combining this, with 
the knowledge gathered in this thesis and elsewhere, I suggest that there are at least two 
distinct ecotypes of R. helvetica one associated with birds [106] and the other associated 
with hedgehogs (chapter 6). If this hypothesis holds true, the question would be which 
of the potential ecotype can cause infection in humans? It is imaginable that mammalian 
associated ecotypes are more suitable to infect humans. In addition, since we show that 
both birds as well as hedgehogs are amplification host of their own Borrelia genospecies 
that can cause Lyme neuroborreliosis (B. garinii and B.  bavariensis, respectively), this could 
explain the co-infection with R. helvetica in the Dutch patient groups. 
5. Unraveling disease risk; many scenarios, many actors at play
Acarological risk
When assessing disease risk of a tick-borne pathogen the term “acarological risk” is often 
used (likewise in chapter 2). This means that the level of the risk depends on the level of 
exposure of an individual to the density of infected questing ticks, infected with tick-borne 
pathogens. Often a so-called “DIN” or density of infected nymphs is calculated (DIN= Density 
of questing nymphs x (times) Nymphal infection prevalence) when assessing disease risk in 
different areas. Especially the latter needs to be used with caution in the case of tick-borne 
pathogens. First, adult (female) ticks can also transmit all the mentioned pathogens, and all 
tick-borne pathogens except B. burgdorferi s. l. and Candidatus Neoehrlichia mikurensis are 
thought to be transmitted transovarially, even though with different efficiencies. In other 
words, larvae do not play a major role in transmitting B. burgdorferi s. l. and Candidatus 
Neoehrlichia mikurensis to humans, but could transmit other tick-borne pathogens. 
Consequently, the contribution of larvae to the disease burden should be re-evaluated 
for each individual tick-borne pathogen. Second, not all microorganisms have the same 
ability to infect and cause disease in humans. Therefore, it is important to differentiate 
between the infectious and non-infectious pathogen strains, genospecies and genotypes, 
and between the invasive and non-invasive ones (chapter 4, chapter 6 and chapter 7). For 
instance, the discrepancy between prevalence of B. bavariensis in questing I. ricinus nymphs 
and its ability to cause severe disseminated neurological disease cannot be captured in this 
simple DIN calculation. Two other factors are also important to incorporate in the analysis, 
when calculating acarological risk: the vertebrate source, meaning the main vertebrate or 
reservoir host(s) of the pathogen, and the abundance of that vertebrate source in a habitat 
or environment. When people are exposed to an infected tick in an urban environment, it 
is likely that the composition of the pathogens carried by that tick is different from ticks 
from dunes, heather and forests (chapters 6 and 7). In this regard, it is interesting to know 
that 31% of the people in the Netherlands reported to have obtained their tick bites from 
their gardens [345]. Furthermore, it is possible that we have underestimated the number of 
people bitten by the hedgehog tick, I. hexagonus while working in their gardens [324]. For 
laypersons, it is very difficult to distinguish between I. ricinus and I. hexagonus ticks, because 
the macroscopic differences are small. This underscores that understanding enzootic 
transmission cycles is important to understand and estimate risks better. All tick-borne 
pathogens described in this thesis have their own specific enzootic cycle and environmental 
drivers. Therefore, a customized approach is required for each pathogen when the disease 
risk is analyzed. In different environments and at each life stage, an I. ricinus bite has an 
impact on the risk of tick-borne infection and co-infection for humans. 
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Surveillance in ticks, the canary in the coalmine  
Surveillance systems monitoring the prevalence of infectious disease in humans, domestic 
animals and wildlife, provide early warning systems of emerging infectious (zoonotic) 
diseases. For most vector-borne disease surveillance, we rely on surveillance of health 
indicators, e.g. trend in mortality or disease syndromes, or laboratory submissions, coupled 
with registration of specific diagnoses [474]. Unfortunately, these surveillance methods 
are reactive at best, and detect emerging pathogens only when the disease burden in the 
disease host is increasing, like in the initial outbreak cases of West-Nile virus, Bluetongue 
and Schmallenberg virus [474]. Thus we are in need of proactive systems allowing for early 
warning for emerging vector-borne infectious diseases, which may trigger implementation 
of containment measures at the source; being the tick in this case. 
For the discovery of the first patients for both B. miyamotoi and tick-borne encephalitis 
virus in the Netherlands, the finding of pathogens in questing ticks preceded the discovery 
of infection in humans. Borrelia miyamotoi was first found in questing ticks and vertebrate 
hosts (chapter 9) after this finding was communicated to Amsterdam Multidisciplinary 
Lyme borreliosis Center the first European patient with relapsing fever B. miyamotoi 
disease was retrospectively identified [95], an immunocompromised patient with a chronic 
meningoencephalitis. In the seroprevalence study of chapter 10, we subsequently showed 
that sero-responses in the high-risk groups like forestry workers and of people that showed 
presumably anaplasmosis-like illness after a tick bite was significantly higher than the 
control group (blood donors). With this study, we facilitated the identification of the clinical 
symptoms of B. miyamotoi infections at the time. Showing that B. miyamotoi infections 
should be considered in patients reporting with a febrile illness or anaplasmosis-like 
symptoms after a tick bite, or even with fever of unresolved etiology.
Another striking example of pathogen surveillance in the environment was the discovery 
of tick-borne encephalitis virus (TBEV) in the Netherlands (chapter 5). By using roe deer 
sera as sentinels for flavivirus (TBEV) antibodies, we could target our surveillance to one 
specific national park and showed the presence of TBEV RNA in two questing ticks (a 
nymph and an adult tick). The National Institute for Public Health and the Environment 
(RIVM) provided this finding to both medical professionals and the public at large. Within 
a week, this communication resulted in the report of an autochthonous TBE infection in 
the Netherlands [475]. After two months, the second Dutch patient was found [476]. This 
patient lives near the area where we described TBEV positive questing ticks. This example 
further underscores the value of proactive monitoring and communication. We do not think 
that the introduction of TBEV is a recent event in the Netherlands, since all the roe deer 
sera were collected in 2010, whereas the ticks were collected 5 years later in 2015. This 
5-year gap implies that TBEV has been circulating in the Netherlands for some time and 
that perhaps human have not correctly been diagnosed, since the medical professionals 
were unaware of the circulation of TBEV in the Netherlands and did not include it in their 
differential diagnosis. As most cases of TBEV are asymptomatic and when symptomatic are 
most likely to have a self-limiting course, with or without long-term sequelae, this is not 
unlikely that patients have been missed.        
Even though less obvious than the previous examples, the same sequel of events was 
followed in the case of Candidatus Neoehrlichia mikurensis (chapters 2 and 3), R. helvetica 
(chapters 2 and 6) and Babesia divergens (chapter 2). Presence of the pathogens in questing 
ticks was shown and enzootic cycles were unraveled before the first evidence of infection in 
humans was found in the Netherlands (chapter 8, [118]).   
6. Human exposure, infection and disease
Over the past two decades, several European countries have reported marked increases in 
the incidence of Lyme borreliosis [9, 12, 24, 162]. In the Netherlands in 1994, the incidence 
for GP diagnosed erythema migrans increased from 39 per 100,000 inhabitants to 134 per 
100,000 inhabitants in 2009, adding up to a total of 22,000 patients with erythema migrans 
in the Netherlands [9]. These number have stabilized from 2009 to 2014 [25]. It most likely 
is not just an increase in reported cases as the prevalence of B. burgdorferi s. l. in ticks also 
increased in the same period [5]. In 2009, the total estimated number of tick bites was a 
dashing 1.1 million tick bites in the Netherlands alone [9]. It is likely that other tick-borne 
pathogens followed the same upward trends as the Lyme borreliosis spirochetes. However, 
in Europe, information on the incidence of human infection with tick-borne pathogens 
other than Lyme borreliosis and TBE is almost completely lacking and disease in humans has 
largely been derived from occasional case reports.
Based on the results from chapter 8, we estimated the number of annual human exposure 
to tick-borne pathogens in the Netherlands to be roughly 3500 for B. divergens, 10,500 for A. 
phagocytophilum, 25,500 for B. miyamotoi, 60,000 for Candidatus Neoehrlichia mikurensis, 
up to 207,000 persons for R. helvetica. Among the 322,000 persons exposed to B. burgdorferi 
s. l. through a tick bite, roughly 105,000 are simultaneously exposed to another pathogen. 
In addition to this number, exposure to more than one tick-borne pathogen can happen 
when people have more than one tick bite at once or several consecutive tick bites. It is 
clear that not all exposure leads to infection and disease. Based on the development of an 
erythema migrans or seroconversion, the risk of infection with B. burgdorferi s. l. after tick 
bites was estimated to be 5.1% [254].  In chapter 10, we show that B. miyamotoi infection 
(by measuring IgG levels) is indeed more widespread than the single case report [95] and 
occurs is different risk groups, not only in immunocompromised patients. 
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Co-infection in humans 
Ticks retrieved from humans frequently contain multiple pathogens (chapter 8). This means 
that the risk of exposure to one or multiple tick-borne pathogens is substantial. Especially, 
due to their omnipresence, we underline the need to consider all of these pathogens (B. 
miyamotoi, A. phagocytophilum, Candidatus Neoehrlichia mikurensis, R. helvetica, R. 
monacensis, and Babesia species) when evaluating the risks of infection and subsequently 
of disease following a tick bite. Therefore, it is quite possible that infections with tick-
borne pathogens other than Lyme spirochetes have been common, but have not been 
distinguished from other infections. Alternatively, it is possible that infections and symptoms 
with these tick-borne pathogens have all been categorized - and in some cases treated as 
- under the collective name of Lyme borreliosis. In chapter 8, we show that the probability 
of infection with a tick-borne pathogen other than Lyme spirochetes after tick bites in the 
Netherlands is roughly 2.4% (95%CI 1.1% – 4.5%). This number is similar to the probability 
of a co-infection with another tick-borne pathogen in patients with erythema migrans 
(2.7%, 95%CI 1.3% – 5.2%). Interestingly, one patient in our study had a co-infection with 
A. phagocytophilum and B. divergens, confirming that co-infection with other tick-borne 
pathogens also is possible even though it has rarely been reported before. Co-infections 
could affect the severity of disease and influence clinical outcomes, especially since some 
tick-borne pathogens such as A. phagocytophilum may modulate host immunity [155, 166, 
477]. Moreover, mixed infections of B. burgdorferi s. l.  with different tick-borne pathogens 
could be partly responsible for the wide variety of reported clinical manifestations of Lyme 
borreliosis [392]. Physicians and others sometimes attribute clinical manifestation such as 
fever and viral-like symptoms to Lyme borreliosis. 
How pathogen biology affects detection methods in the clinical samples 
The studies in chapter 8 and chapter 9 also show that for every pathogen a different 
detection method and consequently different diagnostic method may be required. 
Although culturing is considered the most reliable method in proving the presence of 
living microorganisms and viruses, it is time consuming, costly and often not possible for 
all pathogens. Therefore, the preferred laboratory diagnostic methods for most pathogens 
are either serology or PCR. Compared to DNA amplification with PCR, available serological 
tests generally have a low specificity and/or sensitivity, particularly during the early phase 
of infection. Still there are technical  detection limitations to PCR-based methods, such 
as the timing of sample collection after a tick bite, as well as the pathogen tissue tropism 
that strongly affect the ability of pathogen detection [395, 396]. For instance, in patients’ 
blood, B. burgdorferi s. l. DNA was detected in only one out of the 291 patients with an 
erythema migrans (chapter 8), confirming that the chance of detecting B. burgdorferi s. 
l. DNA in blood samples of confirmed Lyme borreliosis patients is low [395]. This shows 
that serology is still the preferred approach when it comes to Lyme borreliosis diagnostics. 
Rickettsia helvetica is another example of the influence of microbial tropism on diagnostics. 
Despite the high prevalence of R. helvetica in ticks, this bacteria was not detected in the 
626 examined blood samples (chapter 8) whereas molecular evidence for their presence 
was found in cerebrospinal fluid of Lyme neuroborreliosis patients and in a skin sample of 
an erythema migrans patient [117, 118]. Perhaps this finding is not surprising knowing that 
R. helvetica has a tropism for endothelial cells [396]. Because PCR on blood is shown to be 
a sub-optimal method, I would recommend the development of serological test in the case 
of R. helvetica.
Similarly, in chapter 9 B. miyamotoi DNA was not detected in 31 erythema migrans skin 
samples, even though 10% of all B. miyamotoi patients present with an erythema migrans 
lesion. This finding shows that the chosen detection method - in this case PCR on skin 
tissue - was sub-optimal for B. miyamotoi detection. Borrelia miyamotoi, like Candidatus 
Neoehrlichia mikurensis, A. phagocytophilum, and Babesia species are all pathogens that 
can be expected in blood because of their biology and tropism [36, 58, 83, 119]. Therefore, 
in the case of these specific pathogens, the use of PCR-based methods on blood samples is 
a recommended approach when it comes to diagnostics (chapter 8). The data presented in 
this thesis shows that there is no one-size-fits-all approach when it comes to diagnosis of 
infection with tick-borne pathogens. 
How genetic diversity affects diagnostic laboratory tests 
Strain variation can have important implications for development of diagnostic tests, for 
both serological and molecular tests. In the case of serological assays, if variable antigens 
are used as a target in the test, these antigens need to be tested if they are multivalent for 
all the relevant strains. For instance, in the case of A. phagocytophilum, the main diagnostic 
laboratory method now is still serology. When testing for A. phagocytophilum infection, 
commercially available IFA tests with a North American strain (HGA-1 strain) is used in the 
Netherlands and other European countries, even though cross-reactivity between the North 
American and European strain has not been evaluated. Moreover, when novel diagnostic 
laboratory tests are developed (serological and molecular tests) for the A. phagocytophilum 
the zoonotic ecotype (ecotype I) should be used since, the other ecotypes have not been 
proven to cause disease or to be infectious for humans (chapter 4).    
In the case of B. burgdorferi s. l. as discussed above and in chapter 7, five particular 
genospecies seem to be responsible for the clinical manifestations in humans. This presents 
greater challenges for interpretation and development of diagnostic laboratory methods 
in Europe in comparison to North America where only one genospecies seems to cause 
disease. Especially with regard to serologic testing, determining the best combinations 
of epitopes to include in an enzyme-linked immunosorbent assay (ELISA) or similar assay 
for optimal sensitivity and specificity is challenging. It should be noted that there is a high 
level of cross-reactive antibodies to the various B. burgdorferi s. l. genospecies. Currently, 
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a combination of various selected recombinant and native antigens are used of three 
B. burgdorferi s. l. genospecies (B. burgdorferi s. s., B. afzelii, B. garinii) [478]. Current 
guidelines for serological diagnosis should follow the principle of a two-step procedure: 
a sensitive ELISA as the first step, if reactive followed by immunoblot (IgM and IgG) [479]. 
Not surprisingly, the overall sensitivity for this two-tier testing is high for the late clinical 
manifestations that are caused by B. burgdorferi s. s. and B. afzelii, namely acrodermatitis 
chronica atrophicans and Lyme arthritis (~95%) [480]. The sensitivity for diagnosis of Lyme 
neuroborreliosis is significantly less (~77%) [480]. Perhaps choosing to test for antigens 
of the genospecies that cause neuroborreliosis (as shown chapter 7) - B. garinii and B. 
bavariensis - could increase the specificity and sensitivity to certain extend. The sensitivity 
for diagnosis early in the course of the disease, (the erythema migrans stage) is low with 
only ~50% [480]. As shown in this thesis, the different B. burgdorferi s. l. genospecies can 
be considered as separate pathogens, with each their own enzootic cycle and disease 
manifestation in humans, therefore perhaps choosing to specifically test for the genospecies 
involved with the different clinical manifestations might show to be more fitting. Antigens 
could be an array of proteins that are reactive in different stages of the infection. Preferably, 
one multiplex serological test would be developed so all the different tick borne pathogens 
can be tested for at once, as has proven to be valuable with other pathogens like flaviviruses, 
coronaviruses and influenza [481-484]. 
7. Concluding remarks
Many clinicians have limited awareness of and experience in recognizing or managing 
tick-borne pathogens other than Lyme borreliosis, let alone co-infections of different tick-
borne pathogens. When patients report tick bites, clinicians should consider additional 
laboratory testing or differential diagnoses for patients that display an intense or persistent 
array of aspecific, viral-like symptoms, especially fever, chills, and headache with or without 
signs of Lyme borreliosis [155]. Medical professionals should therefore be aware of and 
consider the likelihood of infection with tick-borne pathogens other than Lyme spirochete 
and co-infections with different tick-borne pathogens when pursuing laboratory testing or 
selecting therapy for patients with tick-borne diseases [155], especially since protozoan and 
viral infections are nonresponsive to antibiotics. Furthermore, infections with pathogens 
like A. phagocytophilum and other intracellular bacteria - like Candidatus Neoehrlichia 
mikurensis and Rickettsia - should be considered when (suspected) Lyme borreliosis 
patients fail to respond to β-lactam antimicrobial therapy (like amoxicillin) [155]. Ampicillin, 
ceftriaxone, and amikacin have shown to be not active when tested in vitro on different 
A. phagocytophilum strains [485]. These compounds are also ineffective in treatment of 
infections caused by a range of obligatory intracellular pathogens, including rickettsioses, 
Q fever (caused by Coxiella burnetii), and ehrlichioses [486]. Most diagnostic tests currently 
available are not specific to European (strains of) tick-borne pathogens. Furthermore, 
some tick-borne pathogens have not yet been cultivated in the laboratory - like Candidatus 
Neoehrlichia mikurensis - therefore serological assays like whole-cell IFA and ELISA tests are 
not yet available. Taking all together, more specific laboratory tests need to be developed so 
that estimates of the infection/disease incidence and disease burden of tick-borne diseases 
can be made in different population categories, and clinicians can be supported in selecting 
appropriate therapy. Ideally, we would go towards one multiplex molecular test and one 
multiplex serological protein test where all relevant tick borne pathogens can be tested for 
at once.
The control of tick-borne diseases requires a multidisciplinary and interdisciplinary approach. 
This means that different approaches are required to gain greater insight into the drivers at 
play in vector-, and disease dynamics. Clinical studies are needed to gain a better picture 
of the clinical spectrum of these often newly emerging or re-emerging pathogens, and to 
understand to what extent they affect the diagnoses and the etiology of Lyme borreliosis. 
Especially in Europe, large-scale or systematic surveys of infection with tick-borne pathogens 
are lacking. The prospective, clinical study the LymeProspect study and other future studies 
might help provide some insights into the subject of infection, symptoms and disease. To 
assess the occurrence and burden of other tick-borne diseases, future studies should also 
assess patients suffering from fever following a tick bite. To allow this, improved laboratory 
diagnostic tools are needed, and strict case definitions for each individual tick-borne 
disease would be helpful to measure the (medical) impact. Furthermore, surveillance and 
epidemiological studies for newly emerging or re-emerging pathogens should be integrated 
with ecological and biological driving factors since, especially since we have shown that 
this umbrella approach is successful in this thesis. Such an integrative approach will allow 
the relative public health and animal health burden of each pathogen to be assessed 
appropriately. If the upward trend of Lyme borreliosis is a good predictor for all tick-borne 
diseases, it is quite possible that we have in fact witnessed the beginning of what might be 
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In de meeste Europese landen is er de afgelopen decennia een duidelijke toename in de 
incidentie van de ziekte van Lyme en tekenencefalitis waargenomen. Ook in Nederland zien 
we zowel een aanhoudende toename van consulten voor tekenbeten bij de huisarts als een 
toename in erythema migrans, het eerste stadium van de ziekte van Lyme. De ziektelast 
veroorzaakt door de ziekte van Lyme of Lyme gerelateerde verschijnselen is aanzienlijk, in 
het bijzonder door patiënten met langdurig aanhoudende Lyme-gerelateerde symptomen. 
Lyme-borreliosis heeft een breed scala aan klinische manifestaties. De meest voorkomende 
en eerste manifestatie is een groeiende rode ring op de plaats van de tekenbeet (erythema 
migrans). Wanneer deze rode ring niet adequaat wordt behandeld kan dit in sommige 
gevallen resulteren in gedissemineerde ziekte. De infectie verspreidt zich dan verder en 
beïnvloedt het zenuwstelsel, gewrichten en huid van een patiënt, en, in zeldzame gevallen, 
het hart of de ogen. De pathogenen, of ook wel ziekteverwekkers genoemd, van de ziekte 
van Lyme zijn spiraalvormige bacteriën die behoren tot de Borrelia burgdorferi sensu lato 
(s. l.) complex. Deze bacteriën worden overgedragen door de schapenteek, Ixodes ricinus, 
en worden in stand gehouden in enzoötische cycli met verschillende vertebraten gastheren. 
Doordat deze tekensoort geen specifieke voorkeur voor een gastheer heeft, bijt het allerlei 
soorten gastheren om zich te kunnen voeden inclusief mensen.
Behalve de Borrelia burgdorferi s. l. genospecies, kan deze tekensoort een heel scala aan 
pathogenen overdragen inclusief virussen, bacteriën en parasieten. In Nederland gaat het 
dan vooral om Borrelia miyamotoi, Anaplasma phagocytophilum, Candidatus Neoehrlichia 
mikurensis, Rickettsia helvetica, Rickettsia monacensis, verschillende Babesia soorten, en 
tekenencefalitis virus. In 2009 was het geschatte aantal tekenbeten in Nederland 1,1 miljoen. 
Toch worden ondanks de hoge blootstelling via tekenbeten, infecties, laat staan ziektes, met 
deze pathogenen zelden gediagnosticeerd. De gepresenteerde resultaten in dit proefschrift 
geven inzicht in aanwezigheid van tekenoverdraagbare pathogenen en hun risico voor de 
volksgezondheid. Verder kunnen deze bevindingen worden gebruikt voor risico analyses op 
het gebied van tekenoverdraagbare ziekten ten behoeve van de besluitvorming binnen het 
volksgezondheidsbeleid.
In deel I van dit proefschrift worden de verschillende tekenoverdraagbare pathogenen in 
Nederland bestudeerd en uiteenlopende kennishiaten met betrekking tot hun enzoötische 
cycli ingevuld. In hoofdstuk 2 berekenden we de prevalentie van de verschillende 
tekenoverdraagbare pathogenen in gastheerzoekende teken, en onderzoeken of deze 
pathogenen enzoötische cycli delen. We bestudeerden patronen van co-infectie, ruimtelijke 
en seizoensgebonden dynamiek van infectiegraden in zoekende Ixodes ricinus nimfen.
De infectiegraden van teken waren het hoogst voor Rickettsia helvetica (31.1%) en Borrelia 
burgdorferi s. l. (11.8%) en veel lager voor Candidatus Neoehrlichia mikurensis (5.6%), 
Anaplasma phagocytophilum (0.8%), en Babesia species (1.7%). De infectiegraad van teken 
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varieerde niet alleen tussen pathogenen, maar ook tussen de bestudeerde gebieden van 
0 tot 64%. Rickettsia helvetica en Borrelia burgdorferi s. l. werden ook in alle onderzochte 
gebieden gedetecteerd, terwijl de anderen in de meeste (maar niet alle) gebieden werden 
gedetecteerd. De dichtheid van gastheerzoekende teken varieerde tussen de 1 tot 179/100 
m2. Algeheel genomen was 37% van de teken geïnfecteerd met tenminste 1 pathogeen 
en 6,3% met meer dan 1 pathogeen. Eén-derde (1/3) van de Borrelia burgdorferi s. l. 
positieve teken was geïnfecteerd met ten minste één ander pathogeen. Co-infectie van 
Borrelia afzelii met Candidatus Neoehrlichia mikurensis en met Babesia soorten kwamen 
significant vaker voor dan verwacht op basis van kans, wat impliceert dat deze pathogenen 
reservoirgastheren delen. Het omgekeerd was het geval voor co-infecties van Rickettsia 
helvetica met ofwel Borrelia afzelii of Candidatus Neoehrlichia mikurensis, die significant 
minder frequent voorkwamen dan verwacht.
In hoofdstuk 3 hebben we ons gericht op de infectiegraad van Candidatus Neoehrlichia 
mikurensis in verschillende tekensoorten in Europa. Door het testen van teken met behulp 
van een zelf ontwikkelde real-time PCR-test, toonden we aan dat Candidatus Neoehrlichia 
mikurensis aanwezig is in Ixodes ricinus teken door heel Nederland, België en andere 
Europese landen, maar dat dit pathogeen onder verschillende namen beschreven is in de 
internationaal gepubliceerde artikelen. Daarnaast hebben we dit opkomende pathogeen 
moleculair gekarakteriseerd door gebruik te maken van groEL, 16S rRNA en gltA als 
moleculaire markers. Wij stellen vast dat verschillende kleine zoogdieren reservoirgastheren 
zijn van dit pathogeen. Onze gegevens laten ook zien dat mensen regelmatig worden 
blootgesteld aan Candidatus Neoehrlichia mikurensis via tekenbeten.
In hoofdstuk 4 laten we zien dat Anaplasma phagocytophilum ten minste vier verschillende 
enzoötische cycli (ecotypes) heeft, en dat het groEL gen een geschikte moleculaire marker 
is om deze verschillende ecotypes te identificeren. Alle humane infecties clusteren in maar 
één van deze ecotypen (ecotype I), wat suggereert dat slechts één van deze ecotypen 
zoönotische is. Verder laten we ook zien dat dit zoönotische ecotype de grootste scala 
aan gastheren heeft. Door de significante populatie-expansie - zoals blijkt uit moleculaire 
markers - van het zoönotische Anaplasma phagocytophilum ecotype neemt het risico voor 
mensen en dieren toe.
In hoofdstuk 5, hebben we in reeën-serum neutraliserende antilichamen tegen 
tekenencefalitis virus (TBEV) gemeten. Vervolgens hebben we, met behulp van moleculaire 
methoden, TBEV in gastheerzoekende teken uit één gebied aangetoond. Hierdoor hebben 
we voor het eerst aangetoond dat TBEV endemisch is in Nederland. 
In hoofdstuk 6 onderzochten we de rol van de Europese egel - één van de meest voorkomende 
dieren in het stadse omgeving- in het onderhouden van een aantal tekenoverdraagbare 
pathogenen in de enzoötische cycli in (sub-)stedelijke gebieden. We concluderen dat egels, 
en hun teken bijdragen aan de overdracht en verspreiding van Borrelia bavariensis, Borrelia 
spielmanii, Borrelia afzelii, Anaplasma phagocytophilum en Rickettsia helvetica in deze 
gebieden. 
In deel II wilden we deze bevindingen met betrekking tot de ecologie van tekenoverdraagbare 
pathogenen vertalen naar blootstelling, infectie en ziekte bij mensen. Hiervoor was het 
belangrijk dat er onderscheid gemaakt wordt tussen de Lyme-bacteriën welke alleen 
lokale huidinfecties veroorzaken en de bacteriën welke gedissemineerde infecties kunnen 
veroorzaken. Daarnaast is het essentieel dat de vertebraten gastheren van medisch 
belangrijke spirocheten geïdentificeerd werden. In hoofdstuk 7 hebben we aan de hand 
van i) isolaten van Lyme-borreliosis gevallen met verschillende klinische verschijnselen 
(erythema migrans, Lyme neuroborreliosis, acrodermatitis chronica atrophicans, en Lyme 
artritis) en ii) isolaten uit Ixodes ricinus teken die aangehecht waren aan knaagdieren, vogels 
en egels, verschillende spirocheten genospecies kunnen koppelen aan specifieke klinische 
verschijnselen van Lyme-borreliosis en aan specifieke gastheren. 
Alle isolaten zijn eerst getypeerd op niveau van genospecies door het sequensen van een 
gedeelte van de ‘intergenic spacer’ regio. Een meer diepgaande moleculaire typering 
is uitgevoerd door het sequensen en analyseren van acht extra loci met verschillende 
eigenschappen. 
Hiermee hebben we aangetoond dat Borrelia afzelii de meest voorkomende soort is in 
acrodermatitis patiënten en in teken aangehecht aan knaagdieren. Borrelia burgdorferi 
sensu stricto is wijdverspreid gevonden in erythema migrans patiënten. Borrelia bavariensis 
is wijdverspreid gevonden in Lyme neuroborreliosis patiënten en in teken van egels, maar 
zeldzaam in erythema migrans patiënten. Borrelia garinii was de dominante genospecies in 
teken van vogels. Specifieke genotypen afkomstig van teken die op egels voedden waren 
oververtegenwoordigd in erythema migrans en acrodermatitis patiënten, terwijl genotypen 
afkomstig van teken die op vogels voedden waren oververtegenwoordigd in Lyme 
neuroborreliosis patiënten. Kortom, de analyse van onze datasets ondersteunt het bestaan 
van ‘spilover’ van ten minste drie verschillende enzoötische cycli van genospecies die ten 
grondslag liggen van de verschillende klinische manifestaties van Lyme-borreliosis: 1) teken 
van egels en Lyme neuroborreliosis patiënten, 2) teken van vogels en Lyme neuroborreliosis 
patiënten, en 3) teken van knaagdieren en egels en acrodermatitis chronica atrophicans 
patiënten.
In hoofdstuk 8 zijn we op zoek gegaan naar bewijs van de blootstelling van mensen aan, 
en infectie met tekenoverdraagbare pathogenen. Daarom testten we zowel teken, die 
gevoed hebben op mensen, als het bloed van mensen uit een cohortstudie van mensen 
met tekenbeten en erythema migrans, op de aanwezigheid van een heel scala van 
pathogenen (Borrelia burgdorferi s. l., Borrelia miyamotoi, Anaplasma phagocytophilum, 
230  
NEDERLANDSE SAMENVATTING  NEDERLANDSE SAMENVATTING
 231
Candidatus Neoehrlichia mikurensis, ‘spotted fever’ Rickettsia’s, tekenencefalitis virus 
en Babesia genospecies). De helft (53%) van de op mensen gevoede teken testte positief 
voor Borrelia burgdorferi s. l., Anaplasma phagocytophilum, Candidatus Neoehrlichia 
mikurensis, Rickettsia helvetica, Rickettsia monacensis, Borrelia miyamotoi en verschillende 
Babesia soorten. Drieëndertig procent (33%) van de Borrelia burgdorferi s. l. positieve 
teken droeg ook nog één ander pathogeen van een ander genus met zich mee. Op basis 
van moleculaire detectietechnieken is de kans op infectie met een teken overdraagbare 
pathogenen (Lyme spirocheten uitgesloten) na een tekenbeet ongeveer 2,4% in Nederland. 
Evenzo bij Lyme patiënten met erythema migrans is de waarschijnlijkheid van co-infectie 
met een ander teken pathogeen ongeveer 2,7%. Uit deze gegevens blijkt dat de blootstelling 
aan tekenoverdraagbare pathogenen en infectie met andere dan Borrelia burgdorferi s. l. 
ziekteverwekkers en co-infecties vaker voorkomen dan voorheen aangenomen. Dit gegeven 
verdient daarom verder onderzocht te worden: Vervolg onderzoek moet laten zien hoe vaak 
infecties met deze ziekteverwekkers, al dan niet als co-infectie met Lyme-bacteriën, ziekte 
veroorzaken.
In hoofdstuk 9 onderzochten we een voor Nederland nieuw tekenoverdraagbare pathogeen, 
namelijk de ‘relapsing fever’ spirocheet Borrelia miyamotoi. We hebben dit pathogeen 
in verschillende organen van knaagdieren aangetoond wat duid op systemische infecties. 
Daarnaast hebben we laten zien dat vogels ook besmet kunnen worden met dit pathogeen. 
Bovendien hebben we aangetoond dat er een significante associatie is tussen Borrelia 
burgdorferi s. l. en Borrelia miyamotoi in co-infecties van nimfen. Dit impliceert dat deze 
twee pathogenen gezamenlijke reservoirgastheren hebben. 
Het frequent voorkomen van co-infecties van deze twee pathogenen heeft onze interesse 
gewekt of erythema migrans-achtige huidklachten bij van Lyme verdachte patiënten 
misschien zijn te wijten aan een co-infectie met Borrelia miyamotoi. Wij hebben echter geen 
bewijs kunnen vinden voor een Borrelia miyamotoi infectie bij het testen van huidbiopten 
van Lyme-borreliosis verdachte patiënten, deze bevinding suggereert dat Borrelia miyamotoi 
niet geassocieerd is met Lyme borreliosis-geassocieerde huid manifestaties. En dat patiënten 
met Borrelia miyamotoi infectie - gekenmerkt door koorts, malaise en myalgie - met een 
huidletsel gelijktijdig geïnfecteerd zijn met Borrelia burgdorferi s. l ..
Op basis van de infectiegraad van Borrelia miyamotoi (2 tot 5%)in Ixodes ricinus teken 
in Nederland ontstond de vraag hoe vaak dat verschillende bevolkingsgroepen worden 
blootgesteld aan dit pathogeen? Daarom hebben we in hoofdstuk 10 de blootstelling van 
verschillende risicogroepen aan Borrelia miyamotoi serologisch getest. Hiervoor ontwikkelde 
we Luminex test gebaseerd op een fragment van Borrelia miyamotoi glycerophosphodiester 
fosfodiesterase (GlpQ) als antigeen. Onder de aanname dat een IgG antilichaamreactie 
tegen antigenen een (doorstaande) infectie weerspiegelt hebben we aan de hand van een 
sero-prevalentie studie de blootstelling aan verschillende risicogroepen onderzocht. Sera 
van negen van de tien PCR bevestigde Borrelia miyamotoi patiënten uit Rusland werden 
positief met het gebruikte recombinante antigeen. Er werd geen significante kruisreactiviteit 
waargenomen bij de controle groep (secundaire syfilis patiënten). De seroprevalentie in 
bloeddonoren was 2,0% (95% CI 0,4-5,7%). De seroprevalentie van antilichamen tegen het 
gebruikte antigeen was verhoogd in 5,6% (3,0-9,2%) van de erythema migrans patiënten 
en in 7,4% (2,0-17,9%) van de individuen met serologisch bevestigde en in 8,6% (1,8-23%) 
van de onbevestigde Lyme neuroborreliosis. Echter waren deze waarden niet significant 
in vergelijking tot het percentage van seropositieve bloeddonoren. De prevalentie van 
anti-Borrelia miyamotoi antilichamen onder Nederlandse boswachters was 10% (5,3-
16,8%) en onder patiënten met serologisch onbevestigde maar vermoed van humane 
Anaplasmosis 14,6% (9,0-21,8%). Deze waarden zijn significant hoger bevonden dan die 
van bloeddonoren. Onze bevindingen wijzen erop dat infecties met Borrelia miyamotoi 
optreden bij personen die in Nederlands aan teken zijn blootgesteld. Borrelia miyamotoi 
infecties kunnen waarschijnlijk ook een rol spelen bij patiënten met een tekenbeet en koorts 
met onopgeloste etiologie in andere landen waar Ixodes ricinus teken endemisch zijn.
In het bovenstaande onderzoek hebben we laten zien dat in Nederland het risico van 
blootstelling en infectie met een tekenoverdraagbare pathogeen aanzienlijk is. Ten eerste 
hebben we laten zien dat meer dan één-derde van gastheerzoekende teken en meer dan de 
helft van teken die op mensen voeden  één of meerdere van de geteste tekenoverdraagbare 
pathogenen bij zich dragen. Bovendien hebben we laten zien dat mensen inderdaad 
worden geïnfecteerd met een groot scala van deze pathogenen. Het is heel goed mogelijk 
dat in de kliniek verschillende infecties met tekenoverdraagbare pathogenen niet goed 
onderscheiden worden en allen onder de grotere noemer van Lyme-borreliosis geschaard 
worden, simpelweg omdat de meeste van deze ziekteverwekkers vaak niet-specifieke 
symptomen vertonen.
Veel artsen hebben beperkte kennis van en ervaring in het herkennen en behandelen van 
tekenoverdraagbare infecties anders dan Lyme-borreliosis, laat staan van co-infecties met 
verschillende pathogenen. Clinici moeten, wanneer patiënten zich melden met tekenbeten, 
rekening houden met deze andere infecties in hun differentiaal diagnose. Ze zouden extra 
laboratoriumonderzoek kunnen aanvragen vooral voor patiënten met een intense of 
aanhoudende reeks van aspecifieke symptomen, in het bijzonder koorts, koude rillingen, 
malaise, myalgie en hoofdpijn met of zonder tekenen van Lyme borreliosis. Hierbij is het 
belangrijk te onderkennen dat antibiotica bij protozoïsche en virale infecties niet effectief 
zijn. Bovendien, infecties met intracellulaire bacteriën - zoals Anaplasma phagocytophilum, 
Candidatus Neoehrlichia mikurensis en Rickettsia’s - moet worden overwogen bij 
(vermeende) Lyme patiënten die niet reageren op β-lactam antimicrobiële therapie (zoals 
amoxicilline). 
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De meeste diagnostische tests, die momenteel beschikbaar zijn, zijn niet specifiek voor 
de Europese stammen van tekenoverdraagbare pathogenen. Verder zijn voor sommige 
tekenoverdraagbare pathogenen serologische tests als ‘whole cell’ IFA en ELISA ook niet 
beschikbaar omdat deze pathogenen nog niet gekweekt kunnen worden in het laboratorium. 
Investeringen in het ontwikkelen van specifieke laboratoriumtests zijn essentieel voor 
schattingen van de infectie/ziekte-incidentie en ziektelast van tekenoverdraagbare 
pathogenen kunnen worden gemaakt in verschillende bevolkingsgroepen, en zodat clinici 
kunnen worden ondersteund in het selecteren van de juiste therapie. De komst van één 
moleculaire multiplex test en één serologische proteïne multiplex test waarbij alle relevante 
teken overdraagbare ziekteverwekkers in één keer kunnen worden getest zou ideaal zijn.
Een multi-causaal probleem als door tekenoverdraagbare infecties vereist een 
multidisciplinaire en interdisciplinaire benadering. Dit betekent dat verschillende 
benaderingen nodig zijn om meer inzicht te krijgen in de drijvende krachten die een rol 
spelen in vector- en ziektedynamiek. Er zijn klinische studies nodig om een beter beeld 
te krijgen van het klinische spectrum van deze infecties, en om te begrijpen in welke 
mate ze invloed hebben op de diagnoses en de etiologie van Lyme-borreliosis. Vooral 
in Europa ontbreken er grootschalige of systematische onderzoeken van infecties met 
tekenoverdraagbare pathogenen. De prospectieve, klinische studie de LymeProspect en 
andere studies kunnen helpen om inzicht te krijgen in de infectie, symptomen en ziekte. 
Deze studies zouden dan vooral de patiënten die lijden aan koorts na een tekenbeet verder 
moeten vervolgen. Hiervoor zijn verbeterd diagnostische laboratorium testen en strikte 
case definities noodzakelijk. Bovendien moeten surveillance en epidemiologische studies 
betreffende deze pathogenen worden geïntegreerd met ecologische en biologische studies. 
We hebben in dit proefschrift laten zien dat deze aanpak succesvol is. Bij een dergelijke 
integrale aanpak zal de relatieve ziektelast binnen volksgezondheid en/of diergezondheid 
van elk pathogeen op passende wijze kunnen worden beoordeeld. De opwaartse trend van 
de Lyme-borreliosis is een goede indicator voor wat ons in de toekomst staat te wachten 
voor de andere tekenoverdraagbare ziekten. 
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sweet and caring Mamman, thank you so much for everything you have done for me. You 
have supported me every step of the way. I have always admired your strength and positivity, 
as a single mom in a foreign country you have truly given your all for the sake of us three. I 
would not be where I am today, if it was not for you. Doostat daram! 
Shahin, love of my life, I want to thank you for your unconditional love. You have pushed me 
when I needed it, and pulled me back when I was going too fast and you have done it all with 
great patience and care. We shared it all together; the laughter and the tears, I cannot wait 
to share the rest of it with you. I am a better version of myself because of you; and with you 
on my side, I know I can do anything!      
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